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U n i v e r s i t y  I [l i b r a r y :
Abstract
Adipocytes secrete a range o f proteins, called adipokines, with important roles in a variety 
o f biological processes such as metabolism, cardiovascular function and immunity. 
ACRP30 (also known as adiponectin) is an adipokine that displays anti-diabetic and anti­
inflammatory properties and may prevent atherosclerosis. It is secreted exclusively by 
adipocytes and circulating levels of ACRP30 are reduced in obesity and diabetes. Although 
this protein has been widely studied, little is known about the mechanisms o f secretion of 
ACRP30 in adipocytes.
Here I have examined secretion of ACRP30 in 3T3-L1 adipocytes with the aim of 
understanding the secretory pathways used by ACRP30 as it traffics to the cell surface. 
Using intracellular localisation techniques I have shown that ACRP30 overlaps with 
transferrin-receptor positive membranes, evidence that ACRP30 traffics via the transfernn- 
receptor positive endosomal system. This was supported by results showing that ablation 
o f the transfeiTin-receptor positive endosomes strongly inhibited ACRP30 secretion. I have 
also investigated the effects o f overexpressing mutant foims of the small GTPases Rabl 1 
and Arf6. Overexpression of Rabl 1 S25N significantly reduced basal and insulin- 
stimulated ACRP30 secretion and I have demonstrated that Arf6 plays a role in ACRP30 
secretion.
With the aim of identifying new adipokines, I have conducted a proteomic analysis o f the 
proteins secreted by 3T3-L1 adipocytes. In this study, I identified 25 proteins that had not 
previously been identified as adipocyte-secreted. In functional studies, two of these 
proteins, orosomucoid and Nm23 could be shown to affect insulin-stimulated glucose 
uptake. In monocyte adhesion assays orosomucoid had anti-inflammatory effects.
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Chapterl General introduction
1.1 Adipose tissue and Adipokines
Adipose tissue is found in mammals and has long been known as the main energy reserve 
in the body. Energy is stored in the form o f triglycerides in adipocytes, ready to be used 
when caloric expenditure exceeds intake. Adipose tissue is composed of several different 
cell types. As well as adipocytes, adipose tissue contains adipose tissue matrix and a 
stromal vascular fraction (SVF) that comprises pre-adipocytes, endothelial cells and 
macrophages. Adipose tissue takes the form of loose connective tissue, and is found in 
mammals, fish, birds, reptiles and amphibians. In mammals, fat is found in distinct 
locations in the body and serves different functions in these different locations. Some 
depots of fat have a structural or protective role, like the fat pads found in hands, feet, 
joints and around the eyes. Subcutaneous fat is the layer o f fat found just underneath the 
skin. Visceral fat is a depot found suiTounding the internal organs and is the main fat depot 
associated with the development o f type2 diabetes and cardiovascular disease (Kissebah 
and Ki'akower, 1994).
Energy is stored in adipocytes in the form o f triglycerides, which are broken down to fatty 
acids and glycerol by lipases (lipolysis) (Coppack et ah, 1994). Most o f this stored energy 
comes from ingested triglycerides, but a small amount of fatty acids are synthesised in the 
liver and adipocytes. When other cells in the body require energy, triglycerides stored in 
adipocytes are broken down by the action o f lipases within adipocytes. Fatty acids can then 
be released and used as a fuel by other cells. Fatty acids circulate as free fatty acids (FFA), 
bound to albumin and are taken up, by specific transporter proteins in muscle and liver, 
and oxidised, to provide ATP, or taken up again by adipocytes for storage as triglycerides 
(Large et ah, 1998).
Recently it has been recognised that as well as their role in energy storage, adipocytes 
regulate many diverse processes through their secretion o f a range o f endocrine and 
paracrine signalling molecules called adipokines. These adipokines have a role in 
regulating energy metabolism, insulin sensitivity in the liver and skeletal muscle (Abel et 
ah, 2001), and many other biological processes such as angiogenesis, blood-presssure, 
bone formation, inflammation and the acute-phase response. Whilst the term ‘adipokines’ 
has been used to describe proteins secreted by adipose tissue, it is generally accepted that it 
refers to those proteins secreted by adipocytes (Trayhum and Wood, 2004). Since the
3discovery that adipocytes were a site o f secretion of sex-homiones in 1987 (Siiteri, 1987), 
many more adipokines have been identified, notably adipsin, leptin and TNF-a.
Adipsin was found to be secreted by murine adipocytes but down regulated in some types 
o f obesity (Flier et a l, 1989). Leptin was identified as an important regulator of 
metabolism (Friedman and Halaas, 1998) and TN F-a was the first inflammatory cytokine 
found to be secreted by adipocytes (Hotamisligil et al., 1995). Several adipokines are pro- 
inflammatory cytokines such as TNF-a, IL-6, angiotensinogen which promote endothelial 
dysflinction, through increases in endothelial adhesion, platelet activation and eventual 
plaque fonnation, leading ultimately to cardiovascular disease (Lau et ah, 2005) and others 
like adiponectin, resistin and RBP 4 (Yang et al., 2005) have been identified as adipokines 
implicated in contributing to the development of insulin resistance. Adipocytes also secrete 
acute-phase proteins like C reactive protein (Calabro et al., 2005) and the complement 
factors adipsin (Cook et al., 1987) and ASP (Maslowska et al., 1997).
Because these fat-secreted proteins have metabolic effects on other cells and tissues, they 
have the potential to explain the links between obesity and metabolic diseases, there is a 
gi'eat deal of interest in their biology and physiological actions. Below is a summary of 
what is known of the biology and actions o f the better-studied adipokines, and the role they 
might play in obesity and its associated diseases.
1.1.1 A diponectin
Adiponectin, also called ACRP30, was first described as 30 kDa protein secreted 
exclusively by adipocytes whose mRNA was induced 100-fold during adipocyte 
differentiation (Scherer et a l, 1995). It is thought to be the most abundantly secreted 
adipokine and circulates in normal semm at a concenti'ation o f between 5 and 30pg/mL. 
Unlike many other adipokines, serum concentration decreases with the progi'ession o f 
obesity, cardiovascular disease and insulin resistance (Arita et a l , 1999; Hotta et a l , 2000). 
Treatment o f insulin resistant humans and mice with the insulin sensitising dmg 
thiazolidinedione (TZD), results in increased circulating adiponectin levels (Combs et a l,
2002)
Adiponectin consists o f an amino terminal signal sequence, a collagenous domain and a C- 
terminal globular domain (Shapiro and Scherer, 1998). The C-terminal globular head
4domain o f adiponectin shares structural homology with complement C 1 q and the globular 
domain o f several collagens. The crystal structure o f adiponectin shares structural 
homology with TNF-a, although they share no sequence homology. In its most basic 
form, adiponectin is found as a trimer o f three 30kDa monomers. These trimers 
multimerise further, through disulphide bonds in the collagenous region, to fonn higher 
molecular weight structures (Figure 1.1). The protein circulates in serum as a hexamer of 
low molecular weight and a larger high molecular weight structure of 12-18 subunits 
(Pajvani et al., 2003). Findings from structure-function studies show that the trimeric form 
o f  the protein possesses greater bioactivity, suggesting that the higher molecular weight 
forms may be precursors awaiting proteolytic cleavage to the active trimeric form. Berg et 
al (Berg et al., 2001; Pajvani et al., 2003) demonstrated that full length recombinant 
adiponectin decreased semm glucose by decreasing hepatic glucose output when 
administered to normal and obese/diabetic mice. This action on the liver is dependent on 
the presence o f the collagenous domain and is therefore, only seen with the full-length 
protein. Administration o f the proteolytically cleaved globular head increases fatty acid 
oxidation and glucose uptake in muscle cells in vitro (Fruebis et al., 2001), an effect which 
is mediated by the activation o f AMPK (Yamauchi et al., 2002). There is evidence that 
adiponectin is necessary for the anti-diabetic actions o f the PPAR-binding dmgs called 
TZDs (Thiazolidinediones). TZDs have been shown to raise semm levels of adiponectin 
and increase insulin sensitivity. Adiponectin has also been shown to have potential 
antiatherogenic properties, binding to collagen in the subendothelium of damaged vascular 
tissue (Okamoto et al., 2000) and suppressing monocyte adhesion to endothelial cells by 
inhibiting the expression of the adhesion molecules intracellular adhesion molecule-1, 
vascular cellular adhesion molecule-1 and E-selectin. This action of adiponectin may be 
via suppression of NF-kB, since adiponectin has been shown to inhibit activation o f NF- 
kB by the inflammatory mediator TNF-a, by inhibiting phosphorlation of I-KB-a (Ouchi et 
a l, 2000).
There is evidence that adiponectin is necessary for the anti-diabetic actions of the dmgs 
called TZDs (Thiazolidinediones). TZDs have been shown to raise serum levels of 
adiponectin
Adiponectin acts by binding to one of two receptors AdipoRl, which is expressed in 
skeletal muscle and AdipoR2, which is predominantly expressed in liver (Yamauchi et a l,
2003). Adiponectin binding to the receptor leads to the interaction o f the adaptor protein 
APPLl (Mao et a l , 2006). AdipoRl and AdipoR2 are seven transmembrane domain
5proteins and unlike G protein-coupled receptors their N~terminus is internal and the C- 
tenninus is external. Expression o f Adiporl or Adipor2 in liver can reverse insulin 
resistance and diabetes in db/db (leptin receptor null) mice. Expression studies have also 
shown that AdipoRl is closely associated to activation of AMPK pathways, regulating the 
inhibition o f gluconeogenesis, whilst activation o f AdipoR2 is more associated with 
activation o f PPAR-a pathways, and thus inhibition of inlammation and oxidative stress 
(Yamauchi et ah, 2007). The plant homologue o f the adiponectin receptor, PH036, is also 
a seven transmembrane domain protein and binds a membrane protein osmotin, that 
regulates phosphate and lipid metabolism (Narasimhan et ah, 2005), although the two 
proteins share no homlogy.
The glycosylphosphatidylinositol-anchored protein T-Cadherin has also been identified as 
a receptor for hexameric and high molecular weight forms o f adiponectin (Hug et ah,
2004).
There is an aparent link between Adiponectin levels and insulin resistance. Plasma levels 
od adiponectin are reduced in obese db/db mice (leptin receptor- deficient mose model for 
obesity) (Hu et ah, 1996) and decreased in patients with cardiovascular disease (Hotta et 
ah, 2000), and the metabolic syndrome (Tmjillo and Scherer, 2005), all states which are 
associated with insulin resistance. It is not known whether this link is causitive, although 
the insulin sensitising effects o f adiponectin have been demonstrated by several groups. 
Fmebis et al have shown that the globular 30kDa adiponectin, when administered to mice 
on a high fat diet, resulted in weight loss and a decrease in plasma free fatty acids (Fruebis 
et ah, 2001). Yamauchi et al showed that by administering physiological doses o f 
adiponectin to lipoatrphic/diabetic mice they could ameliorate the state of insulin 
resistance (Yamauchi et ah, 2001). Berg et al shsowed that administration of adiponectin to 
both wild type and ob/ob (a mouse model for Type 2 diabetes) increased hepatic insulin 
action and a suppression o f glucose production (Berg et ah, 2001). These three independent 
studies all provide evidence that a decrease in adiponectin in the obese/diabetic state may 
be causal in the development of insulin resistance.
Reduced levels of circulating adiponectin have been observed in obesity, insulin resistance 
and type 2 diabetes amongst human populations (Hotta et ah, 2000; Trujillo and Scherer,
2005) and also in cardiovascular disease (Kojima et ah, 2003; Kumada et ah, 2003). A 
recent study o f the relationship between adiponectin levels and cardiovascular disease, 
based on data from the Strong Heart Study, the largest study of cardiovascular disease in 
American Indians. This group are a high-risk group for obesity, insulin resistance, type 2
6diabetes and cardiovascular disease. Increased serum levels o f adiponectin were not found 
to predict cardiovascular disease in this gioup (Lindsay et ah, 2005). Differences in results 
fonn these various studies may be indicative o f differences in the populations studied.
1.1.2 Adipsin
Adipsin is a serine protease that is secreted by adipocytes and macrophages and whose 
serum levels are reduced in mouse models o f obesity (Cook et al., 1987), Also known as 
complement factor D. Adipsin is constitutively secreted (Millar et al., 2000) and is a 
component of the alternative complement pathway, cleaving C3-bound factorB (White et 
al., 1992), therefore Adipsin/FactorD is a protein of the immune system, that is also highly 
expressed in adipose tissue.
1.1.3 Acylation stim ulating protein
ASP or C3a-des Arg ASP is generated through the interaction o f precursor C3, cofactor B, 
and the serine protease enzyme, adipsin, all three o f which are secreted by adipocytes. ASP 
stimulates triglyceide synthesis in adipocytes and its circulating levels are increased in 
obesity, diabetes (Koistinen et al., 2001) and coronary heart disease (Cianflone et al., 
1997).
1.1.4 Resistin
Resistin is the product o f the RETN  gene and belongs to a family o f cysteine-rich secreted 
proteins called the RELM family. Mouse resistin is a 114 amino acid polypeptide with a 
hydrophobic 20 amino acid N-tenninal signal sequence that is cleaved before secretion, 
Mouse resistin circulates as a homodimer of these 94 amino acid peptides linked by a 
disulphide bond.
Resistin was first identified as a protein secreted by murine adipocytes and circulating in 
mouse serum and whose serum levels are increased in obesity (Steppan et ah, 2001b). 
Secretion of resistin in 3T3-L1 adipocytes is up regulated by the induction of C/EBP-a but 
reduced by the induction of PPAR-y. This regulation of secretion is controlled via the PI3- 
kinase and MAP kinase pathways (Song et ah, 2002). Secretion o f resistin in stimulated by 
insulin (McTernan et ah, 2003) and down regulated by TN F-a (Fasshauer et ah, 2001). 
Called resistin (for resistance to insulin) and identical to the protein FIZZ3, it was found to 
be up regulated during adipocyte differentiation and down regulated in mature adipocytes
7treated with the anti-diabetic drug TZD and was thus identified as a potential link between 
obesity and diabetes (Steppan et al., 2001b). Increased levels o f circulating resistin were 
observed in obese mice. Treatment o f these mice with a PPAR-y agonist reduced 
circulating resistin levels and injection o f antibodies against resistin improved the insulin 
resistant state of the animals. Human fat cells do not produce resistin (Nagaev and Smith, 
2001), and although it is released by adipose tissue, probably by macrophages, is not 
thought to influence insulin sensitivity (Utzschneider et ah, 2005). There is evidence that 
resistin acts as a pro-inflammatory cytokine, up regulating lL-6 and TN F-a in arthritis 
(Bokarewa et al., 2005).
1.1.5 Leptïn
Leptin is the protein product of the ob gene (Zhang et a l , 1994). It plays a role in 
regulating energy intake and expenditure by controlling appetite and metabolism and as a 
signal o f sufficiency o f energy (Pittas et a l ,  2004). It is mainly produced in adipose tissue 
and is found circulating in plasma in levels that correlate with percentage body fat 
(Considine et a l, 1996). Circualtin levels o f Leptin decline with weight loss, where 
reduced leptin levels are associated with increased appetite and decreased energy 
expenditure. A state o f leptin resistance is observed in many cases of obesity, where high 
serum levels of leptin are ineffective in reducing appetite (Flier, 1998). Leptin resistance in 
obesity is thought to be mediated by S0CS3, a member of the SOCs family of proteins 
(suppressors of cytokine signalling) (Howard and Flier, 2006),
There are two widely studied mouse models that are homozygous for single-gene mutation, 
oh/ob mice are deficient for leptin protein and db/db mice are deficient for the leptin 
receptor. Both mouse models display obesity, insulin resistance, hyperglycaemia and 
hyperlipidemia. Intravenous injection o f leptin to ob/ob mice causes weight loss and 
reduces food intake and serum levels o f glucose and insulin (Pelleymounter et a l ,  1995).
Leptin secretion from adipocytes is increased by treatment with TNF-a and insulin 
although it is not known whether the insulin-dependent increase is caused by an increase in 
the rate o f constitutive secretion, or if  Leptin is stored inside the cell and transported to the 
cell surface in response to the insulin stimulus (Mora and Pessin, 2002), Leptin circulates 
bound to a soluble fomi of its receptor. This binds to a transmembrane receptor Ob-R, 
found in various tissues including adipocytes, liver and skeletal muscle and in the central 
neiwous system and are concentrated in an area of the hypothalamus called the arcuate 
nucleus that is known to be involved in regulating food intake (Tartaglia et a l, 1995), In
8skeletal muscle leptin acts by phosphorylating AMPK, both directly and through the 
central neiwous system. Leptin also inhibits the activity of acetyl CoA carboxylase (ACC), 
thus stimulating fatty-acid oxidation in muscle (Minokoshi et al., 2002). Cohen et al 
showed that leptin’s action in liver depends on down-regulation of stearoyl-CoA 
desaturase-1 (SCD-1), an enzyme that catalyses the biosynthesis o f fatty acids (Cohen et 
a l , 2002).
Leptin is also an important hormone, regulating various processes including immune 
function, hematopoiesis, bone development and angiogenesis (Margetic et a l , 2002). It 
plays a role in immune function, by affecting cytokine production, it affects endothelial 
cell growth and angiogenesis, accelerates wound healing and plays an important role in 
bone development. Leptin deficient ob/ob mice also display increased bone mass. This 
effect probably results from leptin’s influence on the sympathetic neiwous system (Cock 
and Auwerx, 2003).
1.1.6 Visfatin
Visfatin is a protein secreted by visceral fat, whose expression increases with the 
development of obesity. It is the same as pre-B-cell colony enhancing factor, a 52kD 
protein secreted by lyiuphocytes. Visfatin mimics the effects o f insulin in cultured cells 
and lowers plasma glucose levels in mice, and has been shown to bind to insulin receptors 
(Fukuhara et a l , 2005).
1.1.7 TNF-a
TNF-a is a pro-inflammatory cytokine that was first identified as a secreted factor that 
responsible for the necrosis of tumours (Carswell et a l , 1975). It is expressed as a 26kDa 
transmembrane precursor, which is cleaved to release the 17kDa polypeptide. Three o f 
these monomers associate to fonn a homotrimer shown in Figure 1.1. TNF-a binds to two 
cell surface receptors TNFRl and TNFR2 (Vandenabeele et a l ,  1995), and recruits several 
adaptor proteins that can induce signalling pathways leading either to apoptosis or to the 
activation of the NFkP and JNK transcription factors. Activation o f these factors induces 
cellular responses such as inflammation, differentiation and proliferation (Dempsey et a l,
2003). During activation o f the inflammatory response endothelial cells are an important 
target for the actions of TNF-a, including the induction o f adhesion of leukocyte adhesion 
molecules (Macconi et a l ,  1995) and the modulation of nitric oxide production (Yoshizumi 
et a l , 1993). TNF-a is secreted by macrophages, lymphocytes and adipocytes. In rodent
9models o f obesity there is evidence to suggest a positive coirelation between circulating 
TNF-a levels and obesity or insulin resistance (Hotamisligil et al., 1995), (Moller, 2000). 
Adipocytes express both TNFRl and TNFR2 and adipocyte derived TNF-a is thought to 
act mainly in an autocrine manner, increasing lipolysis and releasing FFAs into the 
circulation (Hotamisligil et a l, 1995), thus contributing to insulin resistance.
1.1.8 Retinol-binding protein 4
Retinol-binding protein 4 (RBP4) is an adipocyte-secreted member o f the lipocalin family 
and is associated with obesity and diabetes. Serum levels o f RBP4 are increased with 
insulin resistance. Adipose-specific Glut4 knockout mice show insulin resistance, not only 
in adipose, but also in muscle and liver. These mice also show elevation of adipose- 
secreted RBP4. Overexpression o f RBP4 increases insulin resistance in liver and muscle, 
and treatment with an insulin-sentising drug, also normalised RBP4 levels. Increased 
serum RBP4 induces expression o f the gluconeogenic liver enzyme phosphoenolpyruvate 
carboxykinase (PEPCK), which reduces insulin signalling and lowers glucose uptake by 
the liver, thus contributing to the disease-state of type 2 diabetes (Graham et a l , 2006).
The above experiments suggest that RBP4 is an important link between obesity and 
insulin-resistance, being seereted by fat tissue and having a regulatory effect on insulin 
sensitivity in other tissues. RBP4 is also a human adipokine, but its involvement in the link 
between obesity and disease has yet to be confinued in humans (Janke et a l , 2006). This 
recently discovered adipokine appears to be one o f the sought after links between obesity 
and insulin resistance.
1.1.9 C-reactive protein
C-reactive protein (CRP), an acute-phase reactant, is considered one of the best predictors 
of future cardiovascular disease. CRP comprises 5 23kDa subunits and is produced mainly 
in the liver in response to inflammatory cytokines (Hirschfield and Pepys, 2003), but is 
also produced by respiratory-tract epithelial cells (Gould and Weiser, 2001), coronary 
artery smooth muscle cells and when stimulated by certain cytokines, adipocytes. CRP has 
been found to co-localise with complement components in atherosclerotic plaques (Calabro 
et a l , 2005), and can activate the expression of cell-surface adhesion molecules in 
endothelial cells.
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1.1.10 Significance of Adipokines
It is clear that fat tissue is more complex than first thought and that it has a role to play in 
the development of several metabolic diseases. The adipokines listed above are all secreted 
by adipose tissue and play an important role in regulating cell growth and metabolism and 
altered levels o f secretion of these adipokines is often seen in insulin resistance and 
obesity. Circulating levels of the adipokines ACRP30 and leptin are thought to be crucial 
regulators in the development of insulin resistance and the metabolic syndrome by 
controlling fatty acid oxidation in muscle (Minokoshi et ah, 2002; Yamauchi et ah, 2002).
The regulation of adipokine synthesis and secretion is complex. Unlike the regulated 
secretion seen in neuroendocrine cells, there appears to be a lack o f a clear stimulus- 
triggered secretory pathway in adipocytes, and there is still much to be understood about 
the control of secretion o f adipokines.
Many new adipokines have been discovered recently and their importance in disease 
investigated, and some, like RBP4 have revealed a possible link between obesity and 
insulin resistance. It is likely that there remain yet undiscovered adipokines with a role to 
play in the link between obesity, insulin resistance, diabetes and heart disease. Therefore, 
an important area of research will be the discovery of new adipokines and investigation of 
their contribution to insulin resistance, diabetes and cardiovascular disease.
1.2 Obesity, insulin resistance and the metabolic 
syndrome
1.2.1 Epidemiology of Obesity
Figures published by the World Health Organisation estimate that in the year 2005 there 
were in the region o f 1.6 billion overweight adults worldwide (with a BMI > 25kg/m^), and 
400 million clinically obese adults (with a BMI > 30kg/ m^). There is a prediction that one 
in three children bom this century will develop diabetes in their lifetime. In Europe 
Obesity is considered one of the greatest public health challenges facing society, being 
responsible for 2-8% of total health costs and in the region o f 10% of deaths. Perhaps the
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most won-ying trend associated with the obesity epidemic is the rate of increase o f the 
disease in the developing world. Obesity was previously eonsidered to be a problem of the 
more affluent ‘Western’ cultures, but is now increasing most rapidly in poorer countries 
where governments can ill afford the extra financial burden that comes with its associated 
health problems. Obesity leads to many serious health complications and the risk to health 
increases with BMI. The main chronic conditions for which obesity is a risk factor are: 
cardiovascular diseases (CVD) which kills 17 million people per year worldwide; diabetes, 
whose incidence is predicted to increase worldwide by 50% in the next 10 years; 
musculoskeletal disorders and some cancers (particularly breast and gastro-intestinal) (data 
obtained from The World Health Organisation Ihttp://www.who.int) . There is also a 
wonying increase in the rates of obesity in children and young people. It is predicted that 
by 2010, 1 in 10 European children will be obese, causing an increase in the chronic 
illnesses mentioned above, diseases previously thought only to apply to adults. Obesity 
will also reduce life expectancy in these young people, with a projected average o f 5 years 
lower life expectancy for men by 2050 (data taken from WHO press release EURO/11/06).
1.2.2 Insulin resis tance  and m etabolic syndrom e
Insulin resistance is described as a failure of target organs i.e. muscle, adipose tissue and 
liver to respond to the action of insulin, resulting in increased levels o f blood glucose and 
increased insulin production by the pancreatic (3-cells (Kahn, 1978). The accumulation of 
visceral fat is associated with the development of insulin resistance, type 2 diabetes and a 
cluster of disorders that pose an increased risk of cardiovascular disease, including 
hypercholesterolemia, hyperglycemia and hypertension. Taken together these disorders are 
known as the metabolic syndrome or insulin resistance syndrome (Reaven, 1988). These 
metabolic diseases could be caused by an excess o f impaired fatty acids called non- 
esterified fatty acids (NEFA), which enter the circulation and are taken up by the liver, 
resulting in insulin-resistance in the liver. Visceral obesity often results in an excess of 
these NEFA, caused by atrophy o f the intra-abdominal adipose tissue and large 
hyperlipolytic adipocytes that are resistant to insulin (Mittelman et a l ,  2002).
Circulating levels o f the adipokines ACRP30 and leptin are thought to be crucial regulators 
in the development o f insulin resistance and the metabolic syndrome by controlling fatty 
acid oxidation in muscle (Minokoshi et a l, 2002; Yamauchi et a l, 2002). In addition 
adipose tissue secretes a range o f pro-inflammatory cytokines such as TNF-a, IL-6, PAI-I 
and angiotensinogen, which promote endothelial dysfrmction, through increases in
12
endothelial adhesion, platelet activation and eventual plaque fonnation, leading ultimately 
to cardiovascular disease (Lau et al., 2005). Adipoeytes also secrete acute-phase proteins 
like C reactive protein (Calabro et al., 2005) and the complement factors adipsin (Cook et 
al., 1987) and ASP (Maslowska et al., 1997).
1.3 Obesity and Inflammation
Obesity has been compared to a state o f chronic low-grade inflammation, because o f the 
increased serum levels o f many pro-inflammatory cytokines (Yudkin et al., 1999), It has 
also been recognised, however, that obesity is accompanied by an infiltration into adipose 
tissue by macrophages and these are likely to contribute to the inflammatory state 
(Welsherg et al., 2003). Nonual mature adipocytes and macrophages are derived fi'om 
bone marrow stem cells: adipocytes from stromal or mesenchymal stem cells, and 
macrophages from haematopoietic stem cells. Hematopoietic stem cell give rise to blood 
cells (Abramson et al., 1977) and mesenchymal stem cells give rise to adipocytes, 
chondrocytes and osteocytes (Pittenger et al., 1999). Adipocytes and macrophages are 
distinct cell types, derived from distinct precursors and each with their own genetic and 
phenotypic characteristics. Despite their distinct characteristics and the fact that they are 
derived from different stem cells they do share a common developmental ancestry, as they 
have both developed from mesoderm (Prockop, 1997) and they also share many 
characteristics, including the secretion of pro-inflammatory cytokines like TNF-a ,IL-6 
and the fatty acid binding protein aP2 (Boord et al., 2004). In certain conditions like 
obesity, the distinctions between them become less marked, as adipocytes lose a number of 
their defining characteristics and become more “macrophage-like”. Macrophages express 
adipocyte proteins and vice-versa and the functions of these cells can, in some situations, 
overlap.
Obesity is marked by an increase in adipose tissue comprising adipocytes, preadipocytes 
and macrophages. The pro-inflammatory cytokines produced by macrophages and 
adipocytes have been implicated in the development of insulin resistance that often 
accompanies obesity. With an increase in adipocytes come an increase in cytokines, 
infiltration of macrophages, and an increase in levels o f inflammatory cytokines.
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1.4 Insulin signalling
Insulin is secreted by pancreatic (3-cells in response to elevated blood glucose. It binds to 
tyrosine kinase receptors on the surface o f adipose, liver and skeletal muscle cells. Binding 
of insulin to its receptor triggers the activation of various signalling cascades, resulting in a 
wide range of effects including gene expression, cell gi'owth and differentiation, increased 
glucose uptake and glycogen synthesis in muscle and triglyceride storage in adipose tissue 
(Saltiel and Pessin, 2002). In the liver, insulin stimulates the storage o f glucose as lipids 
and glycogen and inhibits the synthesis and release of glucose by regulating the expression 
o f the enzyiues that catalyse gluconeogenesis and glycolysis (Saltiel and Kahn, 2001).
The insulin receptor is a tetrameric protein comprising two a  and two (3 subunits. The a- 
subunit o f the insulin receptor contains the hormone binding region subunit and insulin 
binding activates the catalytic {3-subunit o f the receptor. This results in 
autophosphorylation o f the {3-subunits at several tyi'osine residues and subsequent 
phosphorylation of other intracellular proteins, like the insulin receptor substrates (1RS 1 
and 2), She and Cbl. Phosphorylation o f these proteins results in the activation o f various 
signalling pathways.
1,4.1 Insulin Signalling via PI 3-kinase
1RS provides docking sites for several SH2 containing proteins (White, 1997). O f 
particular importance is the lipid kinase, PI 3-kinase. Binding o f the p85 regulatory subunit 
of P13-kinase to the 1RS brings it in proximity to the PM thus facilitating the 
phosphorylation of Ptdlns (4,5)p2 by the pi 10 catalytic subunit and resulting in the 
initiation of the PI 3-kinase cascade, which along with the MAP kinase pathway triggers 
downstream events that bring about the Insulin response (Figure 1.2). Phosphorylation of 
Ptdlns (4,5)p2 results in an increase in the intracellular level o f the second messenger 
Ptdlns (3,4,5)P3 which then interacts with phosphoinositide-dependent kinase PD K l, a 
serine kinase that activates PKB/Akt. Akt is itself a serine/threonine kinase that 
phosphorylates a range of substrates, all o f which play a part in the insulin response within 
the cell. GSK3 is inactivated by Akt phosphorylation resulting in increased glycogen 
sythesis. PKB/Akt and two atypical PKC isofonns ^ andA. are thought to be involved in 
translocation of the insulin dependent glucose transporter GLUT4 to the cell surface 
(Lizcano and Alessi, 2002). There is evidence however that activation of PI 3-kinase alone 
is not sufficient for the insulin-stimulated translocation o f GLUT4 and the CAP/Cbl/TClO
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pathway has been proposed as a possible PI 3-kinase independent form of insulin 
stimulated glucose transport (Jiang et al., 1998).
1.4.2 Insulin signalling via CAP/Cbl
In some cell types the proto-oncogene Cbl is phosphorylated in response to insulin binding 
to its receptor (Ribon and Saltiel, 1997). The Cbl protein, in a complex with CAP is then 
translocated to a lipid raft region of the PM. Here the phosphorylated CAP-Cbl complex 
recruits Crkll, along with the GET C3G. C3G is then able to activate TCIO, a Rho GTPase. 
It has been suggested that activated TCIO acts as a signal for PI 3-kinase independent 
translocation of GLUT4 vesicles to the PM (Baumann et al., 2000; Chiang et al., 2001). 
This role of the CAP/CBI/TCIO pathway as a PI 3-kinase independent pathway for insulin 
stimulated glucose transport has however been brought into question by experiments where 
CAP, Cbl and Crkll were depleted in 3T3-L1 adipocytes. Using siRNAs, under these 
conditions, insulin-stimulated glucose transport was not affected, suggesting that CAP, Cbl 
and Crkll are not involved in this process (Mitra et al., 2004).
1.5 Adipocytes
1.5.1 3T3-L1 A dipocytes
3T3-L1 adipocytes are derived from the 3T3-L1 preadipocyte cell line, selected horn 
Swiss 3T3 mouse fibroblasts for its ability to differentiate into adipocytes. When growth 
aiTested in the presence o f foetal bovine serum they become rounded and accumulate 
cytoplasmic vesicles comprised of triglycerides (Green and Kehinde, 1975). This 
differentiation is enhanced when the cells are exposed to a cocktail of inducing agents 
resulting in the activation o f the three transcription factors PPARy, C/EBP, and ADD- 
1/SREBP-l and their subsequent initiation of adipocyte specific protein expression 
(Spiegelman et al., 1993; Tontonoz et al., 1993; Rubin et al., 1978). When differentiated, 
3T3-L1 adipocytes exhibit many of the bioehemical and morphologieal properties of 
noimal mouse adipocytes, and like mouse adipocytes, are insulin-responsive. 3T3-L1 
adipocytes are a popular model used in the study of adipose biology. They are convenient 
source of reproducibly insulin-responsive adipoeytes, and eontain cells that represent only 
the pre-adipocyte and adipocyte fraction. Primary rodent adipocytes on the other hand, 
must be isolated from adipose tissue which contains several different cell types. The 
standard procedure for isolation of primary adipoeytes from adipose tissue induces a 
significant inflammatory response, which results in changes in gene expression. Cultured
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primary rodent adipocytes eventually exhibit down-regulation o f insulin-responsive Glut4 
and an increase in expression o f G lutl(Gerrits et al., 1993).
1.5.2 T ranscrip tional regulation of ad ipocyte differentiation
PPAR-y The adipocyte specific fonu PPAR-y2 is a nuclear receptor that, when activated 
becomes a transcriptional activator. PPAR-y is activated by binding o f a ligand, which 
results in initiation o f adipocyte differentiation. This differentiation process involves 
moiphological changes, lipid accumulation and switching on o f many adipocyte-specific 
genes such as GLUT4 and adiponectin (Rosen et al., 1999).
C/EBP or CCAAT Enhancer binding protein has six family members o f which four (a ,p ,5  
and Ç are expressed during adipogenesis. C/EBPp and C/EBPô are expressed early and are 
involved in the activation of PPARy2 and C/EBPa, which acts later and is responsible for 
the expression of several adipocyte specific genes e.g. GLUT4, aP2 and UCP (Zuo et al., 
2006).
ADD-l/SREBP-1 regulates the expression o f enzymes responsible for FA synthesis and 
uptake and cholesterol synthesis (Kim and Spiegelman, 1996).
1.6 Membrane Trafficking
Traffieking o f proteins in the endocytic and exocytic or secretory pathways involves many 
different steps; delivery of newly synthesised proteins to eell surface or other target 
organelles, internalisation o f materials at the cell surface, transport within the cell and the 
maintenance o f the membranes involved in protein movement around the cell. This is 
achieved by compartmentalisation o f functions within distinct membrane bound organelles 
and transport vesicles that move membrane-bound and soluble proteins tlirouglr the 
secretory pathway. At the various stages o f the pathway, there are mechanisms in place to 
ensure that each protein is delivered, by the transport vesicle, to the correct destination.
1.6.1 The Secretory  Pathw ay
Proteins synthesised in the cytosol may be destined for secretion outside the cell, insertion 
into the plasma membrane, or lysosomal degradation. Wliatever their destination they must
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reach it from their point o f synthesis. In the classical secretory process, newly synthesised 
proteins are inserted into the ER and are subsequently transported to the Golgi apparatus 
where they are processed and packaged into vesicles for transport to the cell surface and 
fusion with the PM.
The sequence o f events in the secretory pathway was first demonstrated in a set of 
experiments using pulse chase autoradiogiaphy on pancreatic acinar cells (Blobel and 
Dobberstein, 1975; Palade, 1975). By varying the pulse chase periods, it was shown that 
labelled proteins appeared first in the ER, then the Golgi and were then canied to the PM 
in secretory vesicles. The pathway was fiirther elucidated in experiments in temperature- 
sensitive mutant yeast strains (Novick and Schekman, 1979). By studying strains o f yeast 
that were deficient for the secretion o f invertase at non-permissive temperatures, five 
stages were identified where secretion could be blocked. These were: transport into the ER 
form the cytosol, budding o f vesicles from the ER, fusion o f vesicles with the Golgi, 
transport to secretory vesicles from the Golgi and transport o f vesicles to the cell surface, 
thus confilining the essential stages in the synthesis and export o f secretory proteins.
1.6.1.1 Synthesis and Insertion into ER
Proteins destined for secretion are synthesised on ribosomes in the cytosol and transported 
co-translationally, either into the lumen o f the ER in the case of soluble proteins (Rapoport 
et al., 1996) or into the membrane o f the ER itself for membrane proteins (Mothes et ak, 
1997). Proteins are targeted to the ER by an N-tenninal signal sequence that binds to the 
cytosolic signal recognition peptide SRP that in turn binds to the SRP receptor in the ER. 
When localised at the ER membrane, the growing polypeptide chain is either translocated 
into the ER through a pore shaped assembly o f membrane proteins called the translocon, or 
in the case of membrane proteins, inserted in the membrane o f the ER. The N-terminal 
signal sequence is subsequently cleaved by signal peptidase in the ER. The newly 
synthesised proteins are then exposed to the resident chaperones and enzymes in the lumen 
o f the ER. Here they undergo various modifications, necessary for coiTect folding, such as 
N-1 inked glycosylation and disulphide bond fonnation, since only correctly folded proteins 
will leave the ER and be transported to the Golgi for transport to the cell surface or to 
lysosomes (Hammond and Helenius, 1994). The ER has several mechanisms for ensuring 
that misfolded or improperly assembled proteins are retained in the ER. Such proteins can 
be marked with an extra glucose at the end o f the N-linked sugar chain. This causes them 
to be bound to chaperones such as calnexin and calreticulin resulting in retention in the ER 
until they are correctly folded (Oliver et al., 1997). Ineorreetly folded or assembled
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peptides can be transported back through he translocon into the cytosol (Plemper et ak,
1997) where they are ubiquitinated and thus targeted to the lysosome for degradation. 
CoiTectly folded proteins are no longer retained by the chaperones and may leave the ER 
for the Golgi complex.
1.6.1.2 ER to Golgi Transport
Proteins leaving the ER travel to the Golgi in special transport vesicles. These vesicles 
budding from the ER are coated with the coat protein COPII, made from a 700kD complex 
o f Sec31 and Seel 3, a 400kD complex o f Sec23 and Sec24 and the GTPase Sari p. COPII 
vesicles form when Secl2p catalyses the exchange of GDP to GTP on SaiTp thus allowing 
it to bind to the ER membrane. SarlpGTP in turn recruits Sec23/Sec24 and Seel 3/ Sec31 
(Barlowe et ak, 1994). This coming together o f the constituent components initiates 
polymerisation of the coat proteins and budding of the membrane, resulting in vesicle 
fonnation. Sec 16 is also required for the fomration o f ER to Golgi transport vesicles, 
possibly acting as a scaffold on which the COPII protein may assemble. After budding off 
from the ER the COPII vesicles lose their coats when Sec 23p (the GAP for the GTPase 
SaiTp) increases the rate o f hydrolysis o f the GTP bound to SaiTp, causing dissociation o f 
the coat. The uncoated vesicles then fuse, fonning vesicular-tubular clusters, which are 
thought to fuse forming the outer-most or cis-face of the Golgi.
Whilst secretory proteins are transported to the Golgi, resident enzymes and chaperones 
must remain in the ER and this is achieved by a retention sequence at their COOH 
tenninak This sequence of four amino acids Lys-Asp-Glu-Leu, or the KDEL sequence, 
binds to an integral membrane receptor in the cis-Golgi and the protein is then packaged 
into COPI coated vesicles and returned to the ER (Wilson et ak, 1993). Membrane 
components from the ER, included in the transport vesicle must also be returned in order to 
maintain the ER membrane (Cosson and Letourneur, 1997). These vesicles form when the 
small GTPase ARFl GTP interacts with coatomer proteins aCOP and (3 COP, recmiting 
them to the membrane (Spang et ak, 1998). It is thought that clustering of Arfl causes the 
membrane to deform resulting in budding and fonnation o f a vesicle.
1.6.1.3 The Golgi Complex
The N-linked oligosaccharides that are added to proteins in the ER are often initially 
trimmed by the removal of mannoses, and further sugars are added.
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The Golgi complex comprises a set o f stacked flat membrane bound cisternae. Each stack 
has a cis and trans face, the cis face being the entry face where proteins annviiig from the 
ER are incorporated and the trans face being the exit face where proteins leaving the Golgi 
are packaged into transport vesicles. The Golgi compartments are also defined by their 
modifying enzymes e.g. phosphatases in the cis-Golgi and galactosyltransferase in the 
trans Golgi. As proteins pass through the Golgi they are fiirther processed in readiness for 
packaging into vesicles and transportation to their final destination (W anen and Malhotra,
1998).
1.6.1.4 Transport from TGN to lysosome
N-linked oligosaccharides that are added to proteins in the ER are further processed in the 
Golgi. Mannose groups are removed and further sugars added. An example o f this is the 
addition o f mannose-6-phosphate; a sugar that ensures the protein is directed to late 
endosomes. Any protein destined for the LE or lysosomes will have anived fi*om the ER 
with an N-linked oligosaccharide precursor already attached. In the cis Golgi one or more 
mannose residues are phosphorylated. Proteins containing mannose-6-phosphate bind to 
man-6-phosphate receptors in the TGN and are ineorporated into clathrin-coated vesicles. 
After budding h'om the TGN the vesicles lose their clathrin coat and the uncoated vesicles 
fuse with the late endosomal compartment. Here the low pH o f the environment causes the 
protein to become dissociated from the mannose-6- phosphate receptor. The receptor is 
recycled back to the Golgi for re-use, and the protein is transported to the lysosome for 
degradation (Munier-Lehmann et ak, 1996).
1.6.1.5 Pathways o f secretion and trafficking from TGN
Most soluble secretory proteins are carried to the cells surface in vesicles that bud from the 
TGN (Figure 1.3), in the elassical ER/Golgi dependent secretory pathway. In constitutive 
secretion i.e. the secretion o f integral membrane proteins and receptors and extracellular 
matrix proteins, secretory vesicles are transported directly to the PM or the organelle where 
they function. Alternatively, in certain cell types displaying regulated exocytosis, cargo is 
packaged into immature storage granules (ISGs). These ISGs mature into secretory 
gianules that are transported to the cell surface, where their contents are released, only in 
response to a specific stimulus e.g. in the case of insulin secretion from pancreatic p-cells, 
or synaptic release from neurons (Aiwan and Castle, 1998; Arvan and Halban, 2004). 
Clathrin-coated vesicles bus from the TGN to transport material to the 
endosomal/lysosomal system. Some secreted proteins exhibit “constitutive-like” secretion 
and traffic to the cell surface via the endosomal system (Millar et ak, 2000; Feng and
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Arvan, 2003). There is also evidence that some proteins are exported from the eell 
independently o f the classical secretory pathway. Interleukin ip , galectin and FGF are 
examples o f secreted proteins that lack a conventional signal peptide and are not found 
associated with classical secretory organelles (Nickel, 2003). Il-ip , along with several 
other cytokines, appears to translocate directly from the cytoplasm into an endolysosomal 
compartment that eventually fuses with the PM (Andrei et a l , 1999). The pro-angiogenic 
growth factors FGF-1 and FGF-2 are thought to be translocated directly from the 
cytoplasm across the PM (Mignatti et ak, 1992). The galectins-I and 3, members o f a 
family o f p-galactoside-specific lectins o f the extracellular matrix, accumulate directly 
below the PM where they are packaged into small membrane-bound vesicles called 
exosomes for transport to the extracellular space (Cooper and Barondes, 1990).
1.6.1.6 Coat Proteins and vesicle budding
There are three distinct coat proteins associated with intracellular transport, namely COPI, 
COPII and Clathrin. These coat proteins mediate budding events, forming vesicles and 
making sure the coiTect cargo is packaged (Cosson and Letourneur, 1997). Clathrin coated 
vesicles bud from the TGN and endosomes, and allow for the endocytosis o f proteins at the 
PM (Crowther and Pearse, 1981). Individual molecules of clathrin self-assemble into a 
lattice around vesicles, as they bud from the membrane. Each clathrin molecule has an N- 
terminal domain that binds to a subunit o f an adaptor complex (AP). API functions at the 
TGN along with GGAs (Golgi-localised, y-ear containing, ARF-binding proteins) to tether 
clathrin toTGN membranes. AP2 is involved in traffic from the plasma membrane, AP3 in 
trafficking to lysosomes and AP4 is found on vesicles in the TGN region (Robinson and 
Bonifacino, 2001). Adaptor complexes have subunits that are involved in cargo selection. 
Whether the coat protein is coatomer (COP) or clathrin, polymerisation of coat proteins is 
necessary for two important features o f  transport vesicles: eoncentration of cargo within 
the vesicle and curvature o f the membrane leading to budding of the vesicle. COP and 
clathrin coated vesicles both shed their protein coat after budding before fusion with their 
target membrane.
1.6.1.7 Fusion with plasma membrane and SNARE hypothesis
Targeting and fusion of vesicles with the appropriate target membrane requires the
interaction o f membrane proteins called SNARES (soluble NSF-attacliment protein 
receptors) (Sollner et ak, 1993; Rothman, 1994). SNARES are present on vesicles (v- 
SNARES) and target membranes (t-SNARES) and form a stable complex, called the trans-
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SNARE complex, when three a-helices from the t-SNARE and one from the v-SNARE 
assemble to make a stmcture o f four parallel a-helices that bridges the two membranes 
(Sutton et al., 1998). Fusion of the membranes results in a cis-SNARE eomplex in which 
all the SNARES are associated with the same membrane. SNARES are disassembled by 
the chaperones NSF and SNAP and the SNARE proteins are recycled to be used in another 
round o f vesicle fusion with its target membrane. At least 50 eukaryote SNARE proteins 
have been identified, eaeh with a distinct localisation (Scales et ak, 2000). It has however 
been demonstrated that the SNARES are not solely responsible for the specificity o f the 
vesicle membrane interaction. Other proteins thought to be involved in detennining the 
specificity o f fusion reactions include tethering factors and the Rab family o f  GTPases. 
Tethering factors are also membrane specific, many are coiled-coil proteins that are 
predicted to assemble in a Rab-dependent manner to bring the two membranes together 
(Jahn et ak, 2003).
1.6.1.8 The Exocyst complex
The Exocyst is a complex o f eight proteins (Figure 1.4) that was first identified in budding 
yeast and is essential for exocytosis (Terbush et ak, 1996). The proteins o f the exocyst 
interact with one another to fonn a complex that is localised in the region o f the PM 
(Grindstaff et ak, 1998). The exocyst is involved in docking of secretory vesicles and is 
thought to have a role in guiding vesicles to fusion sites on the PM (Guo et ak, 1999). 
Acting like a tethering factor, the exocyst complex is involved in the docking of exocytic 
vesicles with the PM. The exocyst complex is a necessary component in the docking o f 
insulin vesicles at the PM in pancreatic p cells (Tsuboi et ak, 2005) and is also required for 
the targeting o f Glut4 vesicles to the PM during the process of insulin stimulated glucose 
transport (Inoue et ak, 2003).
1.6.1.9 A rf and Rab GTPases in membrane transport
Two vital stages during membrane trafficking are regulated by small GTPases o f the A rf 
and Rab families; these are formation and budding of transport vesicles and the delivery o f 
transport vesicles to their target membrane respectively (Figure 1.5)
1.6.1.10 Rab
The Rab family o f small GTPases are involved in the regulation of vesicle transport, 
conferring specificity to vesicle-membrane interactions. That Rab GTPases can regulate 
these interactions in a specific way depends on their ability to switch between the inactive.
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cytosolic GDP-bound and the active, membrane localised GTP-bound forms (Figure 1.5). 
Newly synthesised and prenylated Rab is brought to the membrane by a Rab escort protein 
(REP). Here Rab-GDP is activated by a guanine nucleotide exchange factor (GEF) and, as 
Rab-GTP, is able to recmit effector proteins to the membrane. Rab-GTP is then hydrolysed 
to Rab-GDP with the help of a GTPase aetivating factor (GAP) rendering it susceptible to 
removal from the membrane by a Rab GDP dissociation factor (RabGDI). Rab-GDP and 
Rab GDI fonn a complex in the cytosol and constitute a supply of Rab that can be recycled 
to the membrane and activated (Zerial and McBride, 2001).
More than 60 Rab proteins have been identified with each Rab being localised to a 
particular intracellular membrane. (Figure 1.6) Some facilitate fusion o f vesicles with their 
target membrane by binding to effector molecules that may act as tethers. The specificity 
of membrane tethering is thought to depend on Rab effectors The tethering factor p i 15 was 
shown to be a rab effector that interacts with the SNARE complex (Allan et a l , 2000).
l.ôJJlArfs
Like the Rab proteins, ADP-ribosylation factors (Arfs) are GTP binding proteins that cycle 
between their GTP-bound and GDP-bound confoimations. Their action is dependent on the 
binding and hydrolysis o f GTP, and this is regulated by GTPase activating proteins (GAPs) 
and guanine nucleotide exchange factors (GEFs) respectively.
Arfs were originally classified into three groups, class I (Arfl, Arf2, and Arf3), class II 
(Arf4 and Arf5) and class III (Arf6) (Kahn et ak, 1991). Activated A rf proteins act by 
modifying the lipid composition and recruiting coat proteins on to membranes, resulting in 
the fonnation o f vesicles. The coat proteins include COP I, the clathrin adaptor protein 
API and GGAs (Golgi associated a-adaptin homology ARF-binding proteins) (Robinson 
and Bonifacino, 2001; Bonifacino and Glick, 2004). Arfs regulate lipid-metabolising 
enzymes like Phospholipase D and phosphotidylinositol 4-phophate 5-kinase, resulting in 
the release of PIP2 and leading to curvature of the membrane (Brown et ak, 1993). A rfsl,
3and 5, when in their GTP-bound conformation, associate with Golgi membranes. Whereas 
Arf6 cycles between the PM and recycling endosomes (D'Souza-Schorey et ak, 1998).
1.6.2 The Endocytic pathw ay
Molecules to be internalised bind to specific receptors on the plasma membrane. These 
receptor-ligand complexes are then concentrated in clathrin rich areas called coated pits. 
Polymerisation of clathrin molecules results in a concentration o f sites available to bind the
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cargo adaptor proteins that will in turn bind to cargo molecules. In this way, clathrin 
concentrates cargo into vesicles. During vesicle assembly at the plasma membrane the p2 
subunit of AP2 adaptor complex interacts directly with tyrosine and dileucine motifs on the 
cytoplasmic end o f the receptor (Ohno et al., 1995). After budding, the vesicles lose their 
clathrin coat. These uneoated vesicles fuse to become early endosomes, and these mature 
further to form late endosomes (LE). What happens next depends on the type o f receptor. 
Most receptors dissociate from their ligand in the low pH environment o f the LE e.g. in the 
case of the LDL (low density lipoprotein) receptor. LDL is a complex that canies 
cholesterol in the bloodstream and is internalised after binding to LDL receptors on the cell 
surface. In the LE, the LDL dissociates from its receptor and the receptor is recycled back 
to the PM. The LDL is transported to the lysosome where lysosomal enzymes hydrolyse 
the LDL complex, releasing cholesterol (Brown and Goldstein, 1979)(Figure 1.7). 
Transfemn follows a similar pathway but also recycles it ligand (Hopkins, 1983). 
Transfenin bound to iron binds to the transfenin receptor TfnR and is internalised into the 
EE. Here the low pH causes the iron to leave the Tftr but the Tfn remains bound to its 
receptor and they are both recycled to the PM. Once they have reached the extracellular 
face, the Tfn dissociates ftom its receptor. On its way to the surface some Tfn is held in 
recycling endosomes which is distinct from late endosomes and lysosomes and whose pH 
is slightly higher than that o f the EE (Yamashiro et al., 1984).
1.7 Aims of this study
The main aims of this study were to fiirther investigate the mechanisms o f secretion of 
ACRP30 in 3T3-L1 adipocytes and to analyse the secreted proteome o f 3T3-1 adipocytes 
with a view to identifying novel secreted proteins.
To address some of the questions suiTounding ACRP30 trafficking, I have investigated the 
involvement of subcellular organelles by dismpting trafficking through the Golgi and 
endosomes. I have also examined the involvement of the exocyst complex proteins Sec6 
and Sec8 and syntaxins 8 and 12 in ACRP30 secretion, as well as the GTPases Arf6 and 
Rabl l .
With the aim of identifying novel proteins secreted by 3T3-LI adipocytes, I have analysed 
the secreted proteome o f 3T3-L1 adipocytes by 2D LC-MS/MS, Furthennore I have 
investigated the functional roles of several proteins that were identified as potential novel 
adipokines.
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Figure 1.1 Structure of ACRP30
The crystal structure o f the homotrimeric globular fraction o f ACRP30 at a 
resolution o f 2.1 Â (Shapiro and Scherer, 1998).
Also shown is the crystal structure o f TNF-a, which shows structural 
homology to ACRP30.
%o0
1CD3
ITCD
CDc3o_
CD
O
IS
i f3
O- %  
3 2D) Q- 3  CD
T3
H
§IP
I
S’g(O
3
cn
n§O
2 4
Figure1.2 Insulin signalling pathways
Insulin binding to the tyrosine kinase insulin receptor triggers the 
activation o f intracellular signalling cascades. The Insulin receptor subunit 
(1RS), when phosphorylated becomes a docking site for PI 3-kinase, thus 
bringing about the phosphorylation o f PtdIns(4,5)P2 (PIP:) by the p i 10 
subunit of 1RS and resulting in the activation o f the PI 3-kinase cascade. 
(PIP]) phosphorylates (PIP3), which in turn phosphorylates and activates 
the phosphoinositide-dependent protein kinase 1 (PDKl), which is vital for 
activation o f Akt, or protein kinase B. PKB/Akt and two atypical PKC 
isofonns ^ andX are thought to be involved in translocation o f the insulin 
dependent glucose transporter GLUT4 to the cell surface (Lizcano and 
Alessi, 2002).
On translocation to the plasma membrane GLUT4 causes the cell to take 
up glucose from the extracellular environment.
Insulin binding to the insulin receptor may also initiate phosphorylation of 
the proto-oncogene Cbl. The phosphorylated Cbl, in complex with CAP,
î
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Figure 1.3 Pathways of Secretion
Most soluble secretory proteins are carried to the cells surface in vesicles 
that bud from the TGN, in the classical ER/Golgi dependent secretory 
pathway. In constitutive secretion secretory vesicles are transported 
directly to the PM or their target organelle. In certain cell types displaying 
regulated exocytosis, cargo is packaged into immature storage granules 
(ISGs). These ISGs mature into secretory granules that are transported to 
the cell surface, where their contents are released, only in response to a 
specific stimulus e.g. in the case o f insulin secretion from pancreatic 13- 
cells, or synaptic release from neurons. Clathrin-coated vesicles bus from 
the TGN to transport material to the endosomal/lysosomal system. Some 
secreted proteins exhibit “constitutive-like” secretion and traffic to the cell 
surface via the endosomal system. There is also evidence that some 
proteins are exported from the cell independently o f the classical secretory 
pathway. This “non-classical secretion” may take several forms: 
translocation to the PM directly from an endolysosomal compartment; 
translocation from the cytoplasm across the PM and transport across the 
PM in small, membrane-bound exosomes.
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Figure 1.4 The Exocyst
Figure 1A  shows the eight protein-subunits that make up the exocyst. 
Several of these are known to be effectors o f GTPases: Sec4, R hol, Cdc42 
and Rail all interact with exocyst proteins.
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Figure 1.5 The GTP/GDP cycle of Rab proteins
Newly synthesised and prenyl ated Rab is brought to the membrane by a 
Rab escort protein (REP). Here Rab-GDP is activated by a guanine 
nucleotide exchange factor (GEF) and, as Rab-GTP, is able to recruit 
effector proteins to the membrane. Rab-GTP is then hydrolysed to Rab- 
GDP with the help o f a GTPase activating factor (GAP) rendering it 
susceptible to removal from the membrane by a Rab GDP dissociation 
factor (RabGDI), Rab-GDP and Rab GDI form a complex in the cytosol 
and constitute a supply o f Rab that can be recycled to the membrane and 
activated.
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Figure 1.6 Intracellular distribution of Rab proteins
More than 60 Rab proteins have been identified, each one being associated 
with a distinct membrane in the cell. Figure 1.6 shows the localisation o f some 
o f these Rabs.
Rab Localisation
Rabl GoIgi network
Rab2 ER —> cis-Golgi network
Rab3 Secretory vesicles
RabS PM —>Early endosomes, Early
endosomes-^ Late endosomes
Rab7 Early endosomes ->Late
endosomes
Rab8 Constitutive secretory vesicles
Rab 11 Recycling endosomes

29
Figure 1.7 Endocytosis
Molecules to be internalised bind to specific receptors on the plasma 
membrane. These receptor-ligand complexes are then concentrated in 
clathrin rich areas called coated pits. Polymerisation o f clathrin molecules 
results in a concentration o f sites available to bind the cargo adaptor 
proteins that will in turn bind to cargo molecules. In this way clathrin 
concentrates cargo into vesicles. After budding, the vesicles lose their 
clathrin coat. These uncoated vesicles fuse to become early endosomes, 
these mature further to form late endosomes (LE). The LDL (low density 
lipoprotein) receptor dissociates from its ligand (LDL) in the low pH 
environment o f  the LB. The LDL receptor is recycled back to the PM via 
the endosomes and the LDL is hydrolysed in the lysosome.
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Chapter 2 Materials and Methods
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2.1 Materials
All materials and reagents used were o f the highest quality and were obtained from the 
following suppliers;
2.1.1 General R eagents
Anachem Ltd., Luton, Bedfordshire, UK
Acrylamide solution 30% (w/v) (ratio o f 37.5:1 acrylamide:bis-acrylamide)
Bio-Rad Laboratories Ltd., Hemel Hempsted, Hertfordshire
Bio-Rad protein assay
BDH Ltd., Poole, Dorset, UK
Calcium chloride
Disodium hydrogen orthophosphate 
Sodium chloride
Sodium dihydrogen orthophosphate dihydrate 
Sucrose
Calbiochem, Merck Chemicals Ltd.,Badge Road, Beeston, Nottingham NG9 2JR, UK
Polymyxin B sulphate
Fisher Ltd., Loughborough, Leicestershire, UK
Acetone
Ammonium persulphate 
Ethanol
Ethylenediaminetetraacetic acid, disodium salt (EDTA)
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Glucose
Glycine
N-2 hydroxyethylpiperazine-N’-2-ethanesulphonic acid (HEPES)
Hydrochloric acid 
Magnesium sulphate 
Methanol
Potassium chloride
Potassium dihydrogen orthophosphate 
Sodium dodecyl sulphate 
Tris Base
Kodak Ltd., Hemel Hempsted, Hertfordshire, UK
X-Omat S film
McQuilkin &Co, East Kilbride, UK
Marvel powdered milk
New England Biolabs (UK) Ltd., Hitchin, Hertfordshire, UK
Prestained protein markers, broad range (6-175 kD)
Schleicher and Schuell, Dassel, Germany 
Nitrocellulose membrane (pore size 0.45 pm)
Whatman International Ltd., Maidstone, Kent, UK
Whatman No.l filter paper 
Whatman No.3 filter paper
NEN Dupont (UK) Ltd., Stevenage, Hertfordshire, UK
[^H] 2-deoxy-D-glucose
Roche Diagnostics Ltd., Lewes, East Sussex, UK
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Complete protease inhibitor cocktail tablets
All other general reagents were purchased from Sigma Chemical Company Ltd., Poole 
Dorset, UK., unless stated otheiivise.
2.1.2 Cell culture R eagents and  Materials
American Type Culture Collection 
3T3-L1 Fibroblasts 
Invitrogen Gibco, Paisley, UK
Dulbecco’s modified Eagle’s medium (without sodium pyruvate, with 4500mg/L glucose)
Dulbeeco’s modified Eagle’s medium (without sodium pyiuvate, with 4500mg/L glucose 
without phenol red)
Foetal calf serum
Newborn calf serum
0.05% Trypsin/EDTA solution
PenicilliiVStreptomycin solution comprising 10,000 units/mL penicillin and 10 OOOug/mL 
streptomycin sulphate in 0.85% saline.
200mm (lOOX) L-Glutamine solution
BD Biosciences
10cm culture dishes
12 well culture plates
24 well culture plates
Sterile plastic pipettes
Costar
25cm^ 75 cn7 and 150 cm^ culture flasks
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TCS Cellworks Ltd., Park Leys, Botolph Qaydon, Buckinghamshire, MK18 2LR,
UK
NoiTnal Human Umbilical Vein Endothelial Cells (pooled)
Large Vessel Endothelial Cell Basal Medium 
Large Vessel Endothelial Cell Growth Supplement 
Antibiotic Supplement
2.1.3 A ntibodies
Ambion (Europe) Ltd., Huntingdon, Cambridgeshire, UK
Mouse monoclonal anti-GAPDH IgGi, raised against purified rabbit muscle GAPDH 
(Cat # 4300)
Amersham International Pic, Aylesbury, Buckinghamshire, UK
Horseradish Peroxidase (HRP)-conjugated donkey anti-rabbit IgG (whole molecule) (Cat # 
NA934V)
Horseradish Peroxidase (HRP)-conjugated sheep anti-mouse IgG (whole molecule) (Cat # 
NA934V)
Horseradish Peroxidase (HRP)-conjugated goat anti-rat IgG (whole molecule) (Cat # 
NA931)
BD Biosciences
Mouse anti-Nm23 monoclonal IgG2b, generated from human Nm23 (Cat # 610247)
Sigma, Poole, Dorset
Horseradish Peroxidase (HRP)-conjugated rabbit anti-goat IgG (whole molecule) (Cat # 
A5420)
Promega
Horseradish Peroxidase (HRP)-conjugated rabbit anti-chicken IgY (Cat # G1351)
MBL Ltd., Naka-ku Nagoya, Japan
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Rabbit anti-Hsp70 (Hsp72) whole rabbit serum, raised against recombinant human Hsp70 
(Cat#SR-B812)
Rat monoclonal anti-Hsp90a IgG2a, clone 9D2, raised against purified human Hsp90 (Cat 
# SR-B840)
R&D Systems Europe Ltd., Abingdon, Oxfordshire, UK
Goat anti-mouse CXCL4/PF4 IgG, raised against purified, E, Co//-derived, recombinant 
mouse CXCL4 (Cat # AF595)
Santa Cruz Biotechnology Inc.,(Autogen Bioclear, Caine, Wiltshire, UK)
PPARy (E-8) mouse monoclonal IgG], raised against a sequence mapping at the C- 
terminus of PPARy o f human origin (identical to coiTcsponding mouse sequence) (Cat # 
SC-7273)
Rabbit anti-C/EBPa IgG, raised against a peptide mapping within an internal region of 
C/EBPa (C at#  SC-61)
Rabbit anti c-myc IgG, raised against a peptide mapping near the C-tenninus o f human c- 
myc (Cat # sc-789),
Gentaur BVBA, Brussels, Belgium
Chicken anti-orosomucoid IgY, raised against purified human plasma protein (Cat # 
A22927F)
Anti-adipsin anti-serum was generously provided by Professor Bruce Spiegelman (Dana 
Farber Cancer Institute, Boston) (Kitagawa et a l ,  1989)
Adenovirus
Rabl 1-S25N was kindly donated by Rytis Prekeris, University of Colorado Health 
Sciences Centre, Denver, Colorado (Hickson et a l ,  2003).
Fast-cycling Arf6 mutant was kindly donated by Lorraine Santy, Eberly College of 
Science, Penn State University, PA, USA (Santy, 2002).
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2.1.4 Recombinant and Purified Proteins
Abnova Corporation, Taipei, Taiwan
Full length recombinant Leucine-rich alpha-2-glycoprotein 1. Produced by in vitro 
translation in a cell-free wheat gemi system.
Full length recombinant Nucleoside diphosphate kinase A (Nm23). Produced by in vitro 
translation in a cell-free wheat germ system.
MBL Ltd., Naka-ku Nagoya, Japan
Recombinant HSP70. This protein was purified from an E, Coli protein expression system.
Recombinant HSP90a. This protein was cloned from a HeLa cDNA library and expressed 
in E, Coli
R&D Systems Europe Ltd., Abingdon, Oxfordshire, UK
Recombinant CXCL4/ Platelet Factor 4. A DNA sequence encoding mature mouse PF4 
was expressed in & Co/f Endotoxin: <1.0 EU per Ipg as determined by the LAL method
Scipac Ltd., Sittingbourne, Kent
Orosomucoid purified from pooled normal human serum 
Sigma
Human recombinant Tumour Necrosis Factor-a, expressed in yeast.
Endotoxin: <10EU/mL by LAL test
2.2 Buffers
2.2.1 General Buffers
Phosphate Buffered Saline (PBS)
137mM NaCl, 10 niM Na2HP04, 2.6mM KCl, 1.7mM KH2PO4 (pH 7.4)
Krebs Ringer Phosphate Buffer (KRP)
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64mM NaCl, 2.5mM KCl, 2.5mM NaH2P04.2H20, 0.6mM MgS04.7H20, 0.6mM CaClg 
(pH7.4)
HES Buffer
255mM sucrose, 20 mM HEPES, ImM EDTA (pH 7.4)
SDS Lysis Buffer
20 mM Tris, 0.05% SDS, protease inhibitors 
Sucrose Gradient Bnffer
20mM HEPES, lOOmM NaCl, ImM  EDTA (pH 7.4)
2.2.2 E lectrophoresis Buffers
SDS-PAGE Sample Buffer
93mM Tris-HCl pH6.8, 10% (w/v) glycerol, 2%(w/v) SDS, O.Olmg/mL bromophenol blue, 
20 mM dithiothreitol (added immediately before use)
Electrode Buffer
192mM Tris, 40 mM Glycine, 0.1% (w/v) SDS pH 8.3 
Transfer Buffer for Western blotting
192mM Tris, 40 mM Glycine, 10% (v/v) MeOH pH8.5
2.3 Stains
Coomassie Brilliant Blue Stain
0.25% Brilliant Blue R dissolved in a mixture of 10% (v/v) glacial acetic acid, 45% (v/v) 
MeOH, 45% dHzO
Coomassie Destain
10% glaeial acetic acid, 45% (v/v) MeOH, 45% dHiO
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Oil Red O stain
A stock of Oil Red O stain was prepared by dissolving 0.7 g  Oil Red O in 200 mL 
isopropanol and stirring at room temperature overnight. This stock was filtered through a 
0.2 pm filter and stored at 4°C.
To prepare a working solution, 6 parts Oil Red O stock was mixed with 4 parts dH20 . This 
was allowed to stand at room temperature for 20 min before being filtered through a 0.2 
pm filter.
2.4 Cell Culture Methods
2.4.1 Culture of 3T3-L1 adipocytes
3T3-L1 fibroblasts were cultured in 75 cm^ flasks, using DMEM culture medium 
containing 10% (v/v) newborn calf serum and 1% (v/v) penicillin and streptomycin. Cells 
were cultured at 37°C in a humidified atmosphere o f 10% (v/v) CO2. The culture medium 
was replaced every 48 h. When sub-confluent the cells were sub-cultured by trypsinisation. 
Following aspiration o f medium, the cells were washed IX with 3 mL trypsin/EDTA 
solution, after which cells were incubated at 37°C with 2 mL trypsin/EDTA solution until 
all cells were detached fi'om the surface o f the flask. Following re-suspension in 100 mL 
DMEM containing 10% (v/v) NCS, cells were re-distributed to fresh 75 cm^ flasks, 10 cm 
culture plates or 12-well culture plates.
2.4.2 Differentiaton of 3T3-L1 adipocytes
Cells were differentiated on day 4 post-confluence by the addition o f DMEM containing 
10% (v/v) fetal bovine serum, 1% (v/v) penicillin/streptomycin solution, 0.25pM 
dexamethasone, 0.5mM methyl isobutylxanthine and Ipg/mL insulin. This medium was 
prepared using a stock o f 2.5mM dexamethasone in ethanol, a 500X stock solution of 
methyl isobutylxanthine, which was prepared in IM  KOH, and a Img/mL stock of insulin 
in O.OIM HCI.
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48h later the differentiation medium was replaced with DMEM containing 10% PCS, 1% 
penicillin and streptomycin and Ipg/niL insulin. Following differentiation the medium was 
replaced every 48h with DMEM containing 10% fetal bovine serum and 1% penicillin and 
streptomycin. Cells were used 8-14 days post-differentiation.
2.4.3 Freezing and s to rage  of 3T3-L1 cells
Following incubation at 37°C with trypsin, cells from one 75 cm^ flask of 3T3-L1 cells 
were re-suspended in 3 mL of DMEM culture medium containing 10% (v/v) newborn ealf 
serum and 1% (v/v) penicillin and streptomycin solution, and the cell suspension was 
centriftiged at 2000 x g  for 4 min. The supernatant was removed by aspiration and the cell 
pellet was gently agitated and re-suspended in 2mL of DMEM containing 20% (v/v) NCS 
and 10% (v/v) DMSO. The suspension was divided between two 1.8 mL polypropylene 
cryovials and placed in a Styrofoam box at -80°C overnight before being transferred to 
liquid nitrogen for long-term storage.
2.4.4 Thawing of frozen s to ck s  from liquid nitrogen
A vial o f cells was removed from liquid nitrogen and thawed in a 37°C waterbath. The cell 
suspension was pipetted into a 75 c n f  flask and 15 mL o f pre-warmed growth medium was 
slowly added to the cells. The medium was replaced 24 h later.
2.4.5 Culture, freezing and sto rag e  of U937 cells
U937 cells were gi'own as a suspension culture in 75cm^ flasks in RPMI 1640 medium 
containing 10% (v/v) FCS and 1% (v/v) Penicillin/streptomycin. The cells were 
subcultured every 48h, by removing 50% of the culture and replacing it with an equivalent 
volume o f h esh gi’owth medium. The volume o f the culture was never allowed to exceed 
50mL.
The contents o f one 75 cm^ flask of U937 cells in the log phase o f growth were 
transferred to a sterile centrifuge tube and centrifliged at 2000 x g  for 4 min. The 
supernatant was aspirated and the cell pellet was gently agitated and re-suspended in 5 mL 
of 90% (v/v) FCS, 10% (v/v) DMSO. The cell suspension was divided between five 1.8 
mL polypropylene cryovials and placed in a Styi'ofoam box at -80°C overnight before 
being transferred to liquid nitrogen for long-tenn storage.
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2.4.6 Culture of HEK 293 cells
HEK 293 cells were routinely gi'own in DMEM containing 5% (v/v) fetal bovine senrm,
1% (v/v) penicillin/streptomycin solution and 1% (v/v) L-Glutamine.
2.4.7 Culture of HUVECS
Cryopreseiwed HUVECS were purchased h'oin TCS Cellworks, Park Leys, Botolph 
Claydon, Biiekinghamshire, MK18 2LR, UK. Cells were thawed and seeded at 
approximately 2,500 viable cells per cm^ in Costar 25cm^ flasks, in TCS Large Vessel 
Endothelial Cell Medium. Medium was prepared by adding lOmL TCS Large Vessel 
Endothelial Cell Growth Supplement and 0.5mL antibiotic supplement to 500mL TCS 
Large Vessel Endothelial Cell Basal Medium, Cells were refed with fresh growth medium 
every 48h and subcultured when the cells reached 60-80% confluence. HUVECS were 
used for experiments between passages 2 and 6.
2.4.8 3T3-L1 Differentiation a ssay
3T3-L1 cells were gi’owii to confluence in 12-well culture plates, and 4 days post 
confluence the differentiation protocol was started. Cells were treated with various 
recombinant or purified proteins at different concentrations, and these proteins were added 
at the same time as the differentiation medium (day 0 o f differentiation) and subsequently 
on days 2, 4 and 6 o f differentiation. Differentiation was measured by uptake o f Oil Red O 
stain (see section 2.12)
2.4.9 M onocyte adhesion  a ssay
lO'^  HUVECs were seeded into each well o f a 24-well plate and grown at 37°C for 48 h.
The cells were then incubated for 4 h with the treatments indicated. Each condition was 
repeated in 4 separate wells within one experiment, and each experiment carried out three 
times. After incubating with each condition the medium was aspirated, the cells washed 2X 
with seiTim h'ee HUVEC medium and the cells overlaid with 1X10^ U937 promonocytic 
cells per well in serum-fi'ee HUVEC medium. The cells were allowed to adhere for 1 h at 
37°C before they were removed and the monolayers were washed 3X with semm free 
DMEM. The cells were then fixed in 0.5 mL per well o f PBS pH 7.2 containing 4% (v/v) 
formaldehyde and 5% (w/v) sucrose. The number of U937 cells adhering to HUVECs was 
analysed by phase contrast microscopy. The analysis was carried out by counting 3
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separate fields from each well, making a total o f 12 counts per condition per experiment. 
These 12 counts were averaged to give a result for each condition per experiment. This 
result was expressed as a percentage o f the control (no treatment) and the results from 
three separate experiments were averaged. The results from one experiment were 
independently counted by a colleague, and the same results were obtained. To minimise 
the possible effects o f any contaminating endotoxins fi'om the recombinant proteins, all 
recombinant proteins were incubated for 30m with 2pg/mL Polymyxin B sulphate, which 
binds to and inactivates endotoxins.
2.4.10 Adenoviral infection of 3T3-L1 adipocytes
3T3-L1 were routinely infected on day 8 o f differentiation, unless stated otherwise. Cells 
were washed in serum-fi'ee DMEM and then incubated overnight in 0.5 mL per well o f a 
12 well plate o f serum-free DMEM containing virus at an m.o.i of 50 ifli/cell. The virus- 
containing medium was aspirated and replaced with DMEM containing 10% fetal bovine 
serum, and the cells were used between 24 h and 72 h later, depending on the experiment.
2.5 3T3-L1 Secretion Assay
3T3-L1 adipocytes were cultured on 10 cm culture dishes or 12 well culture plates. Cells 
were used for secretion assays when at day 8-11 post-differentiation, where day 0 is 
equivalent to the day of addition o f IBMX, dexamethasone and insulin. Cells were 
incubated at 37°C in serum free DMEM growth medium for two hours, before being 
washed 2X with ICrebs Ringer Phosphate (KRP) buffer (see Section 2.2.1). Thereafter, 
cells were incubated with 10 mL (for 10 cm dishes) or 0.5 mL (in the case of 12 well 
plates) KRP ± IpM Insulin at 37‘^ C. The KRP was then collected from the cells at defined 
times, and the secreted proteins were TCA precipitated from the KRP buffer.
Where the assay was earned out in 24 well plates the TCA-precipitated pellet was 
resuspended in 50pL 1 X SDS-PAGE sample buffer (section 2.2.2) and 20pL o f this was 
loaded onto a 12% SDS-PAGE protein gel (section 2.13). Separated proteins were 
electrophoretically transferred to nitrocellulose membrane at 90mA overnight, blocked 
with PBS containing 5% Marvel and then incubated in primary antibody or pre-immune 
serum diluted 1:2000 in PBS containing 1% Marvel for Ih  at room temperature. After 
incubation membranes were washed extensively over a period of 20min with PBS and 
incubated with horseradish-peroxidase labelled anti-rabbit IgG. Proteins were visualised 
using enhanced chemiluminescence (section 2.15.1). Because the nature of the experiment
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made it meaningless to measure the protein cocentration of samples being loaded, and 
because there was no protein that could be used as a loading control, great care was always 
taken to ensure that equal volumes o f supernatant were collected fi'om each condition and 
that samples within an experiment were always treated identically. Cells were not counted 
at the time of plating but equal volumes were always added accurately to each well or plate 
from a constantly agitated cell suspension.
2.6 Adenovirus
2.6.1 Large-scale amplification of viral s to ck s
Large scale amplification of Adenovirus was earned out in HEK 293 cells according to the 
method outlined by He et al. (He et al., 1998), with modifications.
For a typical large-scale virus preparation, 20 X 150 cm^ culture flasks o f HEK 293 cells 
were grown to 50% confluence. 50 mL o f infective supernatant was added to 150 mL of 
DMEM, containing 5% (v/v) fetal bovine serum. The infective supernatant was obtained 
by collecting the supernatant from 5X150 cm^ culture flasks of HEK 293 cells, infected 
with purified virus at a concentration of 1 infectious unit (ihi) per cell.
HEK cells were incubated at 37°C for 2 h in 10 mL per flask o f the diluted viras, after 
which 25 mL of DMEM containing 5% fetal bovine serum was added to each flask and the 
cells were incubated for 48 h at 37°C. After the incubation period, cells were examined for 
visual signs of virus infection (cell death). When all of the flasks were showing signs of 
virus infection, the supernatant was poured into sterile 50 mL tubes and centrifuged at 
2000 X g  for 5 min at room temperature. The resulting pellets were pooled into one sterile 
50 mL tube with 25 mL sterile PBS and centrifuged at 2000 x g  for 5 min at room 
temperature. The resulting pellet was re-suspended in 5 mL sterile PBS and incubated at 
room temperature for 10 min with 7 mL 1,1,2- trichiorotrifluoroethane. The preparation 
was centrifuged at 2000 x g  for 5 min at room temperature. The top layer of the 
preparation, containing the virus particles was removed and place atop a CsCl step gradient 
(2.5 mL of 1.4 gim L  in 10 mM tris pH 8.1 on the bottom and 2.5 mL of 1.2 g/mL in 10 
mM tris pH 8.1 on the top) in an SW40 centrifuge tube. The preparation was centrifuged at 
92508 x g at 8°C for 90 min with no brake in a Beckman ultracentrifuge, using an SW40 
rotor. The distinct band of viras particles appeared just below the interface and was 
removed by puncturing the side o f the tube with a needle attached to a syringe. The virus
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band was removed and dialysed overnight, at 4°C in a Pierce slide-a-lyser, with a lOK 
molecuar weight cut-off, against 1 L o f TE pH 7.9. Following dialysis the virus was 
aliquoted and stored at -80°C. One aliquot o f frozen vims was removed, thawed and titred.
2.6.2 Determ ination of A denovirus Titer
Adenovirus titer was detennined using the AdenoX™ Rapid Titer Kit from Clontech. The 
kit uses a hexon-specific antibody which is used to label infected cells. Each labelled cell is 
equivalent to one infectious unit (ifu).
2.7 TCA Precipitation of Proteins
To each 1 mL o f protein solution, was added 50 pL o f 0.15% (w/v) Sodium deoxycholate 
solution. After mixing well and incubating at room temperature for 5 min, 100 pL o f 72% 
(w/v) TCA solution was added. Samples were mixed well, incubated on ice for 20 min, and 
centrifuged at 10,000 x g  for 15 min at 4°C. The supernatant was aspirated and pellets re­
suspended in 1 mL acetone (-20°C), and the centrifligation step repeated. The supernatant 
was aspirated and the pellets allowed to air dry for a few minutes, before being re­
suspended in 60 pL IX  SDS-PAGE sample buffer (see Section 2.2.2) and stored at -80°C.
2.8 Endosome Ablation
3T3-L1 adipocytes were incubated at 37°C for 1 h in serum-free DMEM followed by 1 h 
in seium free DMEM containing 20 pg/mL Tf-HRP conjugate. The cells were then placed 
on ice, washed 3X with cold isotonic citrate buffer (150 mM NaCl, 20 mM tri-sodium 
citrate, pH 5.0) over a period of 10 min. 3.3’-diaminobenzidine was added at a 
concentration of 100 pg/mL to all plates and H2O2 was added at a concentration of 0.02% 
(v/v) to experimental plates only. After incubating for 60min at 4°C in the dark, the 
reaction was stopped by washing the cells with ice-cold PBS.
2.9 Subcellular fractionation of 3T3-L1 adipocytes
The LDM (Low density microsomal) fiaction was obtained as described for the 
fractionation of rat adipocytes (Piper et al., 1991), with modifications (Martin et al., 1994).
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3T3-L1 adipocytes cultured on 10 cm plates were incubated for 2 h at 37°C in seium-free 
DMEM. For the last 15 min o f the incubation period insulin (IpM ) was added to 
experimental plates. Plates were transfeiTcd to ice, and cells were washed 3X with 5 mL 
ice-cold HES buffer. Cells were then scraped in 0.5 mL per plate o f HES buffer containing 
protease inhibitors (complete Protease Inhibitors from Roche), and homogenised with a 
Dounce homogeniser. The homogenate was transfeiTed to pre-chi lied centrifuge tubes and 
centrifliged at 16,000 x g  for 20 min at 4°C. The resulting supernatant was centrifuged at 
46,000 X g  for 20 min at 4"^C, yielding a pellet designated as the high density microsomal 
fraction (HDM). The resulting supernatant was centrifuged at 180,000 x g  for 60 min at 
4°C yielding a pellet containing the low density microsomal fraction (LDM). Protein was 
quantified using the Bradford (Bio-Rad) determination kit (section 2.9.1)
2.9.1 Bradford (Bio-rad) Protein Quantification
Five dilutions of a BSA protein standard were prepared within the linear range o f 0.2-0.9 
mg/mL for BSA. 20pL o f each standard and sample were pipetted into a 1.5mL eppendorf. 
Im L of dye reagent (prepared by diluting 1 part Dye Reagent Concentrate with 4 parts 
deionised water) was added to each tube and vortexed. After incubation for 5min at room 
temperature, absorbance was measured at 595nm, using a spectrophotometer. Sample 
values were plotted against a standard cuiwe generated by the absorbance o f the known 
dilutions of BSA.
2.10 Sucrose Gradients
Gradients were prepared as described by Guilheime et al. (Guilherme et al., 2000b).
Day 8 3T3-L1 adipocytes were incubated for 2h at 37°C in serum-free DMEM. For the last 
15min o f the incubation period, insulin (IpM ) was added to experimental plates. LDM 
samples were prepared as described in section 2.9 Protein was quantified using the 
Bradford assay (Bio-Rad) (see section 2.9.1) and 1.5-2.0 mg o f LDM fi*action was loaded 
atop a 13mL 10-35% (w/v) sucrose velocity gradient in (Sucrose Gradient Buffer: 20mM 
HEPES pH7.4, lOOmM NaCl, ImM EDTA, protease inhibitors) and centrifuged for 3.5 h 
at 105,000 X g  at 4°C in an SW40 rotor (Beekman). ImL fractions were collected from the 
top to the bottom of the gradient. 20pL was removed fr’om each fraction and immunoblots 
were perfonned to identify the GLUT4 containing fi'actions
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The fractions containing most o f the Glut4 membranes, as detected by Western blotting, 
were pooled, pelleted by centrifugation at 180,000 x g  for 60 min at 4°C, and re-suspended 
in Sucrose Gradient Buffer. This resuspended pellet was then loaded on top o f a 10-65% 
(w/v) equilibrium density sucrose giadient and centrifuged at 218,000 x g  for 18 h at 4°C 
in an SW40 rotor. Following centrifugation, fractions were collected, starting from the top 
o f the gradient.
2.11 2 deoxy-D-glucose uptake assay
Glucose uptake in 3T3-L1 adipocytes was measured by the uptake o f [^H] 2-deoxy-D-
glucose (Gibbs et a l , 1988), (Frost and Lane, 1985).
3T3-L1 adipocytes cultured in 12 well plates were washed 2X with 1 mL KRP buffer at 
37°C. Cells were then incubated in 450 pL per well of KRP ± Insulin (Inm  orlOOmn) at 
37°C for 15 min. Duplicate control wells were incubated with the above + lOpM 
cytochalasin B. Glucose transport was initiated by the addition of 50 pL of [^H] 2-deoxy- 
D-glucose (final concentration of 50pM and 0.5p Ci/mL). After 5 min transport was 
terminated by flipping the plates to remove the incubation buffer and washing them by 
dipping the plates in three washes o f ice-cold PBS. The plates were left to air dry, after 
which 1 mL of 1% TritonX-100 was added to each w ell Plates were wrapped in film and 
incubated overnight at room temperature. The detergent solubilised [^H] 2-deoxy-D- 
glucose was detennined by liquid scintillation counting.
2.12 Oil Red O staining of adipocytes
3T3-L1 adipocytes were grown in 12 well culture plates. Growth medium was removed 
and cells were fixed in 10% fonnaldehyde for at least 1 h. Fonnaldehyde was removed and 
cells were washed in 60% (v/v) isopropanol and left to air dry. Cells were stained with 400 
pL per well of Oil Red O solution for 10 min, after which well were rinsed with 4 changes 
o f running dHzO and plates were left to air dry. Oil Red O was eluted with 1.5 mL 100% 
isopropanol per well for 10 min. Oil Red O/isopropanol solution was transfeiTed from each 
well to a 1.5 mL cuvette and OD520 was measured using 100% isopropanol as a blank.
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2.13 SDS-PAGE
SDS-polyacrylamide gel electrophoresis was earned out using the Bio-Rad Mini- 
PROTEAN 3 system.
The resolving gel was prepared to the required acrylamide concentration foi each 
experiment using 30% acrylamide/bisacrylamide solution, 375mM Tris-HCl pH 8.8, 0.1% 
(w/v) SDS, 0.1% (w/v) ammonium persulphate and 0.01% TEMED. The stacking gel was 
prepared using 5% (w/v) acrylamide/bisacrylamide, 125mM Tris pH 6.8, 0.1% (w/v) SDS,
0.1%(w/v) ammonium persulphate and 0.01% TEMED.
Protein samples were re-suspended in IX  SDS-PAGE sample buffer and loaded onto the 
wells in the stacking gel. Pre-stained molecular weight markers were routinely loaded in at 
least one well o f each gel. Gels were electrophoresed at a constant voltage until sufficient 
separation of the molecular weight markers had been achieved.
2.14 Western Blotting
Proteins were transferred from the polyacrylamide gel to nitrocellulose membrane using 
the Bio-Rad Mini Trans-Blot Cell. This transfer was routinely carried out at a constant 
current of 90 mA, overnight.
2.15 Immunodetection of Proteins
Following transfer of proteins, the nitrocellulose membrane was incubated for 1 h m PBS 
containing 5%(w/v) Marvel. The membrane was then incubated with primary antibody, 
diluted in PBS containing 1% (w/v) Marvel washed 5X with PBS over a 30 min time 
period, incubated with horseradish-peroxidase labelled secondary antibody in PBS 
ontainingl%  Maiwel and washed as before.
Times and Temperatures of incubations are antibody specific.
2.15.1 Enhanced Chem ilum inescent Detection
Following incubation with the appropriate HRP-linked antibody, the membrane was 
incubated for 1 min in a solution comprising equal volumes of the following two solutions;
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Solution A 100 mM Tris-HCl pH 8.5, 2.25mM luminol, 0.4mM p-Coumaric acid, 1.44% 
(v/v) DMSO
Solution B 100 mM Tris-HCl pH 8.5, 0.018% (v/v) H2O2
Following incubation in the ECL solution, the membrane was exposed to X-Omat film and 
developed using an X-Omat processor.
2.15.2 Quantification of im m unoblot intensities
Autoradiogi'aphs obtained by the ECL process were scanned and individual bands were 
densitometrically quantified using Image J, the public domain image processing 
programme provided by NIH (http://rsb.info.nih.govL Unless otherwise stated the data 
from each blot was scanned and the values expressed as a percentage of the control. Three 
independent experiments were combined and eiTor Standard deviation calculated using 
Excel. Where appropriate a student’s T test was earned out (also using Excel).
Significance was assessed as p< 0.05.
2.16 Coomassie staining of SDS-PAGE gels
For in gel detection of proteins following SDS-PAGE, gels were stained for >1 h at room 
temperature with Coomassie blue stain, after which they were destained, using Coomassie 
destain, until protein bands were clearly visible and backgiound staining had been 
removed,
2.17 Proteomics
2.17.1 Preparation of sam ple for Proteom ic analysis
10 cm plates of day 10 3T3-L1 adipocytes were washed 5X using 10 mL serum-free 
DMEM and once with serum-fr ee DMEM (without phenol red). The cells were incubated 
in 8ml serum-fi’ee DMEM without phenol red for 10 h. Conditioned medium was 
collected, centrifuged for 10 min at 2000 x g  at 4°C, after which the supernatant was 
passed through a 0.2 pm filter. The filtered supernatant was dialysed overnight, against 5 L 
o f dH20 in a Pierce Slide-a-Lyser dialysis cassette, with a 3.5 kDa molecular weight cut­
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off, and a 3-12 mL capacity. The dialysed sample was concentrated in a vacuum centrifuge 
until the volume was concentrated to approximately 100 gg of protein in a volume o f < 100 
gL.
2.17.2 1DLC-MS/MS
ID LC-MS/MS was performed in the Sir Henry Wellcome Functional Genomics Facility 
and the following protocol was provided by Dr Andy Pitt:
Trypsin digest was performed at 37°C overnight in 25 mM ammonium bicarbonate, 0.1% 
n-octyl-glycoside. Tryptic peptides were dried, resolubilized in 0.5% formic acid and 
fractionated by nanoflow HPLC on a CIS reverse phase column, eluting with a continuous 
linear giudient to 40% acetonitrile over 20 minutes. Eluate was analysed by online 
electro spray tandem mass spectrometry using a Qstar Pulsar XL (Applied Biosystems).
Mass spectrometric analysis was performed in IDA mode (AnalystQS software. Applied 
Biosystems), selecting the four most intense ions for MSMS analysis. A survey scan of 
400-1500 Da was collected for 3 ses followed by 5 sec MSMS scans o f 50-2000 Da using 
the standard rolling collision energy settings. Masses were then added to the exclusion list 
for 3 min. Peaks were extracted using the Mascot script (BioAnalyst, Applied Biosystems) 
and automatically exported to the Mascot (Matrix Science) search engine for protein 
identification.
2.17.3 Prediction of Protein Localisation
Data obtained from the MASCOT search engine was analysed for potential secreted 
proteins. Several prediction programmes were used during this analysis;
PSORT (Nakai and Horton, 1999) is a programme for prediciting the subcellular 
localisation of proteins based on their amino acid sequence. It makes predictions based on 
known sorting signal motifs. W oLF PSORT (Horton et ah, 2006) is an updated version of 
PSORT and was also used in this study.
SignalP 3.0 Server (Bendtsen et ah, 2004b) predicts traditional N-terminal signal peptides 
that target proteins to the ER for passage to the secretory pathway. It also recognises signal 
anchors (signal peptides that are not cleaved by signal peptidase and are a feature of tyi^ell 
membrane proteins).
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SecretomeP 2.0 Server (Bendtsen et a l , 2004a) predicts non-classical protein secretion
i.e. not signal peptide-triggered. Prediction is based on the observation that secreted 
proteins share certain features, regardless o f the secretion pathway. Non-classically 
secreted proteins may be distinguished by properties such as amino acid composition, 
secondary structure and disordered regions.
5 0
Chapter 3 The m echanism  of ACRP30 secretion in 
adipocytes
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3.1 Introduction
ACRP30 is one o f the most abundant proteins to be secreted by adipocytes but in common 
with many of the other adipokines there is little known about the pathway it follows 
between its synthesis in the cytosol and its eventual secretion to the extracellular space. 
Insulin increases the secretion o f a range of molecules h  orn adipocytes including adipsin 
and ACRP30. Adipsin and GLUT4 are known to traffic through the TGN and their 
increased secretion is due in part to an increase in vesicle transport at the TGN. Adipsin 
has however been shown to traffic from the TGN to the PM via endosomes, as its secretion 
is inhibited by endosome ablation and by treatment of the cells with the PI-3 kinase 
inhibitor Wortmannin (Millar et al., 2000), whereas GLUT4 is still transported to the cell 
surface following endosome ablation. GLUT4 is found in basal cells to cycle between a 
population of intracellular vesicles that are positive for the v-SNARE VAMP2 (Ramm et 
al., 2000) and the plasma membrane. Upon insulin stimulation, there is a rapid shift in 
localisation from these VAMP2 positive secretory vesicles to the PM. As well as these 
insulin-responsive storage vesicles, GLUT4 colocalises with the TGN and the endosomal 
recycling compartment (Bryant et al., 2002) and is proposed to involve two main 
intracellular recycling pathways: pathway 1 cycling between the PM and endosomes and 
pathway 2 between the TGN and endosomes Figure 3.1 (Bryant et al., 2002).
In this study I have addressed questions regarding the mechanisms of secretion o f 
ACRP30, namely how does ACRP30 traffic to the PM? Is it transported directly from the 
TGN to the PM in a constitutive manner, or is it packaged into immature storage gi’anules 
and trafficked to the cell surface in a regulated fashion like GLUT4 ? Alternatively, does 
ACRP30, like adipsin, traffic to the cell surface via endosomes? In addressing this question 
I have employed a technique called endosome ablation (Livingstone et a l, 1996) in which 
a Tf-HRP conjugate is taken up by 3T3-L1 adipocytes and delivered to the TfR positive 
endosomal compartment. Subsequent incubation o f the cells with DAB and hydrogen 
peroxide results in cross-linking of the TfRs, and loss of immunoreactive TfR from 
intracellular membranes. This procedure ablates markers o f the recycling endosome 
including TfR and Rab5 with little or no effeet on markers o f the TGN (Livingstone et al., 
1996; Martin et a l, 1996).
Many proteins trafficking to the PM, including GLUT4, recycling transferrin receptors and 
adipsin use the endocytic pathway (Chakrabarti et a l, 1994; Ang et a l , 2004; Millar et a l, 
2000). ACRP30 and GLUT4 have been located by convolution immunofluorescence
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microscopy to distinct subcellular compartments (Bogan and Lodish, 1999) but depletion 
o f the the v-SNARE V tila  decreases both insulin stimulated deoxyglucose uptake and 
ACRP30 secretion suggesting the existence o f an element in the secretory pathway that is 
common to GLUT4 and ACRP30. Despite these findings, little is known about the 
trafficking o f ACRP30.
The exocyst is a complex o f eight protein subunits that are involved in the docking of 
secretory vesicles at the PM (Figure 1.4). Although it was first identified in yeast, it is well 
conserved with mammalian homologues having been identified for all eight proteins (Hsu 
et al., 1996). Several o f the subunits of the exocyst have been identified as effectors of 
GTPases. Sec4, a member o f the Rab family o f small GTPases, interacts with Sec 15 (Guo 
et ah, 1999) and R hol, Rlio3, Cdc42 and R ail all interact with exocyst proteins (Novick 
and Guo, 2002; Zhang et ah, 2001). In mammalian cells the exocyst, or Sec6/8 complex, 
co-localises with exocytic cargo protein on the TGN and at the PM and is necessary for 
transport between these two membranes (Yeaman et ah, 2001). The exocyst has been 
reported to regulate the sorting o f GLUT4 into lipid rafts in adipocytes (Inoue et ah, 2006) 
and is proposed to function in regulated exocytosis (Yeaman et ah, 2001).
I have also examined the roles o f the syntaxins 6, 8 and 12 in the regulation of ACRP30 
secretion. Syntaxins are t-SNARES that are involved in vesicle docking and fusion in the 
secretory and endocytic pathways. To date 18 syntaxins have been identified and they are 
localised to different intracellular compartments(Pelham, 2001). Syntaxins 1-4 are 
localised to the plasma membrane and Syntaxins 6,7, 8 and 12 are involved in the TGN 
and endosomal network (Watson and Pessin, 2000; Tang et ah, 1998).
3.2 Experimental Procedures
3.2.1 ACRPSO/Adipsin Secretion A ssay
Mature 3T3-L1 adipocytes were grown in either 10cm plates or 12-well plates. At days 8-
I I  post-differentiation, cells were serum-staiwed for 2h in serum-ffee DMEM at 
Where the procedure was earned out in 10cm plates, cells were washed tlrree times with 
lOmL Ki'ebs Ringer Phosphate buffer (KRP) and at time t=0 this was replaced with 5mL 
fresh KRP± IpM  Insulin at 37°C. At each time point, 0.5mL KRP was removed to an 
eppendorf. In the case o f 12 well plates KRP was replaced with O.SmL fresh KRP± IpM 
Insulin at 37°C, and at various time points, indicated in each experiment, this was removed
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to an eppendorf. In the 12 well plates, each condition was performed in three neighbouring 
wells, and each experiment was perfomied three times.
In both cases the 0.5niL sample was TCA precipitated (section 2.7), the pellet was 
resuspended in 50pL SDS-PAGE sample buffer containing 20mM DTT (section 2.2.2) and 
20)liL was loaded onto a 10% SDS-PAGE gel (section 2.13), and electro blotted onto 
nitrocellulose. Western blots were blocked with 5% Maiwel in PBS for Ih at room 
temperature, followed by incubation with either rabbit anti-ACRP30 anti-serum diluted 
1:2000 or goat anti-adipsin anti-serum diluted 1:1000 in PBS containing 1% Mai*vel for Ih  
at room temperature. After thorough washing with several changes o f PBS, blots were 
incubated with Horseradish Peroxidase (HRP)-conjugated donkey anti-rabbit IgG (whole 
molecule) or HRP-conjugated rabbit anti-goat IgG diluted 1:1000 in PBS containing 1% 
Marvel for Ih at room temperature. Following thorough washing with several changes of 
PBS, the antigen-antibody complex was detected with enhanced chemiluminescence (see 
section 2.15.1) and visualised by autoradiography. The autoradiographs were scanned and 
quantified denstitometrically, using the image-processing programme Image J. The value 
obtained for each was expressed as a percentage o f the value for the control band in each 
experiment, and the results shown are the combination o f thi*ee experiments (unless stated 
otherwise).
3.2.2 Purification of Insulin-responsive GLUT4-containing m em branes
Day 8 3T3-L1 adipocytes were incubated for 2h at 37°C in serum-ffee DMEM. For the last 
15min o f the incubation period, insulin (IpM ) was added to experimental plates. LDM 
samples were prepared as described in section 2.9 Protein was quantified using the 
Bradford assay (Bio-Rad) (see section 2.9.1). 1.5-2.0 mg o f LDM h'action were loaded 
atop a 13mL 10-35% (w/v) sucrose velocity giadient in (Sucrose Gradient Buffer: 20mM 
HEPES pH7.4, lOOmM NaCl, ImM  EDTA, containing protease inhibitors) and centrifuged 
for 3.5 h at 105,000 x g  at 4°C in an SW40 rotor (Beckman). IniL fractions were collected 
from the top to the bottom o f the gradient. 20pL was removed from each fraction and 
immunoblots were performed to identify the GLUT4 containing fi'actions.
The fi'actions containing most of the Glut4 membranes (fi'actions 6-10), as detected by 
Western blotting were pooled, pelleted by centrifugation at 180,000 x g  for 60 min at 4°C, 
and re-suspended in Sucrose Gradient Buffer. This resuspended pellet was then loaded 
atop a 10-65% (w/v) equilibrium density sucrose gradient and centrifuged at 218,000 x g  
for 18 h at 4°C in an SW40 rotor. Following centrifugation, fractions were collected,
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starting from the top o f the gradient. 15pL o f each fraction was analysed on a 10% SDS- 
PAGE gel.
3.2.3 Ablation of Transferrin receptor-positive endosom ai com partm ent
Four 10cm plates o f day 8-11 mature 3T3-L1 adipocytes were incubated at 37°<u for 1 h in 
lOmL serum-ffee DMEM followed by 1 h in 5mL serum free DMEM containing 20 pg/mL 
Tfn-HRP conjugate. The cells were then placed on ice, washed 3X with cold isotonic 
citrate buffer (150 mM NaCl, 20 mM tri-sodium citrate, pH 5.0) over a period o f 10 min. 
3.3’-diaminobenzidine was added at a concentration of 100 pg/mL to all plates and H2O2 
was added at a concentration o f 0.02% (v/v) to experimental plates only (2 plates). After 
incubating for 60niin at 4°C in the dark, the reaction was stopped by washing the cells with 
ice-cold PBS. Cells were then washed 3X with KRP at 37°C, before being assayed for
secretion o f ACRP30 and adipsin.
3.2.4 Infection of 3T3-L1 ad ipocytes with adenov iruses driving the 
overexpression  of Sec6, Sec8, Syntaxln6, SyntaxinS and Syntaxin12
D ay 8 mature 3T3-L1 adipocytes, grown in 12-well culture plates were infected with 
adenovirus at an moi o f 50pfu/cell. The virus was added to the cells in 0.5mL seram-free 
DMEM for 4h, after which time 0.5mL DMEM containing 10% (v/v) FCS was added to 
each well. Cells were incubated with virus for 48h, before being assayed for secretion o f 
ACRP30.
3.2.5 Brefeldin A treatm ent of 3T3-L1 adipocytes
3T3-L1 adipocytes, grown in 10 cm culture dishes, were incubated with 5 pg/mL o f 
Brefeldin A at 37°C for 1 h before assaying for secretion of ACRP30.
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3.3 Results
3.3.1 C haracterisation and affinity purification of anti-ACRP30 antibody
An antibody was raised in rabbits against a peptide corresponding to the C- terminal 18 
amino acid residues (226-244) o f the mouse ACRP30 protein, and is shown underlined in 
the full sequence below.
MLLLGAVLLLLALPGHDQETTTQGPGVLLPLPKGACTGWMAGIPGHPGHNGAPG
RDGRDGTPGEKGEKGDPGLIGPKGDIGETGVPGAEGPRGFPGIQGRKGEPGEGAY
VYRSAFSVGLETYVTIPNMPIRFTKIFYNQQNHYDGSTGKFHCNIPGLYYFAYHITV
YMKDVKVSLFKKDKAMLFTYDQYQENNVDQASGSVLLHLEVGDQVWLQVYGE
GERNGLYADNDNDSTFTGFLLYFIDTN
This was used to study secretion of ACRP30 from 3T3-L1 adipocytes. Figure 3.2a shows 
the secretion of a protein o f 30kDa from adipocytes over 60 min. This illustrates the 
constitutive secretion of ACRP30. Figure 3.2b shows secreted supernatant horn basal and 
insulin stimulated 3T3-L1 adipocytes blotted with pre-immune serum from the immunised 
rabbit.
3.3.2 Secretion of ACRP30 is adipocyte specific
It is known that differentiation of 3T3-L1 adipocytes results in the activation of 
transcription factors and the subsequent expression of adipocyte specific proteins. ACRP30 
is one of the proteins that are abundantly secreted by 3T3-L1 adipocytes. In order to 
investigate whether ACRP30 was secreted by 3T3-L1 fibroblasts as well as differentiated 
adipocytes, 3T3-L1 pre-adipocytes and 3T3-L1 adipocytes were incubated for 2 h in 
semm-Eee DMEM before being assayed for secretion of ACRP30 as described in Section 
2.5.
Figure 3.3 illustrates that ACRP30 could not be detected in the supernatant of 
undifferentiated 3T3-L1 fibroblasts, confirming that it is not expressed in 3T3-L1 
fibroblasts.
3.3.3 Constitutive and  insulin-stim ulated secretion  of ACRP30 from 3T3-L1 
adipocytes
3T3-L1 adipocytes were cultured in 10 cm plates and incubated in serum-free DMEM 
before being assayed for secretion o f ACRP30. Cells were incubated at 37°C in KRP ±
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1 pM Insulin, and samples were collected at defined time points between 2 min and 30 min. 
Samples were assayed for ACRP30 secretion as described in Section 2.5 and in more detail 
in the experimental procedures section in this chapter (section 3.2.1).
Figure 3.2a shows that ACRP30 is constitutively secreted constitutively from 3T3-L1 
adipocytes. Figure 3.4 illustrates that insulin increases the rate of secretion over a short 
time, with the rate of secretion paralleling basal rates within 30 min-1 h.
3.3.4 Intracellular distribution of ACRP30 in adipocytes
Cmde subcellular fractionation experiments have previously shown that secretory proteins 
such as ACRP30 and adipsin, localise mainly to low density microsomal fractions, in 
common with GLUT4 (Millar et a l , 2000). To more accurately detennine the subcellular 
distribution of ACRP30,1 compared the localisation o f ACRP30 with that of GLUT4/ 
IRAP (the Insulin-responsive aminopeptidase) and the endosomal marker TfR by resolving 
intracellular membranes on velocity (Figure 3.5a) and equilibrium density giudients 
(Figure 3.5b). This two step gradient analysis results in an enrichment of insulin responsive 
GLUT4“Containing vesicles (Guilherme et a l, 2000a). After the velocity gi'adient, (Figure 
3.5a) the majority of ACRP30 was localised to the same fi’actions as those containing 
Glut4/IRAP or transferrin receptors (TfR). The ACRP 3 0-rich fractions (3 to 9 o f Fig 3.5 a) 
were collected, pooled and subjected to density gradient analysis. This was repeated for the 
insulin-stimulated fractions. Fig 3.5b shows fi’actions 4 to 9 o f the basal and insulin- 
stimulated fi’actions. This analysis confirms the previous report that this method can 
effectively resolve the GLUT4/IRAP-containing vesicles and shows that the GLUT4 
within these vesicles is mobilised in response to insulin. ACRP30 exhibits limited overlap 
with GLUT4 using this method, but a gi’eater degree of overlap with the endosomal marker 
(TfR). This data provides evidence for a distinct localisation o f ACRP30 and GLUT4 and 
the overlapping localisation of ACRP30 and TfR suggests that ACRP30 is secreted in a 
constitutive-like manner, through the endosomal system.
3.3.5 Effect of Brefeldin A on secre tion  of ACRP 30
Brefeldin A inhibits protein secretion and intracellular protein transport by preventing Arf 
1 recruitment o f COPI coat protein to Golgi membranes (Orci et a l ,  1991 ; Misumi et a l, 
1986). In order to investigate the involvement o f Golgi trafficking in ACRP30 secretion I 
treated 3T3-L1 adipocytes with Brefeldin A, before assaying for ACRP30 secretion.
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3T3-L1 adipocytes were incubated in DMEM-SF for 1 h followed by DMEM-SF 
containing 5 pg/mL Brefeldin A for 1 h before assaying for the secretion o f ACRP30 as 
described in Section 2.5. Fig 3.6 illustrates that BFA treatment strongly inhibits both basal 
and insulin stimulated secretion of ACRP30, consistent with trafficking o f these proteins 
through the TGN.
3.3.6 Effect of endosom e ablation on ACRP30 secretion .
It has been shown previously that disruption o f the TfR positive endosomal compartment is 
inhibitory for adipsin secretion. In order to determine the involvement of the endosomal 
system during trafficking of ACRP30,1 disrupted the transferrin receptor positive 
endosomal system by loading the cells with TfHRP and incubating with hydrogen 
peroxide. After this procedure, the cells were assayed for secretion of ACRP30. Fig 3.7 
shows that disruption of this compartment strongly inhibits ACRP30 secretion, suggesting 
that during secretion, ACRP30 and adipsin follow a pathway that involves the recycling 
endosomal compartment. This is consistent with the observation that a fraction o f the 
intracellular ACRP30 co-localises with TfR positive membranes (Figure 3.5b)
3.3.7 Role of the exocyst proteins Sec6 and Sec8 in ACRP30 secretion
In order to investigate the role of the exocyst proteins in ACRP30 secretion, I 
overexpressed the exocyst proteins Sec6 and Sec8 in 3T3-L1 adipocytes and examined the 
effect of this overexpression on ACRP30 secretion.
3T3-L1 adipocytes gi'own in 12 well culture plates and infected with with empty 
adenovirus (Sh) or adenoviruses designed to drive over expression o f the exocyst proteins 
Sec6 and Sec8. The cells were infected with adenoviruses expressing fiill length Sec6F, 
Sec8F or a truncated fonn o f each (Sec6T and SecBT). Fig 3.8 shows a typical immunoblot 
o f secretion o f ACRP30 from these 3T3-L1 adipocytes. Over expressing Sec6 and Sec8 
appears to have no effect on secretion of ACRP30. A study by Ewart et al. showed that 
adenoviral overexpression of Sec6 and Sec8 significantly enhanced the maximum rate of 
insulin-stimulated deoxyglucose uptake (Figure3.9)*, in agreement with the proposition 
that the exocyst has a role in regulated exocytosis. The results in Figure 3.8 show no 
evidence o f a role for the exocyst in ACRP30 secretion and suggest that ACRP30 and 
GLUT4 traffic to the PM by distinct pathways.
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* Figure 3.9 is not part o f this study but is the work of M. A. Ewart (Ewart et al., 2005) and 
was perfonned contemporaneously with the data o f Figure 3.8.
3.3.8 Role of Syntaxins in ACRP30 secretion
3T3-L1 adipocytes were infected with adenovirus expressing syntaxins 6, 8 or 12 and the 
cells were assayed for secretion of ACRP30 as described in Section 2.5.
A previous study has shown that in adipocytes ~ 85% of Syntaxin 6 is found localised with 
GLUT4-containing vesicles (Perera et al., 2003), and that overexpressing the cytosolic 
domain of Syntaxins 6, 8 and 12, using an adenoviral vector, had no effect on the maximal 
rate of insulin-stimulated deoxyglucose uptake. The rate o f deoxyglucose transport in the 
absence of insulin was increased by overexpression of Syntaxin 6, implicating a role for 
Syntaxin 6 in the trafficking o f G lut 4 within the endosomal system o f adipocytes. Figure 
3.10 shows that the rate o f decline o f insulin-stimulated deoxyglucose transport after 
insulin withdrawal is slower in cells overexpressing Syntaxin 6, suggesting that 
perturbation o f the Syntaxin 6 function results in GLUT4 remaining in the recycling 
endosomes for longer. This data suggests a role for Syntaxinb in to GLUT4 trafficking 
between the endosomal comparhnent and GLUT4 storage vesicles.
In this study I investigated the role of the Syntaxins 6, 8 and 12 in ACRP30 secretion by 
overexpressing the proteins, using an adenoviral vector, in 3T3-L1 adipocytes, before 
assaying for secretion o f ACRP30. 3T3-L1 adipocytes were infected with adenovirus 
designed to overexpress the cytosolic domains of Syntaxins 6, 8 and 12 and the cells were 
assayed for secretion o f ACRP30 as described in Section 2.5. Fig 3.11 shows that the over 
expression o f syntaxins 6, 8 and 12 has no effect on either basal or insulin stimulated 
secretion of ACRP30.
* Figure 3.10 is not part of this study but is the work o f H.K.I. Perera (Perera et a l ,  2003) 
and was performed contemporaneously with the data in Figure 3.11.
3.4 Discussion
In this study, I have shown that, in common with adipsin, ACRP30 is secreted in a 
‘constitutive-like’ manner by 3T3-L1 adipocytes and that although the rate of secretion is 
increased over a short time period in response to insulin (Figure 3.4), there is no evidence 
that ACRP30 exhibits regulated secretion Ifom 3T3-L1 adipocytes. Both basal and insulin
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stimulated secretion of ACRP30 are inhibited following endosome ablation (Figure 3.7), 
presenting further evidence that the increase in secretion seen in response to insulin (Figure 
3.4) is less likely to be brought about by regulated secretion, than insulin stimulation o f the 
recycling endosomal system.
In intracellular localisation studies, ACRP30 was found in the same fractions as GLUT4 
(an example of a protein that is transported to the PM from an intracellular compartment in 
a regulated fashion) but showed a greater degi’ee o f overlap with the TfR positive 
compartment, suggesting that these two proteins may populate the same compartment. 
Brefeldin A treatment o f 3T3-L1 adipocytes strongly inhibited basal and insulin-stimulated 
secretion of ACRP30, indicating that secretion of this protein is dependent on a functioning 
TGN. This parallels the results seen with adipsin. These data suggest that ACRP30- 
containing secretory vesicles traffic througli the TGN and the endosomal system on their 
way to the plasma membrane, pointing to a constitutive-like secretory route. It has been 
suggested that ACRP30 is secreted via a regulated secretory pathway (Bogan and Lodish, 
1999), based on a lack o f co-localisation of ACRP30 with the TfR by 
immunofluorescence. I have however shown that in subcellular fractionation studies 
ACRP30 does in fact, overlap with TfR positive fractions (Figure 3.5), frirther evidence for 
a constitutive-like secretory pathway for ACRP30. These same subcellular fractionations 
demonstrated little overlap between ACRP30 and GLUT4-containing membranes 
suggesting that ACRP30 does not traffic to the cell surface using the same regulated 
secretory route as GLUT4.
Figure 3.8 shows that overexpressing the exocyst proteins Sec6 and SecS in 3T3-L1 
adipocytes has no effect on secretion o f ACRP30. Since the exoeyst is proposed to play a 
role in regulated exocytosis, and there is evidence for involvement of the exocyst in 
GLUT4 vesicle docking at the PM, the lack of involvement o f the exocyst in secretion of 
ACRP30 provides evidence that ACRP30 and GLUT4 traffic to the PM by distinct 
pathways.
Further evidence that ACRP30 and GLUT4 traffic to the PM through distinct pathways is 
shown in Figure 3.11. This data shows that overexpressing the Syntaxins 6, 8 and 12 has 
no effect on ACRP30 secretion. A previous study of the involvement o f these three 
Syntaxins in GLUT4 trafficking to the PM suggests a role for Syntaxinô in GLUT4 
trafficking (Perera et al., 2003).
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In addition, other studies have implicated Syntaxins 8 and 12 in trafficking within the 
endosomal system (see section]. 1). I have suggested that endosomal traffic is involved in 
ACRP 30 secretion based upon ablation and co-localisation of TfR, and therefore sought to 
determine whether Syntaxin 8 or 12 perturbed ACRP30 traffic. I was however unable to 
detennine any effect, which could indicate that Syntaxins 8 and 12 are not necessary for 
ACRP30 traffic or may reflect an inability of the overexpressed protein to function as an 
inhibitor of the endogenous molecule. Since there are no available assays for the function 
o f Syntaxin 8 and 12, this area was not pursued.
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Figure 3.1 GLUT4 Trafficking
A model that depicts the transport o f GLUT4 in insulin-responsive cells. The 
model depicts two main intracellular-recycling pathways: cycle 1, between 
the cell surface and endosomes; and cycle 2, between the trans-Golgi 
network (TGN) and endosomes. GLUT4 transport is intricately controlled at 
several points along these cycles. On entry into the endosomal system, 
GLUT4 is selectively retained at the expense o f other recycling transport, 
such as the transferrin receptor that constitutively moves through cycle 1. 
This retention mechanism might predispose GLUT4 for sorting into transport 
vesicles that bud slowly from the endosome and that are targeted to the 
TGN. GLUT4 is sorted into a secretory pathway in the TGN. This sorting 
step probably involves a specialized population of secretory vesicles that 
excludes other secretory cargo, and that does not fuse constitutively with the 
plasma membrane. Vesicles that emerge from this sorting step, which we 
have previously refeiTed to as GLUT4 storage vesicles or GSVs, might 
constitute most o f the GLUT4 that is excluded from the endosomal system.
In the absence of insulin, GSVs might slowly fuse with endosomes, thereby 
accounting for the presence o f a significant but small pool o f GLUT4 in 
endosomes, even in the absence o f insulin. Insulin would then shift GLUT4 
from this TGN-endosome cycle to a pathway that takes GLUT4 directly to 
the cell surface. (Bryant et al., 2002)
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Figure 3.2 Secretion of ACRP30 by 3T3-L1 adipocytes
3T3-L1 adipocytes were assayed for secretion of ACRP30 as 
described in Section 2.5.
Figure 3.2a shows the secretion o f ACRP30 at defined timepoints.
Figure 3.2b shows secreted proteins from 3T3-L1 adipocytes, 
blotted with pre-immune seium from the rabbit that was immunised 
during the production o f the anti-ACRP30 antibody.
a32.5kD ACRP30
0 5 10 35 60 time(min)
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Figure 3.3 ACRP30 secretion is adipocyte specific
Pre-adipocytes and mature adipocytes were assayed for secretion of 
ACRP30. Only mature 3T3-L1 adipocytes secrete ACRP30
ACRP30% % % XV
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Figure 3.4 Insulin-stimulated ACRF30 secretion
3T3-L1 adipocytes were grown in 12 well culture plates and assayed for 
secretion o f ACRP30 at defined time points between 2 min and 30 min. 
Cells treated with insulin showed a slight increase in the rate o f secretion 
over a short time period. Blots from two independent experiments were 
measured by densitometry and combined. The results shown are ± S.D,
The x-axis is non-parametric because the results show the time points 
collected in the experiment.
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Figure 3.5 Intracellular localisation of ACRP30
3.5a. The immunoblot shown is from basal cells; insulin stimulation of 
IpM for 30min did not alter the distribution among the fractions.
3.5b Shows equilibrium gradient analysisof fractions 3 through 9 o f the 
velocity gradient. Equal amounts of the fractions were separated by SDS- 
PAGE and immunoblotted with tha antibodies indicated. This analysis 
clearly shows that ACRP30 exhibits limited overlap with Glut4, however 
there is more overlap of ACRP30 with the endosomal marker (TfR).
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Figure 3.6 Effect of Brefeldin A treatment on secretion of ACRP30
Shown in 3.6a is a representative Western blot. The blot shows that, 
consistent with its effect on adipsin secretion, Brefeldin A strongly 
inhibits secretion o f basal and insulin stimulated ACRP30 secretion.
The blots from three independent experiments were scanned and the 
results combined.
3.6b shows the results from the denstometric scans of the adipsin blots ± 
S.D, ^ indicates a result with value o f p < 0.01.
3.6c shows the results from the denstometric scans o f the ACRP30 blots 
±  S.D. ^ indicates a result with value o f p < 0.01.
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Figure 3.7 Effect of Endosomal Ablation on ACRP30 secretion in 3T3-Ll-adipocytes
Shown in 3.7a is a representitive Western blot. The blot shows that, 
consistent with its effect on adipsin secretion, endosome ablation inhibits 
secretion of basal and insulin stimulated ACRP30 secretion.
The blots from three independent experiments were scanned and the results 
combined
3.7 b shows the results from the denstometric scans o f the adipsin blots ±
S.D. ^ indicates a result with value o f p < 0.01.
3.7e shows the results from the denstometric scans of the ACRP30 blots ±
S.D. indicates a result with value o f p < 0.01.
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Figure 3.8 Effect of overexpression of the exocyst proteins Sec6 and Sec8 
on secretion of ACRP30
Fig 3.8a shows a typical immunoblot of secretion of ACRP30 from these 
3T3-L1 adipocytes.
The blots from three independent experiments were scanned and the results 
combined
3.8b shows the results from the denstometric scans o f the ACRP30 blots ± 
S.D.
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Figure 3.9
Sec6 and Sec8 overexpression affect insulin-stimulated deGlc uptake
3.9a Over-expression of FLAG-tagged rsec6 or rsec8.
3T3-L1 adipocytes were infected with empty virus (control) or viruses 
designed to drive over-expression of rsec6 or rsec8 as described in 
Materials and Methods. Lysates were then prepared as outlined and 
immunoblotted with anti-FLAG antibodies. Data from a representative 
experiment is shown in the comer o f Figure 3.9b; Figures to the left 
indicate the approximate positions o f molecular weight markers (kDa).
rsec6 and rsec8 over-expression increases maximal insulin-stimulated 
deGlc uptake,
3T3-L1 adipocytes were infected with empty virus, rsec6 or rsec8-virus 
and deGlc uptake detennined as outlined in Materials and Methods. After 
2h in serum-ft ee media, cells were rapidly washed in KRP buffer at 37C, 
then incubated in the same in the presence or absence o f insulin for the 
indicated times. Shown are representative experiments from over 6 o f this 
type, each point representing triplicate determinations (+ s.d.) at each 
condition. In Figure 3.9b, filled circles are empty-virus infected cells, open 
circles are cells over-expressing rsec8. In Figure 3.9c, filled circles are 
empty-virus infected cells, open circles are cells over-expressing rsec6.
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Figure 3.10 Syntaxin 6 slows the reversai of insulin-stimulated deGlc transport
Day 6 3T3-L1 adipocytes were infected with either empty virus or virus 
expressing the cytosolic domains of Syntaxins 6, 8 and 12, and assayed 
48 h later. Figure 3.10a shows overexpression o f Syntaxins 6, 8 and 12 in 
lysates prepared from infected cells.
Before assay, cells were incubated in serum-free medium for 2 h. Cells 
were stimulated with 1 GO nM insulin for 20 min, and then either assayed 
immediately or washed with KRM to induce reversal o f insulin- 
stimulated deGlc transport for the times shown. DeGlc was assayed and 
Figure 3.10b shows that the rate of reversal of insulin-stimulated deGlc 
transport was significantly slower in cells overexpressing Syntaxin 6, 
compared with the empty virus cells or cells expressing either Syntaxin 8 
or Syntaxin 12.
a
STX6
STX8
STX12
Con Inf
C  100
3
« J  «  (/)
^  3
â g
«2 c/5:  .5k. —H  «s
XRs
%
o Control
■ STX6
» STX8
)* STX12
Time of reversal (min)
72
Figure 3.11 Effect of overexpression of Syntaxins 6, 8 and 12 on 
secretion of ACRP30
Fig 3.1 la  shows a typical immunoblot o f secretion o f ACRP30 from 
3T3-L1 adipocytes overexpressing Syntaxins 6,8 and 12.
The blots from three independent experiments were scanned and the 
results combined
3.1 lb  shows the results from the denstometric scans of the ACRP30 blots 
+ S.D.
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Chapter4 Role of GTPases In ACRP30 secretion
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4.1 Introduction
The impairment of secretion o f ACRP30 by ablation o f transferrin receptor positive 
endosomes (Figure 3.6) strongly suggests that secretion of this protein involves trafficking 
to the cell surface via endosomes. Here I have explored the pathway o f ACRP30 secretion 
from adipocytes.
The control of traffic in the endosomal system is regulated by a range o f small molecular 
weight GTPases of both the Rab and ADP ribosylation factor, or Arf, classes (Fischer et 
al., 1994; Zeriai and McBride, 2001; Donaldson and Jackson, 2000). Arf6, the sole 
member of the Class 111 A rf protein family has been localised to endosomes, endosomal 
tubular-vesicular structures and the PM (D'Souza-Schorey et al., 1998; Gaschet and Hsu, 
1999), where there is evidence for its involvement in the regulation of such diverse 
membrane trafficking events as clathrin-dependent and clathrin-independent endocytosis, 
endosome recycling, regulated secretion and actin remodelling. Many of these functions 
are likely to be a result o f activation o f PIP(5)K and phospholipase D (PLD) and a 
resulting increase o f phosphatidylinositol (4,5)-bisphosphate (Honda et a l, 1999; Brown et 
a l ,  2001). Cell migiation membrane ruffling and phagocytosis are all thought to depend on 
Arf6-regulated actin remodelling (D'Souza-Schorey and Chavrier, 2006). Arf6 has 
previously been implicated in the secretion of adipsin (Yang and Mueckler, 1999) a further 
reason for investigating its involvement in ACRP30 secretion.
Ullrich et al. have shown that Rabl 1 is associated with the pericentriolar recycling 
endosome, (Ullrich et a l , 1996) and Rabl 1 mutants modify the morphology of this 
compartment, and have been shown to influence transport between the early endosome 
and the TON (Wilcke et a l , 2000). Rabl 1 has also been localised to GLUT4-containing 
vesicles and is thought to be involved in the endosomal recycling and sorting o f GLUT4 
(Kessler et a l, 2000).
Because of the involvement o f Rabl 1 and Arf6 in endosomal trafficking and the existence 
of adenoviruses that drive the overexpression of various mutants of these two proteins, 
opportunities exist to explore the pathway of secretion of ACRP30 fi'om 3T3-L1 
adipocytes. In order to define the role o f Rabl 1 in the trafficking of ACRP30,1 
overexpressed a GDP-restricted mutant of Rabl 1 (Rabl 1S25N) in 3T3-L1 adipocytes and 
obseiwed a significant reduction in the secretion o f ACRP30. Studies of GTPase function 
often use dominant negative or constitutively active mutants. Dominant negative mutants
7 5
cannot be activated because they are unable to bind GTP and constitutively active mutants 
are lacking in the GTPase that is necessary to hydrolyse GTP, resulting in mutants that are 
locked in the GDP or the GTP bound confonnation. A1T6 T157A can bind and release GTP 
more quickly than the wild type and is therefore called a fast cycling mutant. It has been 
shown to induce actin rearrangements in HeLa cells and increases motility o f MDCK cells 
(Santy, 2002) Using a fast-cycling mutant o f A1T6 , Arf6-T157A (Santy, 2002), I provide 
further evidence for a role for A1T6 in constitutive secretion from cultured adipocytes. The 
data presented here are consistent with a role for R abl 1 in this secretion and suggests that 
ACRP30 secretion arises mainly tlnnugh recycling TfR-positive endosomes and involves 
Arf6 function.
4.2 Experimental Procedures
4.2.2 A ssay  for secre tio n  of ACRP30
Mature 3T3-L1 adipocytes were grown in 12-well plates. At days 8-11 post-differentiation, 
cells were serum-staiwed for 2h in serum-free DMEM at 37°C. Where the procedure was 
carried out in 10cm plates, cells were washed tlnee times with lOmL Krebs Ringer 
Phosphate buffer (KRP) and at time t=0 this was replaced with 5mL fresh KRP± IpM  
Insulin at 37°C. A t each time point, O.SmL KRP was removed to an eppendorf. In the case 
o f 12 well plates KRP was replaced with 0.5mL fresh KRP± IpM  Insulin at 37°C, and at 
various time points, indicated in each experiment, this was removed to an eppendorf. In the 
12 well plates, each condition was perfonned in thi’ee neighbouring wells, and each 
experiment was perfoimed three times.
In both cases the 0.5mL sample was TCA precipitated (section 2.7), the pellet was 
resuspended in 50pL SDS-PAGE sample buffer containing 20mM DTT (section 2.2.2) and 
20pL was loaded onto a 10% SDS-PAGE gel (section 2.13), and electroblotted onto 
nitrocellulose. Western blots were blocked with 5% Maivel in PBS for Ih at room 
temperature, followed by incubation with rabbit anti-ACRP30 anti-serum diluted 1:2000 in 
PBS containing 1% Marvel for Ih  at room temperature. After thorough washing with 
several changes o f  PBS, blots were incubated with Horseradish Peroxidase (HRP)- 
conjugated donkey anti-rabbit IgG (whole molecule), diluted 1:1000 in PBS containing 1% 
Maiwel for Ih at room temperature. Following thorough washing with several changes of 
PBS, the antigen-antibody complex was detected with enlianced chemiluminescence 
(section 2.15.1) and visualised by autoradiography. The autoradiographs were scanned and
76
quantified denstitometrically, using the image-processing progiamme Image J. The value 
obtained for each was expressed as a percentage o f the value for the control band in each 
experiment, and the results shown are the combination o f three experiments (unless stated 
otheiwise).
4.2.2 infection of 3T3-L1 cells with ad en o v iru ses  d esig n ed  to  drive the 
ov erexp ression  of Rab11S25N, Arf6T157A, wild type ArfS and  Arf5T31N
Day 8 mature 3T3-L1 adipocytes, gi'own in 12-well culture plates were infected with 
adenovirus at a moi o f 50 pfu/cell. The virus was added to the cells in 0.5mL serum-free' 
DMEM  for 4h, after which time 0.5niL DMEM containing 10% (v/v) FCS was added to 
each well. Cells were incubated with virus for 48h, before being assayed for secretion of 
ACRP30.
Cells infected with the Arf6T157A adenovirus and cells infected with the adenovirus 
containing the empty pShuttle vector were lysed 48 h after infection, in 500 pL per well o f 
HES buffer. Lysates were homogenised lOX with a needle and centrifuged at 4°C for 30 
min at 10,000 x g. Proteins were precipitated as described in Section 2.7 and re-suspended 
in 100 p 1 of IX  SDS-PAGE sample buffer. 10 pL was loaded on a 12% gel and 
immunoblotted with rat anti-HA antibody diluted 1:1000 in PBS containing 1% Marvel for 
111 at room temperature. This revealed the presence o f a band o f just over 25 kDa in the 
Arf6T157A virus infected cells, which was absent from the pShuttle virus infected cells.
Ai'f5wt and Arf5T31N adenoviruses both express GFP and confirmation o f expression o f 
these two proteins was carried out microscopically. When > 60% o f cells infected 
expressed GFP, the experiments proceeded.
4.2.3 Ablation of the T ransferrin  receptor-positive endosom al com partm en t 
in 3T3-L1 ad ipocy tes o v erex p ressin g  Rab1125N
Day 8 3T3-L1, adipocytes grown in 12 well culture plates, were infected with an 
adenovirus overexpressing the GDP-locked Rab 11 mutant Rabl 1-S25N, or containing the 
empty pShuttle vector at an moi o f 50 pfu/cell. 48h after infection, half the plates were 
treated to ablation o f the recycling endosome compartment see Section 2.8, after which
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cells were assayed for secretion of ACRP30. IpM  Insulin was added at t = 0 o f the 
secretion assay to experimental plates only.
Cells infected with the Rabl 1-S25N adenovirus and cells infected with the adenovims 
containing the empty pShuttle vector were lysed 48 h after infection, in 500 pL per well o f 
HES buffer. Lysates were homogenised 1 OX with a needle and centrifuged at 4°C for 30 
min at 10,000 x g. Proteins were precipitated as described in Section 2.7 and re-suspended 
in 100 p 1 o f 1X SDS-PAGE sample buffer. 10 pL was loaded on a 12% gel and 
immunoblotted with rabbit anti-myc antiserum diluted 1:1000 for Ih at room temperature. 
This revealed the presence o f a band o f just over 20 kDa in the Rabl 1-S25N virus infected 
cells, which was absent from the pShuttle virus infected cells.
4.3 Results
4.3.1 Rab 11S25N overexpression  inhibits secre tion  of ACRP30
3T3-L1 adipocytes were infected with empty adenovirus or adenovirus containing 
Rabl 1S25N. In Rabl 1S25N virus-infeeted cells, both basal and insulin-stimulated 
secretion of ACRP30 were significantly inhibited by over-expression of Rabl 1S25N as 
shown in Figure 4.1. A small fraction o f ACRP30 secretion was still evident after 
expression o f Rabl 1S25N and this was sensitive to ablation o f the TfR positive 
endosomes, suggesting that Rabl 1S25N is unable to completely inhibit trafficking through 
the recycling endosomes.
4.3.2 Effects of o v erexpression  of a Fast Cycling Arf6 Mutant on ACRP30 
secre tion
3T3-L1 adipocytes were infected with empty virus or virus containing the fast-cycling 
Arf6-Tl 57A mutant. Cells were then assayed for secretion of ACRP30 Over-expression of 
Arf6-T157A stimulated basal secretion o f ACRP30. Insulin treatment o f virus infected 
cells resulted in reduction o f secretion (Figure 4.2).
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4.3.3 Effects of o v erexpression  of wild type ArfS and a GDP-locked m utan t of 
ArfS on ACRP30 secre tio n
Arf5 is a member o f a group o f soluble Arfs that are thought to be involved in the 
recruitment o f coat proteins to membranes during membrane trafficking (Kahn et al.,
2005), and, unlike Arf6, is thought to function in the Golgi and ER. Arf5 is a class II A rf 
and it is suggested that these A rf may have multiple and overlapping functions. In order to 
investigate any possible role for Arf5 in adipocyte secretion, I infected 3T3-L1 adipocytes 
with adenovirus vectors designed to overexpress Arf5 and the GDP-locked Arf5 T31N. 48 
h post-infection cells were assayed for secretion o f ACRP30.
Figure 4.3 is a representative blot which shows that overexpression o f the wild type Arf5 
and the GTP-hydrolysis-deficient Arf5 T3 IN has no effect on secretion o f ACRP30.
4.4 Discussion
Rabl 1 is thought to control recycling between endosomes and the PM. To find out whether 
this GTPase was involved in ACRP30 secretion, I over-expressed a GDP-restricted mutant, 
Rabl 1-S25N in 3T3-L1 adipocytes and examined the effect on secretion. Figure 4.1 shows 
that expression of the mutant significantly reduced basal and insulin stimulated ACRP30 
secretion. This result suggests that, in common with GLUT4, insulin-stimulated secretion 
o f ACRP30 is Rabl  1 controlled. I have previously suggested that ACRP30 and GLUT4 do 
not traffic to the cell surface using the same regulated route (see Chapter 3). The 
involvement o f Rabl 1 may however be a common feature o f the insulin-stimulated 
secretion o f these two proteins. If secretory traffic from recycling endosomes is under the 
control o f insulin, this could be the point at which Rabl 1 controls the trafficking o f 
ACRP30 and GLUT4. This is flirther evidence to support the involvement o f recycling 
endosomes as an intennediate in trafficking o f proteins to the cell surface in 3T3-L1 
adipocytes.
Arf6 has also been implicated in the regulation of trafficking in endosomes, and its 
involvement in the secretion o f adipsin fi om 3T3-L1 adipocytes has been demonstrated. 
Yang and Mueckler showed that overexpressing a dominant negative XTPase mutant o f 
Arf6 in 3T3-L1 adipocytes inhibited basal and insulin stimulated secretion o f adipsin fiom 
these cells (Yang and Mueckler, 1999). I have shown further evidence o f a role for Arf6 in 
secretion from adipocytes by overexpressing the fast cycling Arf6 and demonstrating a 
stimulation o f secretion of ACRP30 in the absence of insulin (Figure 4.2). Treatment with
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insulin however, strongly inhibits secretion. A previous study o f the role of Arf6 in 
membrane traffic, looked at the effects o f overexpressing the mutant Arf6 Q67L in HeLa 
cells (Brown et ah, 2001). This GTP-restricted mutant induced the formation of PIP2- 
enriched, actin coated vacuolar stmctures that were unable to cycle back to the PM, 
implicating PIP2 in trafficking through the Arf6 endosomal recycling pathway, and 
consistent with the role o f PIP 5-kinase as a downstream effector o f Arf6. This result was 
mimicked by over-expression o f PIP 5-kinase, consistent with earlier evidence pointing to 
PIP 5-kinase as a downstream effector of Arf6 and demonstrating that alterations o f 
membrane lipid composition, induced by over-expression o f Arf6 can shut down traffic 
through the Arf6 dependent endosomal pathway. Here I have found that over-expressing 
the fast cycling mutant o f Arf6 increased basal secretion o f ACRP30 but this secretion was 
strongly inhibited by the addition o f insulin. This suggests that under basal conditions Arf6 
T157A induces PIP2 production through the activation of PIP 5-kinase and insulin 
stimulation causes the further activation o f Arf6 T157A, raising PIP2 levels sufficiently to 
cause fonnation o f these large vacuoles identified by Brown and co-workers (Brown et al., 
2001). Therefore overexpressing T157A under basal conditions, may induce PIP2 
production enough to see the increase that I see in Figure 4,2. Stimulation with insulin, 
however could raise PIP2 levels to a point where they become inhibitory, and traffic 
through the Arf6 regulated pathway shuts down, thus explaining the inhibition o f secretion 
seen in the insulin-stimulated samples in Figure 4.2.
Arf6 is a regulatory molecule in the secretory pathway. It may be involved in the control of 
an intracellular pool o f PIP2 (Aikawa and Martin, 2003), through the activation of PIP5- 
kinase. Arf6 also has a role in recycling between the endosomal compartments and the PM 
(Brown et ah, 2001) and is thought to control actin dynamics at the periphery (D'Souza- 
Schorey and Chavrier, 2006). I have presented further evidence that Arf6 is an important 
regulator o f secretion in adipocytes.
Arf5 is a member o f the Class II Arfs that are mainly involved in trafficking in the Golgi 
and ER. Overexpression o f wild type Arf5 and the guanine nucleotide exchange factor 
deficient Arf5T31N had no effect on ACRP30 secretion in 3T3-L1 adipocytes. A previous 
study has shown, using siRNA, that knocking down Arf5 alone had no effect on 
moi*phology o f the Golgi or endosomes or localisation o f coat-proteins. Double knock­
downs however, involving Arf4 and Arf5, showed enhanced Golgi localisation o f the 
KDEL receptor and a 45% impairment o f Tfn recycling (Volpicelli-Daley et ah, 2005).
This apparent need for both Arf4 and Arf5 to be knocked down in order to see functional
8 0
effects could explain why I saw no effect on trafficking o f ACRP30 in cells overexpressing 
Arf5T31N.
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Figure 4.1 Effect of overexpression of RabllS25N on
ACRF30 Secretion
4,1a Reveals the presence o f a band o f  just over 20kDa in the Rabl 1- 
S25N virus -infected cells, which is absent from the pShuttle virus 
infected cells.
4.1b Shows that in Rabl 1S25N virus-infected cells, both basal and 
insulin-stimulated secretion o f ACRP30 are significantly inhibited.
The blots from three independent experiments were scanned and the 
results combined
4.1c shows the results from the denstometric scans o f the ACRP30 blots 
±S.D .
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Figure 4.2 Effect of overexpression of a fast cycling Arf6 mutant on
secretion on ACRP30 secretion in 3T3-L1 adipocytes
Figure 4.2a shows that overexpression o f the fast-cycling Arf6 mutant 
stimulates basal secretion of ACRP30, and that insulin-stimulation o f 
these cells results in inhibition o f secretion.
The blots from three independent experiments were scanned and the 
results combined
4.2b shows the results from the denstometric scans o f the ACRP30 blots 
±S .D .
ACRP30
Arf6-T157A
Insulin
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Figure 4.3 Effect of overexpression of ArfS and Arf5 T31N on ACRP30
secretion in 3T3-L1 adipocytes
Figure 4.3a shows a typical blot o f ACRP30 secretion in cells infected 
with either pshuttle, ArfSwt or Arf5T3 IN. Overexpression o f the virus 
has no effeet on secretion o f ACRP30
Fig4.3b Two independent experiments were scanned and 
densitometrically measured. n=2 ± S.D
0 °# /
ACRP30
5wt 5TN
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Chapter 5 Proteins secreted  by 3T3-L1 adipocytes 
-  A Proteomic Screen
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5.1 Introduction - Secreted proteins from 3T3-L1 
adipocytes
Obesity is one o f the major health problems facing the world in the 21“' century, and is
defined by excess body fat (> 30% o f body weight made up o f adipose tissue). This 
adipose tissue is an endocrine organ that secretes a variety o f metabolic or differentiation- 
controlling honuones called adipokines. Many novel secreted proteins with involvement in 
glucose and lipid metabolism have been identified recently, but the complete picture of 
proteins secreted fi'om fat cells has not been described. In the search for new adipocyte- 
secreted proteins many different approaches have been adopted; adipocyte-specific genes 
have been screened, resulting in the discovery o f resistin (Steppan et ah, 2001a); ID- 
electrophoresis and 2-D-electrophoresis combined with liquid chromatogiaphy-based 
separation and tandem mass spectrometry (MS/MS). Using a combination o f ID gel- 
electrophoresis and nanospray tandem mass spectrometry to analyse the differential 
expression o f secreted proteins between 3T3-L1 pre-adipocytes and day 9 mature 
adipocytes Kratchmarova and co-workers identified four secreted molecules that had not 
been previously shown to be expressed during adipocyte differentiation (Kratchmarova et 
ah, 2002). In another study (Chen et ah, 2005) adopted a quantitative approach, using 2D 
LC-MS/MS to examine the secreted proteome fi'om rat primary adipocytes. They 
compared the difference in secreted proteins between basal and insulin-stimulated cells and 
identified 84 proteins that they believed to be adipokines, 53 o f which had not previously 
been identified as such.
The key aims of this study are to identify new adipokines and to characterise them for their 
biological role and with this aim, I have chosen 3T3-L1 adipocytes as a source o f secreted 
proteins. I have carried out a screen o f the secreted proteins o f mature day 10 3T3-L1 
adipocytes with a view to identifying novel secreted proteins fr om these cells. This clonal 
cell line is a well-accepted model for primary adipocytes and the cells are known to secrete 
resistin, ACRP30, and adipsin (Millar et ah, 2000).They are an excellent model system for 
studying secretion in adipocytes. Since the adipocytes are differentiated from pre­
adipocytes, they provide a valuable source o f reproducible material from which 
conditioned medium can be collected.
This study analyses the total secreted proteome from 3T3-L1 adipocytes by using 2D 
Liquid Chromatography, eoupled to tandem mass spectroscopy. This method separates 
intact soluble proteins by liquid chromatogi'aphy, before subjecting them to the proteolytic
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digestion that precedes mass spectroscopy, and was chosen as an approach for this study 
because it allows a greater scope for inclusion o f all proteins than some o f the earlier 
approaches. 2D-PAGE (polyacrylamide gel electrophoresis), coupled to mass 
spectroscopy, a common approach for proteomic analysis, was tried and rejected for this 
study because o f the problems encountered with solubilising the whole sample in the first 
dimension sample buffer. M any o f the proteins secreted by 3T3-L1 adipocytes are heavily 
glycosylated and the detergent-free buffer first dimension sample buffer proved ineffective 
at completely solubilising the sample. Since one aim of the study was to identify as many 
proteins as possible form the whole secreted proteome, it was necessary to find a way o f 
including the whole sample in the experiment. This was achieved by modifying the sample 
preparation method used by ICratchmarova and co-workers (see section 5.2.1 for details). 
Using this method, I have identified 67 secreted proteins from the Mascot Search results,
25 o f which have not previously been identified as adipocyte-secreted proteins.
Six o f these potential new adipocyte-secreted proteins have been screened for their effects 
on insulin sensitivity in 3T3-L1 adipocytes, on pre-adipocyte conversion to adipocytes and 
on adhesion o f U937 cells to Human Umbilical Vein Endothelial cells (HUVECs).
5.2 Experimental Procedures
5.2.1 P reparation  of sec re ted  protein sam ple  for P roteom ic analysis
The sample was prepared from the conditioned medium o f 3T3-L1 cells using a modified 
version o f  the method used by Kratclunarova et al (Ki'atclunarova et al., 2002). Day 10 
3T3-L1 adipocytes were washed six times using 10ml serum free DMEM per 10cm culture 
dish. The final wash was with semm-free DMEM without phenol red, and the cells were 
left in 8ml semm free DMEM without phenol red for 10 hours. Conditioned medium was 
removed and passed thiough a 0.2pm filter, after which it was dialysed in a dialysis 
cassette with a molecular weight cut o ff 3500 IcDa against distilled H2O. The dialysed 
sample was concentrated in a vacuum centrifuge but not to dryness. When the sample was 
concentrated to approximately lOOpg in less than 100pi, it was used for 2D LC-MS/MS.
IX  10cm plate o f day 10 3T3-L1 adipocytes was washed 6X with 5ml o f serum free 
DMEM, before being incubated in 2.5ml semm fr ee DMEM at 37°C for 2h. The medium 
was collected and the proteins were precipitated with TCA see Section 2.5. The protein
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pellet was re-suspended in 20pl High Urea sample buffer and 1 Opl sample was loaded on 
each o f two lanes o f a 12% SDS-PAGE gel. The gel was stained with Coomassie Brilliant 
Blue stain (see Section 2.16),
5.2.2 Proteom ic analysis
Trypsin digest was perfoiined at 37°C overnight in 25 mM ammonium bicarbonate, 0.1% 
n-octyl-glycoside. Tryptic peptides were dried, resolubilized in 0.5% fomiic acid and 
fractionated by nano flow HPLC on a C l 8 reverse phase column, eluting with a continuous 
linear gradient to 40% acetonitrile over 20 minutes. Eluate was analysed by online 
electrospray tandem mass spectrometry using a Qstar Pulsar XL (Applied Biosystems).
Mass spectrometric analysis was performed in IDA mode (AnalystQS software. Applied 
Biosystems), selecting the four most intense ions for MSMS analysis. A survey scan o f 
400-1500 Da was collected for 3 sec followed by 5 sec MSMS scans o f 50-2000 Da using 
the standard rolling collision energy settings. Masses were then added to the exclusion list 
for 3 mill. Peaks were extracted using the Mascot script (BioAnalyst, Applied Biosystems) 
and automatically exported to the Mascot (Matrix Science) search engine for protein 
identification.
5.2.2 in terpretation of M ascot S earch  R esults
Mascot search results were initially divided into proteins that were known to be secreted 
and proteins not known to be secreted. From the list o f proteins not known to be secreted, I 
removed those that were known not to be secreted i.e. known intracellular proteins. The 
proteins remaining (possible secreted proteins) were analysed using various sequence 
prediction prograimnes, and secreted protein databases, until a final list of likely secreted 
proteins was developed.
Only those proteins with two peptide hits, each with a probability based MASCOT score 
greater than the cut-off score that indicates homology or identity, were included in the list 
o f  secreted proteins. Proteins with only one bold red *or faint red **peptide hits above the 
cut-off score o f  40 were manually validated by checking several parameters in the results.
* Indicating the highest score and first appearance in the list for this particular peptide.
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** Indicating the highest score but not the first appearance for this peptide.
The mass spectrum, included for each protein in the MASCOT search results, displays all 
the labelled, matched fragment ions. Also displayed in the Mascot results are the matched 
fragment ions in tabular form. With the “one peptide” protein hits, I checked that they 
displayed a reasonably full set o f matched y or b ions across the length o f the peptide. 
Where there was not a good set o f y or b ions I further checked the sequence by blast 
searching the section o f the sequence that was well matched for ions. W hen the blast 
search agreed with the original protein identification, I took this as further validation of the 
protein. Where appropriate i.e. when there were amino acids present in the sequence whose 
cleavage would result in strong immonium ions I further validated the sequence by 
checking for the presence o f immonium ions on the spectrum. The 16 proteins that were 
further validated in this way have been included in the list of secreted proteins but are 
listed as manually validated (Table 5.1).
5.2.2 Im m unoblotting of serum  pro te ins
Plasma taken from lean and fatty Zucker rats was re-suspended in 3X SDS-PAGE sample 
buffer containing 50 mM DTT and 5 pL was loaded on a 10% SDS-PAGE gel. Gels were 
immunoblotted for HSP90Ca, HSP70 and orosomucoid. Using rat anti HSP90a diluted 
1:150,000, rabbit anti-HSP70 diluted 1:100,000 and Chicken anti-orosomucoid diluted 
1:500 .HSP90a blots were subsequently incubated horseradish peroxidase conjugated anti­
rat IgG 1:1000; HSP70 blots were incubated with horseradish peroxidase conjugated anti­
rabbit IgG 1:1000 and orosomucoid blots were incubated with horseradish peroxidase 
conjugated anti-chicken IgY 1:1000. All incuabtions were carried out in PBS containing 
1% Maiwel, and all for Ih  at room temperature.
In the case o f blot a., showing HSP90a, the sample was diluted 1:10 in PBS before re­
suspension in sample buffer, and the samples were separated by SDS-PAGE and Western 
blotted, according to sections 2.14 and 2.15.
As a loading control, equal amounts of semm from lean and fatty rats were separated by 
SDS-PAGE and blotted with horseradish peroxidase linked anti-rat IgG, diluted 1:1000 in 
PBS, containing 1% Marvel for Ih  at room temperature.
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5.2.3 D etection of sec re ted  p ro te ins in the  3T3-L1 conditioned  m edium  by 
im m unoblotting
3T3-L1 adipocytes were grown on 12 well culture plates and secretion assay was carried 
out at day 8 post-differentiation as described in section 2.5. Cells were incubated in KRP ± 
IpM  Insulin for lOmin, and secreted proteins were TCA precipitated as described in 
section 2.7. Antibody incubations were carried out as in section 5.2.2.
5.2.4 2 -deoxyglucose uptake by 3T3-L1 cells
Triplicate wells o f 12 well plates o f day 8 3T3-L1 adipocytes were incubated overnight in 
serum-free DMEM containing defined concentrations o f recombinant proteins. Cells were 
washed 3X in KRP and incubated w ith or without insulin (InM  or lOOnM) for 15min at 
37°C. Glucose transport was measured by the assay o f 2-deoxy-D-glucose as described in 
section 2.7, adding an equivalent o f  25uCi [^H] per well. Data was combined from tlrree 
experiments for each protein except autotaxiii and LRG l where two experiments were 
combined.
5.2.3 Oil Red O A ssay
3T3-L1 adipocytes were grown on 12 well culture plates and treated with defined 
concentrations o f  recombinant proteins, on days 0, 2, 4 and 6 o f differentiation, where day 
0 is the first day o f  the addition o f IBMX, dexamethasone and insulin. On day 8 of 
differentiation cells fiom duplicate wells were fixed in 10% foimaldehyde and stained with 
Oil red O as described in section 2.8. Oil Red O stain was extracted from the cells and the 
OD520 was measured.
5.2.4 3T3-L1 Differentiation A ssay
3T3-L1 adipocytes were grown on 12 well culture plates and treated with PF4 (2pg/mL), 
Nni23 (lOng/mL), LRG l (5pg/mL), orosomucoid (5pg/mL), HSP90a (5pg/mL), and 
HSP70 (5pg/mL) on days 0, 2, 4 and 6 o f differentiation, where day 0 is the first day o f the 
addition o f IBMX, dexamethasone and insulin. On day 8 o f differentiation cells from 
duplicate wells were lysed in 125 pL per well of SDS Lysis Buffer. Cell lysates was mixed 
with 3X SDS-PAGE sample buffer containing 50 mM DTT and sample were loaded on a 
10% SDS-PAGE gel and immunoblotted for PPARy and CEBPa.
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Blots were incubated with either mouse anti-PPARy diluted 1:200, rabbit anti-C/EBPa 
1:200, or mouse anti-GAPDH 1:5000 in PBS containing 1% Maiwel for Ih at room 
temperature.
This blot shows results from a single experiment. For each condition, at least two wells 
were combined to make the lysates.
Equal loading was deteimined by immunoblotting for GAPDH.
5.2.5 M onocyte adhesion  to  HUVECs
10"^  HUVECs were seeded into each well o f a 24-well plate and grown at 37°C for 48h. In 
order to remove any potential inflammatory effect caused by endodtoxin contamination o f 
the recombinant proteins, they were pre-incubated with 2pg/mL Polymyxin B sulphate for 
30m The cells were then incubated for 4h with the recombinant proteins indicated in the 
Figure legend, and the cells overlaid with U937 promonocytic cells. U937 cells were 
allowed to adhere for Ih, after which time the monolayers were washed to remove non­
adhering monocytes and adherent cells were counted. At least 300 HUVECs were counted 
in 9 separate fields (3 each from 3 different experiments) and the number o f adherent U937 
cells was calculated per 100 HUVECs for any given treatment.
5.3 Results of proteomic analysis
5.3.1 Proteom ic analysis  of se c re te d  pro teins
We performed 2D LC-MS/MS analysis to identify the secreted proteome o f mature 3T3-L1 
adipocytes. The sample was prepared from the conditioned medium o f 3T3-L1 cells using a 
modified version of the method used by Kratclunarova et al (Kratclunarova et al., 2002). 
Kjratchmarova et a l, suggest vacuum centrifuging the protein sample to dryness before re- 
suspending it in buffer for 2D LC-MS/MS. When following this protocol I experienced 
problems with re-suspending the sample, presumable because o f the presence o f  heavily 
glycosylated proteins like collagen. By stopping the drying process at an earlier stage, the
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resulting sample was more representative o f the entire secreted proteome as there was no 
insoluble material left behind.
Figure 5.1 shows a 10% SDS-PAGE gel, stained with Coomassie brilliant blue o f a typical 
set o f secreted proteins from mature 3T3-L1 adipocytes.
401 candidate proteins were returned from the Mascot search results. A number o f which 
were non-secreted proteins that had leaked into the conditioned medium from dead cells.
To ensure that only secreted proteins were identified, the candidate proteins were validated 
by one or more sequence prediction seiwers. Signal P 3.0 predicts the presence and location 
o f  signal peptide cleavage sites in amino acid sequences, PSORT is a programme for the 
prediction of cellular localisation o f a protein and Secretome P 2.0 produces predictions o f 
non-classical i.e. not signal peptide triggered protein secretion. Using a combination of 
these prediction programmes and previously published data on each o f the proteins, a set of 
67 secreted proteins was compiled, and these are listed in Table 5.1.
An example o f a protein hit that was manually validated is TSC-36/FRP (gi 2498391), 
which has an ions score of 52. This protein scored one bold red * peptide hit with an ions 
score o f 43. Figures 5.2a and 5.2b show the mass spectrum and the ions table respectively 
for this peptide. The peptide sequence is LIQWLEAEIIPDGWFSK. The table o f ions for 
this peptide shows a broken run of y ions in the section IPDGWFSK, and a strong run o f b 
ions in the section IQWLEAE. The shorter section o f the peptide sequence with a strong 
sequence o f b ions was compared against the mus musculus database in BLAST (Basic 
Local Alignment Search Tool) and the results indicated that follistatin-related protein was 
the most statistically significant match. This sequence data gave me reasonable confidence 
that this peptide hit was follistatin-related protein and should be included in the list of 
novel secreted proteins.
Several of the proteins in Table 5.1 were previously identified as being secreted from 
primary adipocytes. As one o f my aims was to identify which o f the proteins secreted by 
primary adipocytes were also secreted by cultured 3T3-L1 adipocytes, I compared the 
results o f this screen with those of Chen and co workers. Table 5.2 shows those proteins 
that are common to both studies.
O f the 84 proteins identified by Chen and colleagues, I show here 14 that are also secreted 
by 3T3-L1 adipocytes. Although previous studies of the secreted proteome o f 3T3-L1 cells 
have identified proteins in common with those secreted by primary adipocytes, there are
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several that do not appear on the list o f primary adipocyte secreted proteins, including 
some o f the co Hagens (types I, II And VI). Chen and co workers suggest that the different 
profiles o f secreted proteins are a likely reflection o f the different biological characteristics 
o f  these two cell types. Our analysis shows that the difference in secreted proteome o f the 
two cells types is not as great as suggested by the comparison of the data o f Chen et al and 
Kratchmarova et al. I have found 14 proteins in common, suggesting that there are clear 
similarities between the two cell types. The relative distribution o f proteins, according to 
type, varied between the two studies, as illustrated in Figure 5.3.
5.3.2 Extracellular Matrix
In addition to the proteins shown in Table 5 .2 ,1 have identified a further 25 novel proteins 
secreted from 3T3-L1 adipocytes cells (Table 5.3). A large proportion (39%) o f these are 
associated with the ECM. This includes matrix proteins and those involved in regulation o f 
the matrix and its attachment to cells. These ECM associated proteins found in my study 
and the study undertaken by Chen et al are listed in Table 5.4. Chen et al have suggested 
that these may represent proteins secreted by 3T3-L1 adipocytes during their adaptation to 
growth in culture. It is true that adipocytes in vivo are surrounded and supported by 
extracellular matrix proteins (Nakajima et al., 1998), which play a dynamic role in the 
differentiation o f adipocytes and the development o f adipose tissue. There is evidence that 
in vivo the ECM is much more than a structural support for cells but is in fact a more 
dynamic element in adipose tissue. It is known that during adipogenesis, the 
differentiation o f a pre-adipocyte into an adipocyte is dependent on the cell changing shape 
and it is thought that this shape change is dependent on remodelling o f the matrix by 
MMPs (Spiegelman and Ginty, 1983; Bouloumie et al., 2001). ECM and ECM-associated 
proteins are involved in processes such as cell movement, tissue remodelling and 
intracellular signalling (Damsky et al., 1992; Mott and Werb, 2004). The extracellular 
matrix also acts as a pool o f proteins that can interact with cells and activate signalling. 
Below I comment on some of those proteins listed in Table 5.4.
Fibronectin Laminin and Vitronectin are adhesive proteins found in the basal lamina. 
They attach cells to the supportive matrix via specialised domains. Fibronectin has several 
binding domains specific for matrix molecules like collagen, and others specific for cell 
surface receptors (integrins) that are known to activate intracellular signalling cascades 
(Potts and Campbell, 1994). Attachment o f  these ECM molecules to cell surface integrins 
is known to activate NFkB, a transcription factor that plays a central role in many cellular 
responses e.g. inflammation, migi’ation, differentiation and development and ECM
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stimulation o f NFkB via integi'ins is necessary for glucose stimulated insulin secretion in 
paneleatic B cells (Hammar et al., 2005; Mott and Werb, 2004), Proteolytic fragments o f 
fibronectin can promote adipocyte differentiation and induce cell migi'ation (Mott and 
Werb, 2004). Decorin (connective tissue) and biglycan (bone and cartilage) are both small 
leucine rich proteoglycans (SLRP) that bind collagen and C lq  and act as inhibitors of 
activation o f the complement cascade and C lq  dependent cytokine production (Groeneveld 
et al., 2005) Versican is a large chondroitin sulphate proteoglycan, found in many tissues. 
Versican has anti-adhesive activity in the globular domain but the carboxy tenuinal is 
involved in the formation of focal adhesions via binding to integi'in. Versican also binds to 
molecules on the surface o f inflammatory leucocytes and has been shown to bind, through 
its chondroitin chains, chemokines involved in inflammation (Hirose et al., 2002).
Perlecan is found in all basement membranes. Its GAGs are mainly heparan sulphate and 
it has a domain that is homologous to the LDL receptor (Murdoch et al., 1992)
5.3.3 Extracellular matrix a sso c ia te d  pro te ins
In addition to the proteins that make up the extracellular matrix, there is a range of 
bioactive molecules in the pericellular matrix, which along with the extracellular matrix 
proteins affect cell behaviour. Some examples o f these proteins were identified in my 
screen (Table 5.4) and are discussed below.
Metalloproteinases are proteases that act on proteins o f the ECM. As well as being 
lesponsible foi lemodelling and degi adation o f the matrix during the progi*ession o f certain 
diseases including invasion o f tissue by cancer cells, they can release cryptic biologically 
active fragments from ECM molecules (Matrisian, 1992). MMP2 exposure o f an epitope 
on collagen IV is required for angiogenesis (Xu et al., 2001). MMP2 acts on decorin to 
release sequestered TGF-p (Imai et a l ,  1997). Anti-angiogenic fragments are also released 
from the NCI domain o f collagen IV (Ortega and Werb, 2002), and from collagen XV and 
perelecan (Ramchandran et a l , 1999; Mongiat et a l , 2003). Metalloproteases also release 
sequestered growth factors like VEGF and TGFp from the ECM (Belotti et a l , 2003; 
Ki'ishnan et a l , 2004), and can alter cell attachment to the ECM via their action on 
syndecan and dystroglycan (Mott and Werb, 2004). MMP2 can be inhibited by a fragment 
o f procollagen C enhancer protein (Mott et a l ,  2000), and also by the action o f serine 
protease inhibitors. Thrombospondin 2 binds to MMP2, resulting in its endocytosis thus 
removing it from the ECM (Bornstein et a l, 2000), Collagens I and IV, fibronectin,
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laminin and vitronectin are all substrates for MMP2. Secreted HSP-90a is an activator o f 
MMP2 (Eustace and Jay, 2004)
Thrombospondin 2 is thought to be involved with the disruption o f focal adhesion 
contacts by binding to cell surface receptors (Sage and Bornstein, 1991). Follistatin 
related protein/TSC-36 is also a member o f the BM-40/SPARC/osteonectin family of 
extracellular glycoproteins, which contain an extracellular calcium binding domain and a 
follistatin-like domain (Shibanuma et a l ,  1993)
MMP2 is known to be responsible for fibronectin degradation during cell migration, 
mesenchymal cell differentiation, enhanced collagen affinity (by cleavage o f osteonectin), 
increased availability of TGF-p and IGF-1, It is also reported to have an anti-inflammatory 
role through the degradation o f IL-1 and monocyte chemo attractant protein 3 (Visse and 
Nagase, 2003). Papilin is an ECM associated protein with homology to ADAMTS 
metalloproteinases (Kramerova et a l ,  2000). Peroxidasin is an ECM stabilising protein 
with peroxidase activity (Nelson et a l ,  1994).
5.3.4 Novel sec re ted  pro te ins
In addition to the ECM associated proteins and the proteins in common with primary 
adipocytes I have identified another gi oup o f proteins that have not previously been found 
in the secreted proteome of adipocytes. Table 5.4 is a list o f potential new adipokines listed 
according to their biological function. This list includes protease inhibitors; proteins 
involved in inflammation, lipid binding and cell giowth and metabolism and includes the 
novel ECM associated proteins.
5.3.5 Inflam m ation asso c ia ted  p ro te ins
27% o f the proteins identified in my screen are inflammation associated, including acute- 
phase proteins, consistent with the strong association between obesity and inflammation. 
Obesity has been described as a chronic low-grade inflammatory eondition (Das, 2001) 
and the condition is accompanied by elevated levels o f inflammatory cytokines such as 
T N F-a and IL-6, contributed, in part, by infiltrating macrophages (Weisberg et a l ,  2003). 
Adipocytes and macrophages share a marked number o f biological and functional 
characteristics. They both express the adipocyte fatty acid binding protein aP2, PPARy and 
the “macrophage” proteins TN F-a, IL-6 and MMPs and under certain stimuli pre­
adipocytes can be made to differentiate into macrophage-like cells (Chaniere et a l ,  2003).
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During the progi'ession of insulin resistance that often accompanies obesity adipocytes 
become enlarged, secrete more pro-inflammatory cytokines like 11-6 and TN F-a and less o f 
the anti-inflammatory adipokine, adiponectin (Xu et al., 2003), In atheroselerotic blood 
vessels macrophages can also become more like adipocytes by accumulating lipids 
(Gargalovic and Dory, 2003).
I have identified six novel secreted proteins that have a potential role in the link between 
obesity and inflammation.
Cyclophilin B has an extracellular role as a strong chemo-attractant for peripheral blood 
lymphocytes and also supports T-cell adhesion to the ECM (Allain et al., 2002). 
Cyclosporin binds to Cyclophilin A, blocking its chemotactic activity and Cyclophilin C- 
associated protein is a secreted glycoprotein and a homologue o f human Mac-2 binding 
protein. It has a role in immune regulation and inflammation and its expression in mouse 
macrophages is up regulated by the pro-inflammatory cytokine T N F-a (Trahey and 
Weissman, 1999). This is a strong indication that the cyclophilins and cyclophilin 
associated proteins could be involved in the inflammatory state in obesity, with secreted 
cyclophilins acting as chemotactic factors and cyclosporin acting as a regulator o f  this 
activity. Platelet factor 4/CXCL4 is a pro-inflammatory chemokine secreted by platelets.
It is a strong chemoattractant for neutrophils and monocytes (Deuel et al., 1981) and is also 
a potent inhibitor of endothelial cell proliferation (Sharpe et al., 1991). Evidence points to 
a possible role for orosomucoid as an anti-inflammatory mediator also secreted by liver, 
endothelial cells and leukocytes. Orosomucoid is a 41kD glycoprotein found in serum. It is 
an acute phase protein, also secreted by macrophages whose serum concentration increases 
with the obese state (Fournier et al., 2000). It binds to sites on the surfaee o f endothelial 
cells. Endothelial cells treated with orosomucoid show increased metabolic activity 
(Sorensson et al., 2000). Plasma levels of orosomucoid are raised in the obese state (Akbay 
et al., 2004). Unnamed protein produce that is homologous to ITIH4 Inter-a-trypsin 
inhibitor is unregulated in inflammation and may be an acute phase protein (Duan et al., 
2005). Sex limited protein shows homology to eomplement C4 but has no complement 
activity (Nonaka et al., 1985).
5.3.6 Growth and differentiation
It is known that adipocytes are a source o f factors that can affect cell growth and 
differentiation, including TGF-p, VEGF and IGF. I have identified four possible new 
adipokines that have a role in giowth and differentiation in other cell types.
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I Factor is a secreted nucleoside diphosphate kinase (NDPK-A) that is encoded by the 
NM23 gene and is sometimes called Nm23 protein. It is a differentiation inhibitory factor 
in the mouse myeloid leukaemia M l cell line (Okabe-Kado et a l , 1995). Follistatin 
related protein. In human lung cancer cells, FRP had negative regulatory effects on 
growth. FRP is the product o f expression o f the TGF-p induced gene TSC36. (Sumitomo et 
al., 2000). It inhibits proliferation and migi'ation in vascular smooth muscle cells and 
inhibits invasion in human lung cancer derived cells (Johnston et a l ,  2000). Leucine rich 
a2-g!ycoprotein is a marker o f gi'anulocytic differentiation (O'donnell et a l , 2002)
5.3.7 O ther pro teins
Selenium binding protein is similar to liver fatty acid binding protein and is known to be 
involved in Golgi protein transport (Porat et a l ,  2000). I have included it here as a putative 
secreted protein because it is predicted to be a non-classical secreted protein by the 
Secretome P server. It has previously been identified in plasma (Morrison et a l ,  1989).
H SP 9 0 a  is secreted by vascular smooth muscle cells and behaves like an oxidative stress 
factor and activates ERK.1/2 (Liao et a l ,  2000). It is also secreted by fibrosarcoma cells 
where it binds to, and inactivates MMP2, suggesting that this heat shock protein has a 
regulatory role in the process o f cell invasion (Eustace and Jay, 2004). HSP70 is now 
recognised as a secreted protein that is involved in immune regulation. Exogenously added 
HSP70 stimulates the production o f pro-inflammatory cytokines in monocytes, tlrrough 
activation o f NF-kB (Eustace et a l ,  2004a).
5.4 Functional studies on six proteins
I selected six proteins from the gi oup o f proteins that had not previously been identified as 
being secreted by adipocytes on which to carry out hinctional studies. These proteins were 
selected because of their potentially interesting role as adipokines, based on what was 
published about their effects in other experimental systems. Another criterion for selecting 
these particular proteins was the commercial availability o f recombinant or purified 
proteins and suitable antibodies for the following studies.
5.4.1 Introduction
Considering the possibility that some o f these novel secreted proteins might have a 
physiological effect on either adipocytes or other cells, I examined the effects of several o f 
these proteins on three aspects of gi owth and metabolism in 3T3-L1 adipocytes. Firstly, I
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measured the effects of these proteins on glucose uptake in 3T3-L1 adipocytes. Several 
adipokines have been shown to affect insulin signalling (Uysal et al., 1997) and it has been 
suggested that they do this by acting through NF-kB (Yuan et al., 2001) and the JNK/AP-1 
signalling pathways (Hirosumi et al., 2002) thus enhancing the inflammatory state and 
decreasing insulin sensitivity.
Secondly, I examined the effects o f the putative adipokines on the differentiation of pre­
adipocytes into adipocytes. The protein Nm23 is an inhibitor o f differentiation in certain 
haematopoietic cell lines (Willems et a l ,  2002; Okabe-Kado et a l ,  1995). Platelet factor 4 
induces the differentiation o f monocytes into macrophages (Scheuerer et a l ,  2000) and 
influences the differentiation o f monocyte derived dendritic cells (Xia and Kao, 2003). The 
leucine-rich a-2-glycoprotein (LRG l) is an early marker o f granulocyte differentiation 
(O’donnell et a l , 2002).
I also investigated the effects o f these proteins on adhesion of the human promonocytic cell 
line U937 to human vascular endothelial cells. The vascular endothelium forms a layer on 
the inside o f blood vessel walls, acting as a banier between blood components and the 
underlying interstitium (Risau and Flamme, 1995). Mononuclear cell invasion into the 
vascular wall is an important initial step in the development of atherosclerosis. Under 
certain conditions, including the effects of some cytokines, endothelial cells are stimulated 
to produce an inflammatory response that includes the expression o f adhesion molecules. 
Integrins and other ligands on the surface o f  monocytes bind to these adhesion molecules 
and migiate into the sub-endothelial space where they transform into macrophages (Lusis, 
2000). T N F-a induces the expression o f adhesion molecules on the surface o f endothelial 
cells and it has been shown that ACRP30 inhibits the surface expression o f several o f these 
adhesion molecules thus reducing monocyte adhesion (Ouchi et a l ,  1999). Other 
adipokines increase monocyte adhesion, enable migration of monocytes, or enhance their 
conversion into macrophages. Angiotensinogen is the precursor o f Angiotensin II, which 
stimulates the expression of the adhesion molecules ICAM-1 and VCAM-1 in endothelial 
cells (Tham et a l , 2002) and increases macrophage accumulation in the vascular wall 
(Wang et a l ,  2001b). Another adipokine PAI-1 is involved in thrombus formation (Sobel, 
1999) and circulating levels of PAI-1 are associated with atherosclerosis (Thogersen et a l ,  
1998). Obesity is associated with increased risk of cardiovascular disease and the 
association has not been fully explained at the molecular level. Orosomucoid binds to sites 
on the surface o f endothelial cells and endothelial cells treated with orosomucoid show 
increased metabolic activity (Sorensson et a l ,  2000).
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PF-4 has previously been shown to induce neutrophil adhesion to endothelial cells (Kasper 
et ah, 2004) and has not been included in this assay.
5.4.2 Confirm ation of secre tion  of newly identified secre to ry  p ro te ins from 
3T3-L1 cells by im m unoblotting.
To confirm the secretion o f these proteins identified by proteomic analysis, secretion 
assays were performed as described previously. Supernatant from basal and insulin 
stimulated 3T3-L1 adipocytes was TCA precipitated and the resulting precipitated proteins 
weie sepaiated on SDS-PAGE gels, electro-blotted onto nitrocellulose membrane and 
detected by Western blotting. Figure 5.4 shows a panel o f blots. O f the proteins tested by 
this method only HSP-70, FlSP-90cc and Orosomucoid were detectable in the supernatant 
fi'om 3T3-L1 adipocytes. LRG-1 was not included in this panel because of the lack of a 
commercially available antibody. Platelet factor 4 and Nm23 could not be detected in 
supernatant secreted from 3T3-L1 adipocytes by immunoblotting. It is not clear why these 
proteins cannot be detected immunologically. It is possible that they are secreted at levels 
that are too low to be detected by the available antibodies, or that the antibodies are not o f 
high enough affinity.
5.4.3 D etection by Im m unoblotting of newly identified p ro te ins in the p lasm a 
of lean and  fatty Zucker rats
Zucker rats suffer from a recessive mutation in the leptin receptor, Ob-R . Animals that are 
homozygous for the mutation (fa/fa) eat more, build up more fat and quickly become 
insulin resistant. Zucker rats are used as an animal model o f genetic obesity (Stem et al., 
1972). The rats are genotyped at birth and divided into lean and fatty animals before the 
phenotype is expressed. Plasma from lean and fatty animals was analysed by Western 
blotting for the piesence and relative levels o f the newly identified secreted proteins. Equal 
volumes o f either lean or fatty plasma were loaded on SDS-PAGE gels and these were 
immunoblotted with antibodies for HSP90a, HSP70, orosomucoid, PF4 and Nm23. Figure 
5.5 shows that HSP90a, HSP70 and orosomucoid can be detected by immunoblotting in 
the plasma o f lean and fatty Zucker rats and levels o f these proteins are raised in the 
plasma o f the fatty animals. It has not been possible to detect PF4 or Nm23 in either o f the 
serum samples. The CXC family o f cytokines, o f which PF4 is a member, are found in 
pico gi-am to nano gium amounts per mL in serum (Rotondi et al., 2005), a concentration 
that is too low to be detected by Western blotting. Human Nm23 circulates in serum at less 
than 10 iig/mL (Okabe-Kado and Kasukabe, 2003). PF4 and Nm23 m aybe secreted by
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3T3-L1 adipocytes in concentrations that are too low to be detected by immunoblotting, or 
the antibodies may not be o f a high enough affinity to detect the proteins in plasma.
5.4.4 Effects of sec re ted  pro te ins on uptake of 2-deoxy-D -glucose in insulin- 
stim ulated  3T3-L1 ad ipocytes
Proteins secreted by adipocytes are involved in regulating many biological processes .Of 
particular interest in the field o f diabetes and obesity is the gi'owing evidence of a role for 
certain adipokines in the development o f insulin resistance.
To investigate whether the proteins play a role in insulin-stimulated GLUT4 translocation 
day 8 3T3-L1 adipocytes were incubated overnight in serum free DMEM containing the 
proteins PF4 (1 pg/mL), orosomucoid (10 pg/mL) and (30 pg/mL), Nm23 (200 ng/mL), 
LRGl (150 pg/mL), HSP-90a (1 pg/mL) and (0.1 pg/mL), before assaying the cells for 
insulin stimulated uptake o f 2-deoxyglucose (see Section 2.11). Fig 5.6 shows the 
effects o f treatment with various proteins on 2-deoxyglucose uptake. The concentrations 
for this experiment were decided by extrapolating from serum concentrations (where 
known) e.g. orosomucoid circulates in the semm o f nonual individuals at concentrations of 
around Img/mL (Easton et al., 1962). I deduced that concentrations secreted by adipocytes 
would likely be much lower and decided to start with 10 and 30 pg/mL. Platelet factor 4 is 
an example of a CXCL cytokine and they have been found circulating in serum in pg/mL- 
ng/mL concentrations (Easton et a l ,  1962), and initial experiments were carried out with 
these concentrations, gi’adually increasing to 1 pg/mL when no effect was seen at the lower 
concentrations, Autotaxin was included in the initial 2-deoxyglucose uptake experiments 
because 1 originally identified it as a potential new adipokine. It was however subsequently 
identified by another gioup profiling secreted proteins during adipocyte differentiation 
(W ang et a l ,  2004), and was not therefore included in subsequent experiments.
Orosomucoid decreased insulin-stimulated glucose uptake by 20-40% in maximally 
stimulated cells and by up to 50% in cells stimulated with InM insulin. It has been shown 
that low-gi ade inflammation as measured by the presence o f inflammatory semm proteins 
like orosomucoid and haptoglobin contributes to the regulation o f insulin sensitivity and 
lipid metabolism (Heliovaara et a l ,  2005), although there is no clear evidence to suggest 
that these inflammatory proteins directly influence molecule transporters (Flower et a l , 
1993), Other members o f this family include the plasma retinol binding proteins, one of 
which, RBP4 has recently been shown to contribute to insulin resistance in obesity and 
type 2 diabetes (Flower et a l ,  1993), Like RBP4, elevated levels o f orosomucoid are
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found in obesity and its presence in serum is a predictor o f the development o f diabetes 
(Duncan et a l ,  2003). Secreted orosomucoid has also been detected in the urine o f patients 
with non-insulin dependent diabetes (Ito et al., 1989), where it is a strong predictor o f 
cardiovascular disease and mortality (Christiansen et a l , 2002).
Autotaxin reduced insulin stimulated glucose uptake by 20-40%. This could be an effect o f 
Autotaxin binding to the insulin receptor as it has been found to co-precipitate with the 
insulin receptor a-subunit (Belfiore et a l ,  1996; Maddux and Goldfme, 2000), and is an in 
vitro inhibitor o f insulin receptor tyrosine kinase activity (Sbraccia et a l ,  1991) (Maddux 
et a l ,  1993) (Maddux et a l , 1995). Autotaxin is secreted from adipocytes and its 
expression is up regulated in the db/db mouse model of obesity, and is up regulated in 
insulin resistant patients (Boucher et a l , 2005), suggesting a possible link with insulin 
resistance. It has been reported that cellular levels o f Autotaxin were inversely coiTelated 
with insulin sensitivity in skeletal muscle cells (Maddux et a l , 1995).
Figure 5.6 shows that Platelet factor 4, Nm23 and LRG 1 had no significant effect on 
insulin stimulated 2-deoxyglucose uptake at the concentrations tested. HSP70 and HSP90a 
had no significant effect on insulin stimulated 2-deoxyglucose uptake at the concentrations 
tested.(Data not shown for HSP 70 and HSP90).
5.4.5 Effects of novel sec re ted  pro te ins on the differentiation of 3T3-L1 
ad ipocy tes
The proteins PF4 (2 pg/mL), Nm23 (10 ng/mL), LRGl (5 pg/mL), orosomucoid (5pg/mL), 
HSP-90a (5 pg/mL) and HSP-70 (5 pg/mL) were added to differentiating cells to ascertain 
whether they would have any effect on the differentiation process. Proteins were added on 
days 0, 2, 4 and 6 o f differentiation, day 0 being the day o f addition o f dexamethasone, 
IBMX and insulin (see section 2.4.7). Differentiation was assayed by both Oil Red O 
staining as described in section 2.12 and western blotting o f cell lysates for the expression 
o f the transcription factor C/EBP-a, which is expressed during pre-adipocyte conversion to 
adipocytes. If any o f these recombinant proteins acts as a differentiation inhibitor, we 
might expect to see a reduction in the intracellular level o f C/EBPa.
Oil Red O is a suspension o f Sudan Red stain, which stains lipids. Wlien 3T3-L1 
adipocytes are fixed and stained with this dye, the intracellular lipid droplets stain with 
Sudan red. This is a measure o f differentiation, since fat cells accumulate lipids as they 
differentiate. After staining, the Sudan Red is extracted from the cells and the amount o f
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dye is measured with a spectrophotometer. Figure 5.7 shows the Sudan Red extracted from 
the treated cells and measured as the OD520. Two recombinant proteins HSP 90a and 
LRGl show a statistically significant increase in uptake of Oil Red O. This increase is very 
slight and is unlikely to be biologically significant.
Differentiation was also assayed by examining the expression o f the transcription factors 
C/EBP a  and PPARy. C/EBPa and PPARy are transcriptional activators that are expressed 
during adipocyte differentiation and result in the expression o f adipocyte-specific proteins 
(Ramji and Foka, 2002). 3T3-L1 cells were incubated in the presence o f various secreted 
proteins during the differentiation process, at the end of which cells lysates were prepared. 
Equivalent amounts of these lysates, as deteimined by blotting for glyceraldehyde-3- 
phosphate dehydrogenase (GAPDH), were analysed by SDS-PAGE and western blotting 
for the expression o f C/EBPa and PPARy. Figure 5.8 shows a panel of Western blots from 
this experiment. Lysates made fr om cells treated with recombinant proteins orosomucoid, 
Nm23, LRG l, HSP90a and HSP70 did not show an obvious increase in expression o f 
C/EBPa. Treatment with PF4 may be causing an increase in expression o f C/EBPa, 
through an inflammatory response. It has been shown that C/EBPa is up-regulated in some 
cells that have been exposed to inflammatory cytokines (Wang et al., 2001a).
5.4.6 Effects of sec re ted  p ro te ins on m onocyte adhesion  to vascu lar 
endothelial cells.
Human vascular endothelial cells (HUVECS) were incubated with either TN F-a, which 
evokes a pro-inflammatory response or with Orosomucoid (Img/mL), LRGl (0.75|ug/mL), 
HSP70 (0.75 pg/mL) and H SP90a (0.75 pg/mL). It was decided to start with 
concentrations that were close to those found in serum, and gradually increase these until 
an effect was seen. Orosomucoid is an acute phase protein that circulates in semm and has 
been measured in the serum of control individuals at concentrations o f between 0.235 and 
3 pg/mL, and with this as a guide I decided to start with 0.75 pg/mL for both of the heat 
shock proteins (Njemini et al., 2003). Following a four-hour incubation with these proteins, 
HUVECs were assayed for their ability to bind U937 promonocytic cells. After fixing the 
cells with formaldehyde, monocyte adhesion was assayed by counting the number o f 
adherent cells per 100 HUVECs for any given treatment. Figure 5.9 shows the monocyte 
adhesion as a percentage o f the value obtained from the TN F-a stimulated cells.
Incubating HUVECs with either Img/mL orosomucoid significantly decreased the 
adhesion o f  U937 monocytes to these cells. Monocyte adhesion to endothelial cells is the
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important initial step in their migi'ation through the endothelium and into the vascular 
interstitium, where they fonu lesions that eventually become atherosclerotic plaques 
(Lusis, 2000). Several adipokines are known to be involved in the various stages of 
formation of atherosclerotic lesions (see 5.3.1). This finding that orosomucoid is acting as 
an anti-inflammatory agent on endothelial cells, coupled with the fact that it is found in 
increased levels in the serum of fatty Zucker rats, suggests a role for orosomucoid as an 
anti-inflammatory adipokine.
5.5 Discussion
O f the 67 probable secreted proteins in Table 5.1, 39% are ECM proteins. This is a higher 
percentage than that found by Chen and colleagues (Chen et al., 2005). They suggest that 
the secreted proteome from 3T3-L1 adipocytes may have different characteristics from the 
primary adipocytes used in their study, on account of the physiological changes that 3T3- 
L1 cells have undergone by adapting to the cultured environment and that the extracellular 
matrix proteins secreted by 3T3-L1 adipocytes are stimulated in the culture o f these cells. 
The protocol used by Chen and co-workers involves a collagenase digestion step which 
will remove collagens and severely dismpt the extracellular matrix. All adipose tissue in 
vivo secretes and is supported by an extra-cellular matrix, and therefore by including the 
extracellular matrix proteins in the proteome we see a more representative set o f secreted 
proteins.
A number of proteins were identified in this study as potential new adipokines, several o f 
which exhibited effects in functional assays to measure their effects on; insulin sensitivity 
in 3T3-L1 adipocytes; differentiation from pre-adipocytes to adipocytes and adhesion o f 
U937 promonocytic cells to Human Umbilical Vein Endothelial cells
Orosomucoid exhibited anti-inflammatory properties by decreasing monocyte adhesion to 
human vascular endothelial cells. It also significantly inhibited insulin-stimulated glucose 
uptake. Orosomucoid has previously been shown to have anti-inflammatory or protective 
effects against inflammation (Kuzuhara et a l , 2006; Hochepied et a l ,  2003). It strongly 
inhibits platelet aggregation (Costello et a l ,  1979) and more specifically, has been shown 
to interact directly with lipopolysaccharide (LPS), but the mechanisms by which it works 
are not known. It is a 41-43 kDa protein, which is composed of approximately 45% 
carbohydrate (five complex V-linked glycans)(Yoshima et a l , 1981). Changes in these 
sugar residues appear early in the acute-phase o f the inflammatory response, and IL-1, IL-6 
and TN F-a appear to be involved in these modifications (van Dijk and Mackiewicz, 1995).
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It has been suggested that the immunoprotective effects of orosomucoid are glycosylation 
dependent. Experiments have shown that desialylation o f orosomucoid enhances its effect 
on platelet aggiegation (Costello et a l ,  1979). Williams and co-workers have suggested 
that a sialyl Lewis X fonn of orosomucoid which is induced during inflammation, could 
mediate the immunomodulatory effects o f the protein, since sialyl Lewis X is a ligand for 
the cell adhesion molecules E-selectin and P-selectin, both o f which are involved in 
monocyte adhesion to endothelial cells (Williams et a l , 1997).
Like Orosomucoid, Nm23 significantly reduced insulin-stimulated glucose uptake. The 
mechanisms by which it does this are unclear and further investigations o the actions o f 
this protein will be necessary.
LRGl and HSP90 appeared to have a small but statistically significant effect on Oil Red O 
uptake in differentiating 3T3-L1 adipocytes, suggesting that treatment with these 
recombinant proteins increased differentiation. Lysates made from cells treated with LRGl 
and HSP90a during differentiation showed no obvious increase in expression o f C/EBPa. 
Treatment with recombinant PF4 may cause an increase in expression o f C/EBPa.
Neither o f the secreted heat shock proteins, HSP70 nor FISP90a identified in this study had 
any effect in the functional assays, at the concentrations or times tested. They were both 
detected in the conditioned medium from 3T3-L1 adipocytes, and in the semm o f lean and 
fatty Zucker rats, by Western blotting. Both o f the heat-shock proteins appeared to be more 
abundant in fatty Zucker serum, than in lean, suggesting that these proteins are increased in 
obesity, and may play a role in the development of this condition. Previous studies have 
shown that extracellular HSP 70 and HSP90a have a pro-inflammatory effect on rat 
microglial cells, resulting in expression o f cytokines, by activating NF-kB and p38- 
mitogen-activated protein kinase (MAPK), through the Toll-like receptor TLR4 (Kakimura 
et a l ,  2002). In this assay, cytokine production was seen after incubating migroglia for 24h 
with lOpg/mL o f the HSPs. I saw no effect on endothelial cells treated for 4h with 5pg/mL. 
Further experiments are necessary to investigate the effects o f different doses and 
incubation times o f HSPs on endothelial cells.
The proteomic screen o f proteins secreted by 3T3-L1 adipocytes has identified a range of 
proteins with the potential to be adipokines. Several o f the proteins identified have been 
shown to influence the frmction o f other cells. The anti-inflammatory effects o f 
orosomucoid on HUVECs makes it a potential factors in atherosclerosis development. 
Orosomucoid, an acute-phase serum protein that has been found to be elevated in obesity
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and Type II Diabetes, significantly decreased insulin-stimulated glucose uptake in 3T3-L1 
adipocytes, making it a potential contributor to insulin resistance. These effects may be 
difficult to reconcile as they suggest that the same protein appears to ameliorate a condition 
associated with obesity, while appearing to worsen another. Until the mechanisms involved 
in these effects are elucidated, it is difficult to explain this anomaly. This question 
reinforces the need for further work to examine the biological activities and the 
mechanisms of action of these potential new adipokines.
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Figure 5.1 SDS-PAGE of Proteins secreted from 3T3-L1 adipocytes
Figure 5.1 shows an SDS-PAGE representation o f the proteins in the sample 
used for proteomic analysis
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Figure 5.2
Mass Spectrum and Ions score data for manually validated protein
Figure 5,2a shows the mass spectrum for the manually validated protein 
hit; TSC-36/FRP (gi 2498391).
Figure 5.2b is the ions score table for TSC-36/FRP (gi 2498391).
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Figure 5.3 Distribution of secreted proteins by function
Pie-charts illustrating relative distribution o f secreted proteins between 
this study and the study o f Chen and co-workers (Chen et a l , 2005)
Figure 5.3a shows the distribution, according to function, o f proteins 
identified in this study
Figure 5.3b shows the distribution, according to function, o f the the 
combined proteins identified in this study and in the study o f Chen and 
co-workers.
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Figure 5.4 Secretion of HSP70, HSP90a and Orosomucoid by
3T3-L1 adipocytes
Figure 5.4 shows that HSP90a, HSP70 and orosomucoid are detectable 
by immunoblotting in the conditioned medium from 3T3-L1 adipocytes.
This is a single experiment n=l
a insulin +
hsp90
insulin +
hsp70
insulin
orosomucoid
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Figure 5.5
HSP90a and Orosomucoid in plasma from Lean and Fatty Zucker Rats
HSP90a, HSP70 and orosomucoid are detectable in plasma, by 
immunoblotting. HSP90a and orosomucoid are present in higher levels in 
the plasma o f Zucker Fatty rats than in Zucker Lean rats. HSP70 is 
detectable in the plasma of Zucker Fatty rats, but not detectable by this 
method in the plasma o f Zucker Lean rats.
To show that equal volumes o f serum were loaded in each well, samples 
were blotted with ant-ratlgG.
Each blot shows the results from one experiment. n=l
83-
47.5-
-Orom
-HSP70
-HSP90a
-igG
lean obese
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Figure 5.6 Effect of recombinant proteins on Insulin-Stimulated
2-Deoxy-D-Glucose uptake in 3T3-L1 adipocytes
Pre-incubation o f 3T3-L1 adipocytes with lOpg/mL or 30pg/mL 
orosomucoid resulted in a significant reduction in insulin-stimulated glucose 
uptake by 3T3-L1 adipocytes.
Pre-incubation with Nm23 resulted in a small but statistically significant 
reduction.
The results from each condition are expressed as a percentage o f the control 
sample (no protein treatment, stimulation with lOOnM insulin).
* Indicates a result with a value o f p < 0.05.
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Figure 5,7 Oil Red O Uptake by 3T3-L1 adipocytes treated with 
recombinant proteins
Incubation o f 3T3-L1 adipocytes with Spg/mL H SP90a or with 75ng/mL 
LRGl during differentiation o f pre-adipocytes, resulted in a small but 
statisicaliy significant increase in uptake o f Oil Red O.
The results are expressed as OD520
The results shown are the combined results of n =3 for all recombinant 
protein, except HSP70 (n=2).
* Indicates a result with a value o f  p < 0.05.
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Figure 5.8 Expression of the transcription factors CEBPa and
PPARy in 3T3-L1 adipocytes treated with recombinant proteins
Incubating 3T3-L1 adipocytes with PF4, orosomucoid, Nm23, LRGl, 
HSP90a and HSP70 had no effect on expression o f  the differentiation 
associated transcription factor PPAR-y. There appears to be an increase 
in the expression o f C/EBPa with PF4-treated 3T3-L1 adipocytes. These 
blots shown are from a single experiment, in which at least two wells 
were combined to make each lysate.
Equal loading was determined by immunoblotting for GAPDH.
m m
'
—  — : * * *
C/EBPa
PPAR-y
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Figure 5.9 Adhesion of U937 monocytes to HUVECs treated with 
recombinant proteins
Human Umbilical Vein Endothelial Cells incubated with Img/mL 
orosomucoid, resulted in a significant decrease in adhesion of U937 cells.
This shows an n =3. Error bars show standard deviation
^ Indicates a result with a value o f p < 0.01
o<D 0 )Q .s i | i
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Table 5.1 3T3-L1 adipocyte-secreted proteins identified by proteomic analysis
Table 5.1
Protein Score Function Database
Accession
Number
PEDF 173 Serpin gi 2961472
Serine protease inhibitor 75 Serpin gi 27806487
Unnamed Prot product 326 Trypsin Inliib? g i 12836422
Adipsin 172 Ser. protease g i 673431
Complement C lr 149 S er .protease/Inflamm gi 12963529
Complement C l s 82 Ser.protease gi 21450097
Complement C lq 159 Ser.protease g i 6137745
Complement C3 1513 Inflammation g i 28175786
Complement C3d 101 Inflammation gi 9954969
Complement C4 817 Inflammation gi 2944420
Angiotensino gen 853 Serpin gi 113881
MIF 100 Pro-inflammatory
cytokine
gi 694108
ACRP30 121 Inliibitor o f Inflammation gi 21426809
Haptoglobin 620 Acute phase protein gi 2144486
ceruloplasmin 201 Ferroxidase gi 6680997
Extracellular SOD 229 Antioxidant/ gi 3320907
Periostin 107 Activin binding gi 7657429
Lipoprotein lipase 426 Lipid metabolism gi 387406
Lipid binding protein 1726 Lipid binding gi 3318748
PE binding protein 199 Lipid binding gi 12841975
IGF BP 7 395 Binds IGF gi 28502909
CyC C-AP 348 SCY chemokine gi 397800
Cyclophilin A 89 Chemotaxis gi 1431788
Nucleobindin 122 Ca binding gi 6679158
Platelet factor 4/ CXCL4 84 SCY cytokine/chemotactic gi 266800
Tln*ombospondiii2 312 Adhesive glycoprotein gi 6755779
Orosomucoid 273 Acute phase protein g i 15215270
Selenium binding protein 117 Se/lipid binding gi 134259 (NCS)
Sex limited protein 491 Acute-phase gi 220604
Collagen VI a  1 657 ECM gi 6753484
Collagen VI a 2 328 ECM gi 3913189
Collagen VI a3 1493 ECM gi 31791061
Vimentin 139 IF gi 5030431
Fibronectin 193 ECM gi 38372875
Laminin B1 206 ECM gi 126367
GelatinaseA/MMP2 69 Regulation of ECM gi 1813503
ECM associated protein 154 SPARC-like g i 1498641
Osteonectin 146 SPARC/HSP45 gi 600381
Autotaxin-t 392 M onocyte chemotaxis 
5 ’-nucleotide PDE activity
g i 1160616
Gelsolin 227 Actin binding gi 2833344
HSP 90a 102 MMP2 activation gi 41200885
Protein Score Function Database
Accession
Number
HSP 70 377 Secreted HSP/cytokine gi 72288
Fibulin-2 174 ECM gi 4959705
Similar to Collagen XV 65 ECM gi 34868476
Perlecan 92 ECM g i 6680311
Versican 54 ECM gi21361116
Vitronectin 73 ECM gi 73587073
Lamnin a4 401 ECM g i 1869967
Decorin 151 Sm. proteoglycan g i 6681143
Biglycan 499 Sm. proteoglycan gi 348962
Leu.richa-2 glycoprotein 88 secreted glycoprotein g i 16418335
N D PK B 84 ?same as I factor gi 6679078
Manually Validated 
confident
a-am ylase 67 Digestive enzyme gi 67370
Thioredoxin 50 Cytokine gi 16740761(NCS)
ApolipoproteiiiA-I bp 67 Lipid binding g i 21553309
CyP-Sl 60 ? Chemotactic g i 2118329
Cathepsin B 52 Cys. Protease(Lysosomal) gi 227293
Laminin B2 67 ECM g i 293691
Unnamed protein product 56 Likely leucine 
aminopeptidase
gi 195269(NCS)
TSC-36/FRP 52 Inliibition o f  growtlVdiffn gi 2498391
Nm23/I Factor 67 Inhibition o f  differentiation gi 35068
Leucine aminopeptidase 57 M l secreted peptidase g i 13161142
Serpin 3n 81 Serpin gi 75765653
MV not confident
Thrombospondin 1 45 Adhesive glycoprotein gi 567240
PBEF/visfatin 43 Cytokine g i 10946948
MKIAA02320/peroxidasin 52 ECM stability g i 28972103
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Table 5,2 Common proteins identified by this study and by Chen
and co-workers
Table 5.2
Protein Database accesssion number
PEDF g 2961472
Adipsin g 673431
Complement C l g 12963529
Complement C4 g 2944420
Angiotensinogen g 113881
MIF g 694108
ACRP30 g 21426809
Haptoglobin g 2144486
Lipoprotein lipase g 387406
IGF bp7 g 28502909
Cyclophilin A g 1160616
Nidogen g 6754854
Gelatinase A/MMP2 g 1813503
Collagen IV a  1 g 34879634
Vimentin g 5030431
Laminin B g 126367
Nucleobindin g 189308
Cathepsin B g 227293
Gelsolin g 2833344
Thioredoxin
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Table 5.3 Extracellular Matrix Proteins identified in both
this study and that of Chen and co-workers
Table 5.3
Protein Functon Database Accession 
number
*Procollagen V a  2 ECM gi 6680970
* Laminin B ECM gi 817975
**ADAMTS-17 Matrix metalloproteinase gi 37999850
*M M P2 ECM regualtion g i 13591991
**MMP 9 ECM regualtion gi 13591993
**TIMP-1 ECM regulation gi 1174697
*nidogen ECM interaction gi 6754854
* osteonectin SPARC g i 600381
** Laminin y-1 chain ECM gi 20825636
** tetranectin ECM g i27721871
Thrombospondin 2 Adhesive glycoprotein gi 554390
MKIAA02320/peroxidasin ECM stability g i28972103
Fibulin-2 ECM gi 4959705
ProcollagenC proteinase ECM associated gi 6919942
enhancer
Collagen I a l ECM gi 2506305
Collagen I a l ECM gi 16758080
Collagen II a l ECM gi 109679
Collagen III a l ECM gi 2119163
* Similar collagen IV a  1 ECM gi 34879634
Collagen VI a  1 ECM gi 6753484
Collagen VI a2 ECM g i 3913189
Collagen VI a3 ECM g i 31791061
Collagen VII a  1 ECM gi 6680972
Similar to Collagen XV ECM gi 34868476
Fibronectin ECM gi 38372875
Perlecan ECM gi 6680311
Papilin ECM proteoglycan g i 18700030
Versican ECM gi21361116
Vitronectin ECM gi 36573
* Laminin B ECM g i 126367
Lamnin a4 ECM gi 1869967
Decorin Sm. proteoglycan gi 6681143
Biglycan Sm.proteoglycan gi 348962
ECM associated protein SPARC-like gi 1498641
papilin ECM gi 18700030
Similar tenascin R ECM/Inliibition o f diffiii gi 28483364
"^ClarkeT- Chen "^*Chen
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Table 5.4 Potential novel adipokines identified in this study
Table 5.4
Novel secreted proteins
Protein score function Accession
number
Unnamed Prot product 326 Trypsin Inliib? g 12836422
CyC C-AP 348 SCY chemokine g 397800
Platelet factor 4/ CXCL4 84 SCY cytokine/chemotactic g 266800
Thrombospondin2 312 Adhesive glycoprotein g 6755779
Orosomucoid 273 Acute phase protein g 15215270
Selenium binding protein 117 Se/lipid binding g 134259 (NCS)
Sex limited protein 491 Acute-phase g 220604
ECM associated protein 154 SPARC-like g 1498641
HSP 90a 102 MMP2 activation g 41200885
HSP 70 377 Secreted HSP/cytokine g 72288
Fibulin-2 174 ECM g 4959705
Similar to Collagen XV 65 ECM g 34868476
Perlecan 92 ECM g 6680311
Versican 54 ECM g 21361116
Vitronectin 73 ECM g 73587073
Lamnin a 4 401 ECM g 1869967
Decorin 151 Sm. proteoglycan g 6681143
Biglycan 499 Sm. proteoglycan g 348962
N D PK B 84 ?same as I factor g 6679078
a-am ylase 67 Digestive enzyme g 67370
CyP-Sl 60 ? Chemotactic g 2118329TSC-36/FRP 52 Inhibition o f growth/diffn g 2498391
Nni23/I Factor 67 Inhibition o f diffn g 35068 toSerpin 3n 81 Serpin g 75765653
Leu. richa-2 glycoprotein 88 Secreted glycoprotein g 16418335
1 1 8
Chapter 6 Summary and Perspectives
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6 . 1  Secretion of ACRP30 in 3T3-L1 adipocytes
Adipocytes secrete a variety of proteins that are involved in metabolism, the immune 
response and cardiovascular function. Several of these adipokines have been studied and 
well characterised, including adipsin, TN F-a, leptin and ACRP30. Relatively little 
however, is known about the trafficking o f  these adipokines or about the mechanisms 
involved in their secretion. Unlike secretory neuroendocrine cells, there is no evidence for 
regulated secretion in adipocytes, other than the insulin-responsive trafficking o f GLUT4 
to the cell surface. No other secreted protein has been found sequestered in secretory 
vesicles, awaiting the stimulus that sends it to the extracellular environment, rather there 
appear to be many pathways o f secretory traffic to the cell surface in secretory cells (see 
Introduction Section 1.5.1). Insulin-stimulation of 3T3-L1 adipocytes causes only a modest 
increase in ACRP30 secretion (Figure 3.4), more in common with recycling o f the 
transfenin receptor than trafficking o f GLUT4. In specialised secretory cells, like 
neuroendocrine cells, Arvan et al. observed that in addition to secretion directly from the 
TGN to the PM, there is traffic o f secretory cargo from the TGN to ISGs and from there to 
the PM via the endosomal system. This led them to suggest that constitutive-like secretion 
involves two limbs: one from ISGs to endosomes and the other from endosomes to the PM.
By examining the intracellular distribution (Figure 3.5), and by disrupting trafficking 
through the TGN, by treatment with Brefeldin A (Figure 3.6) and trafficking through the 
endosomes by endosomal ablation(Figure 3.7), I have shown clear evidence that the 
adipokine ACRP30 is secreted in a constitutive-like pathway, in vesicles that traffic to the 
PM via the TGN and endosomes. This result parallels those fi'om previous investigations o f 
the secretory routes taken by other adipokines including leptin (Bradley et al., 2001) and 
adipsin (Yang and Mueckler, 1999).
I have also demonstrated roles for the small GTPases Rabl 1 and Arf6 in the trafficking o f 
ACRP30 to the PM in 3T3-L1 adipocytes. Rabl 1 is a small GTPase that controls vesicular 
trafficking between the endosomes and the PM. Overexpression o f the GDP-restricted 
Rabl 1-S25N mutant, reduced basal and insulin-stimulated secretion o f ACRP30, provides 
evidence that ACRP30 traffics via endosomes, on its way to the PM.
Overexpression o f GTP or GDP-restricted mutants o f small molecular weight GTPases in 
mammalian cells is a very useful tool for dissecting intracellular membrane trafficking. As
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a method it has been responsible for giving insight into the role o f the small GTPases 
throughout the cell (Ullrich et a l , 1996; Wilson et a l , 1994; Chavrier and Goud, 1999; 
Martinez et a l , 1997). Infecting adipocytes with adenovimses expressing these small 
GTPases can be problematic. Adipocytes are not as easy to infect as mammalian 
fibroblasts such as HeLa or CHO cells, and therefore much higher virus titers are needed 
for successful infection. There are however alternative approaches for looking at the role o f 
A rf and Rab proteins in the secretory pathway in 3T3-L1 adipocytes. The method of 
knocking down protein expression by small interfering RNAs (siRNA) has been used 
successfully in adipocytes (Mitra et a l ,  2004) and could be used in future experiments to 
further elucidate the role o f Rabl 1 and Arf6 in the secretory process in 3T3-L1 adipocytes. 
By knocking down Rabl 1 or Arf6, we could examine the effects on secretion o f ACRP30. 
There is evidence that some small GTPases work in close association with others. An 
example o f this is Rabl 1/Rab25. Using siRNA to knock down both o f these Rabs might 
give a clearer picture of how they are invovlved in ACRP30 secretion and GLUT4 
trafficking. I saw no effect on ACRP30 secretion by overexpressing ArfS wt and 
Arf5T31N. A rf 5 is also known to work closely with Arf4, and other gi’oups have shown 
tha tit is necessary to knock down Arfs 4 and 5 together to see a morphological effect 
within the cell. Using si RNA to knock down Arf4 and Arf5 in 3T3-L1 adipocytes may 
reveal a role for these in the trafficking o f secretory molecules in adipocytes.
Several Rabl 1 effector molecules have been identified, belonging to the Rabl 1 family o f 
interacting proteins (FIP), that appear to have distinct roles in regulating membrane traffic 
between the recycling endosomes and the PM (Prekeris, 2003). The role o f Rabl 1 effector 
molecules in lecycling is an area that could be investigated in 3T3-L1 adipocytes, by using 
techniques such as expression knockdown by si RNAs and immunofluorescence.
As more adipokines are identified, it becomes more important to understand the 
mechanisms controlling their secretion. As obesity progresses, adipocytes become larger 
and display an altered pattern o f secretion. Some adipokines exhibit increased secretion 
and others are reduced. This study has revealed information about the pathway taken by 
adiponectin from its synthesis to its secretion, and the role o f certain GTPases in regulating 
that secretion. Very little is yet known about the control o f secretion o f the various 
adipokines and why there is a difference in the expression o f adipokines from anti­
inflammatory to pro-inflammatory with progression o f obesity and increase in adipocyte 
size. Using some o f the teclmiques employed in this study, it will be possible to investigate 
the mechanisms o f secretion of other adipokines, including several o f those potential new 
adipokines identified in this work, and by illustrating the molecules and mechanisms that
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are involved in secretion, so identify potential pharmacological targets in the adipocyte 
secretory pathway.
6 . 2  Secreted proteins -  novel adipokines?
In a detailed proteomic screen o f  the secreted proteins of mature day 10 3T3-L1 
adipocytes, a number o f proteins were identified as potential new adipokines with several 
o f them exhibiting effects in flinctional assays. The screen has identified two secreted 
proteins, not pieviously been identified as being secreted by adipocytes, orosomucoid and 
Nm23 that significantly affect insulin-stimulated glucose uptake. In addition, orosomucoid 
exhibited anti-inflammatory properties by decreasing monocyte adhesion to human 
vascular endothelial cells. LRGl and HSP90 appeared to have a small but statistically 
significant effect on Oil Red O uptake in differentiating 3T3-L1 adipocytes, suggesting 
that treatment with these recombinant proteins increased differentiation. Lysates made 
fi'om eel Is treated with LRGl and HSP90a during differentiation showed no obvious 
increase in expression o f C/EBPa. Treatment with recombinant PF4 may cause an increase 
in expression o f C/EBPa.
A large number o f the adipocyte-secreted proteins identified are ECM or ECM associated 
proteins and I have identified several ECM and ECM associated proteins that have not 
previously been identified as adipocyte secreted proteins. These include collagens and the 
adhesive proteins that make up the basal lamina, and the small leucine-rich proteoglycans, 
decorin and biglycan. A picture emerges from the list o f ECM and ECM associated 
pioteins o f a complex environment surrounding the cells, Adipocytes secrete matrix 
pioteins like collagen and laminin and adhesive proteins in order that they can attach to the 
matrix. They also secrete proteases and metalloproteinases that modify the matrix, 
allowing for cell movement and the release o f growth factors. Finally, they secrete protease 
inhibitors, which control the action o f the proteases. The regulation o f  secretion o f each o f 
these proteins is vital during the development and normal function o f healthy tissue, and a 
loss o f this balance has been associated with various states o f disease: Matrix 
metalloproteinases (MMPs) are endoproteinases that are involved in ECM remodelling. 
Extracellular HSP90a is involved in the maturation o f MMP2, and through this action 
promotes the invasion o f cancer cells through the ECM (Eustace et al., 2004b). It is 
possible that H SP90a secreted by fat cells assists the remodelling o f adipose tissue in the 
same way. Metalloproteinases and their inhibitors have been implicated as factors in 
tumour cell migiation, angiogenesis and atherosclerosis Reviewed in (Bomstein and Sage,
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2002). Evidence suggests that the ECM, through its interaction with cytokines and 
proteases, provides signals for the recruitment o f monocytes during their recruitment to 
sites o f inflammation (Vaday and Eider, 2000). The development of adipose tissue depends 
not only upon the development o f a supporting matrix but also on the means to remodel 
that matrix, since as fat tissue mass increases, so does the requirement for blood vessel 
development, and a vital step of angiogenesis is the degradation o f connective tissue by 
secreted pro teases. A possible future direction for study in this area might be to search, 
using a process called positional proteomics that relies on the recovery and analysis o f N- 
terminal proteolytic peptides (McDonald et a l , 2005), for peptides that have been 
generated by proteolysis as they are secreted from the cell
This might help to build a picture of the role o f the proteases that are secreted and might 
reveal more about how they are involved in remodelling o f the extracellular environment. 
Obesity is also marked by infiltration of fat tissue by macrophages, a process that also 
requires matrix remodelling. It has been suggested that angiogenesis could be a target for 
future therapy and that inhibitors of angiogenesis and matrix protease inhibitors might be 
employed as anti-obesity therapy
Several of the novel secreted proteins identified are known to be involved in inflammation, 
either as acute-phase proteins or pro-inflammatory cytokines. Obesity is characterised by a 
state of inflammation and an accumulation o f macrophages in adipose tissue, and these 
macrophages contribute to the insulin resistant state that is associated with obesity and type 
2 diabetes (Xu et a l ,  2003). With inflammation playing such a strong role in the 
development o f diabetes, these adipocyte-secreted inflammatory proteins may help to 
elucidate the mechanisms that link obesity, insulin resistance and diabetes.
Orosomucoid exhibited anti-inflammatory effects on endothelial cells, resulting in reduced 
adhesion o f U937 cells. There are reports of the anti-inflammatory effects o f orosomucoid 
in various assays but the mechanisms by which it elicits these effects are unclear. Results 
from other laboratories suggest that the anti-inflammatory effect is dependent on the 
glycosylation o f the protein and that its carbohydrate chains may be ligands for cell 
adhesion molecules and therefore compete with the ligands on the U937 cells. If this is the 
reason for the anti-inflammatory effects o f orosomucoid, then it should be possible to 
observe an effeet without having to pre-incubate endothelial cells with the protein for 4h. 
TN F-a stimulates monocyte adhesion to endothelial cells by activation of the IkB /N F kB 
signalling cascade, resulting in increased expression of cell surface adhesion molecules. 
Future experiments might test the hypothesis that orosomucoid interferes with this
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signalling. This could be done by assaying NFkB-mediated transcriptional activation. 
Another approach might be to determine, by flow cytometry, whether orosomucoid affects 
the expression of cell surface adhesion molecules such as VCAM-1 and IC A M -1. The anti­
inflammatory effect was seen using orosomucoid at Img/mL and under inflammatory 
conditions orosomucoid is found circulating in serum at concentrations up to 3mg/mL. 
Future experiments should measure any dose-dependent effects. As orosomucoid is a 
potential anti-inflammatory adipokine, future studies might involve investigating its 
therapeutic possibilities by administering it to animal models o f diabetes and obesity.
The heat shock proteins HSP70 and HSF90a, which were both found to be secreted by 
3T3-L1 adipocytes, had no significant effects in the functional assays, at the concentrations 
tested. Further experiments are required to establish the role o f these extracellular heat 
shock proteins. HSP 70, HSP90 and orosomucoid were all identified, by Western blotting, 
in the serum from lean and fatty Zucker rats and appeared to circulate in higher 
concentrations in fatty semm. This increase is suggestive o f a role for these proteins in 
obesity and future work should involve an examination o f the levels o f these adipokines in 
human populations. A detennining factor o f adipokines is that their semm levels correlate 
with factors associated with insulin resistance or type 2 diabetes and therefore it will be 
important to determine whether serum levels con'elate with obesity or insulin resistance.
All o f the proteins that have exhibited an effect in these functional assays should be studied 
further. It will be important to investigate the mechanisms, by which they are acting, to 
find out how, as extracellular proteins, they bring about intracellular changes. Wliat are the 
signalling pathways that are involved? How do the serum levels o f these secreted proteins 
in nonnal individuals compare with that o f patients with diseases such as obesity and Type 
II diabetes? These are all possible future directions for this project.
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Publications arising from the work in this thesis;
Syntaxin6 regulates GLUT4 trafficking in 3T3-L1 adipocytes (Perera et al., 2003),
Evidence o f a role for the exocyst in insulin-stimulated GLUT4 trafficking in 3T3-L1 
adipocytes (Ewart et ah, 2005),
ACRP30 is secreted fi'om 3T3-L1 adipocytes via a Rab 11-dependent pathway(Clarke et 
ah, 2006)
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